<SEC-DOCUMENT>0001628280-24-019056.txt : 20240429
<SEC-HEADER>0001628280-24-019056.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429165425
ACCESSION NUMBER:		0001628280-24-019056
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20240429
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			X4 Pharmaceuticals, Inc
		CENTRAL INDEX KEY:			0001501697
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				273181608
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38295
		FILM NUMBER:		24892153

	BUSINESS ADDRESS:	
		STREET 1:		61 NORTH BEACON STREET
		STREET 2:		4TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02134
		BUSINESS PHONE:		857-529-8300

	MAIL ADDRESS:	
		STREET 1:		61 NORTH BEACON STREET
		STREET 2:		4TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02134

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Arsanis, Inc.
		DATE OF NAME CHANGE:	20100920
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2024def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if48504d5cdfb4b02afccfa7e833b9374_1"></div><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.728%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A INFORMATION</font></div><div style="margin-top:3pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section&#160;14(a) of the</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</font></div><div style="text-align:center"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.305%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed by a Party other than the Registrant&#160;&#160;&#9744;</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.299%"><tr><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Preliminary Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9746;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Definitive Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Definitive Additional Materials</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Soliciting Material Pursuant to &#167;&#160;240.14a-12</font></td></tr></table></div><div style="margin-top:1pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">X4 Pharmaceuticals, Inc.</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified In Its Charter)</font></div><div style="margin-top:16pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of filing Fee (Check the appropriate box)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9746;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No fee required.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fee paid previously with preliminary materials.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rule 14a-6(i)(1) and 0-11</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_4"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:5pt"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">X4 PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">61 North Beacon Street, 4</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Floor</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Boston, Massachusetts 02134</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held On June 10, 2024</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder of X4 Pharmaceuticals, Inc.&#58;</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2024 Annual Meeting of Stockholders of X4 Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;). The Annual Meeting will be held on Monday, June 10, 2024 at 12&#58;00 p.m. Eastern Time at the offices of Goodwin Procter LLP, 100 Northern Avenue, 17th Floor, Boston, Massachusetts 02210.  The Annual Meeting will be held for the following purposes&#58;</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;To elect the three (3) nominees named in the accompanying proxy statement (the &#8220;Proxy Statement&#8221;), David McGirr, M.B.A&#59; Paula Ragan, Ph.D.&#59; and Michael S. Wyzga, to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified until their earlier death, resignation or removal.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&#160;31, 2024.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160; To hold a non-binding advisory &#8220;say-on-pay&#8221; vote on our named executive officer compensation.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">4. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">   To conduct any other business properly brought before the Annual Meeting.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These items of business are more fully described in the Proxy Statement accompanying this Notice.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The record date for the Annual Meeting is April&#160;15, 2024. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment or postponement thereof. A list of stockholders entitled to vote at the Annual Meeting will be available at our principal executive offices for examination during normal business hours by any stockholder for any purpose germane to the Annual Meeting for a period of ten days ending the day prior to the Annual Meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By Order of the Board of Directors,</font></div><div style="margin-top:12pt"><img alt="adamsignature.jpg" src="adamsignature.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:204px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.202%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Adam Mostafa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer, Treasurer and Corporate Secretary</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2024</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_7"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;padding-right:6.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.172%"><tr><td style="width:1.0%"></td><td style="width:2.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">You are cordially invited to attend the Annual Meeting. Whether or not you expect to attend the Annual Meeting, please vote by telephone or through the Internet, or, if you receive a paper proxy card by mail, by completing and returning the proxy card mailed to you, as promptly as possible in order to ensure your representation at the Annual Meeting. Voting instructions are provided in the Notice of Internet Availability of Proxy Materials, or, if you receive a paper proxy card by mail, the instructions are printed on your proxy card and included in the accompanying Proxy Statement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Even if you have voted by proxy, you may still vote in person if you attend the Annual Meeting. Please note, however, that if your shares are held of record by a brokerage firm, bank or other agent and you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from that agent in order to vote your shares that are held in such agent&#8217;s name and account.</font></div><div><font><br></font></div></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_10"></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Page</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_13" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PROPOSAL 1 ELECTION OF DIRECTORS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_16" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Independence of the Board of Directors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_22" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board Leadership Structure</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_25" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Role of the Board in Risk Oversight</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_28" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Meetings of the Board of Directors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_31" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Information Regarding Committees of the Board of Directors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_34" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:60pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Audit Committee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_37" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:60pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Committee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_40" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:60pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nominating and Corporate Governance Committee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_43" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Communications with the Board of Directors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_46" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code of Ethics</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_49" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">PROPOSAL 2 RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_52" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PROPOSAL 3 NON-BINDING ADVISORY VOTE ON </a><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NAMED </a><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EXECUTIVE </a><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OFFICER </a><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COMPENSATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_55" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_64" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EXECUTIVE OFFICERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_64" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_67" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PRINCIPAL S</a><a href="#if48504d5cdfb4b02afccfa7e833b9374_67" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">TOCKH</a><a href="#if48504d5cdfb4b02afccfa7e833b9374_67" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_67" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_70" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EXECUTIVE COMPENSATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_70" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Summary Compensation Table</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_73" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outstanding Equity Awards at Fiscal Year-End</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Narrative to Summary Compensation Table</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_79" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director Compensation Table</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_85" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">32</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Narrative to Director Compensation Table</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_88" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_91" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_91" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">35</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_94" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_97" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Related-Person Transactions Policy and Procedures</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_97" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Related-Person Transactions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_100" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_103" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">37</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">HOUSEHOLDING OF PROXY MATERIALS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_106" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#if48504d5cdfb4b02afccfa7e833b9374_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OTHER MATTERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><a href="#if48504d5cdfb4b02afccfa7e833b9374_109" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:none">39</a></font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_13"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">X4 PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">61 North Beacon Street, 4</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Floor</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Boston, Massachusetts 02134</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June&#160;10, 2024</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">When are this Proxy Statement and the accompanying materials scheduled to be sent to stockholders&#63; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have elected to provide access to our proxy materials to our stockholders via the Internet. Accordingly, on or about April 29, 2024, we will begin mailing the Notice of Availability. Our proxy materials, including the Notice of the 2024 Annual Meeting of Stockholders, this Proxy Statement and the accompanying proxy card or, for shares held in street name (i.e., held for your account by a broker, bank or other nominee), a voting instruction form, and the 2023 Annual Report to Stockholders (the &#8220;2023 Annual Report&#8221;), will be mailed or made available to stockholders on the Internet on or about the same date. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Why did I receive</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">a notice regarding the availability of proxy materials on the Internet&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to rules adopted by the Securities and Exchange Commission (the &#8220;SEC&#8221;), we have elected to provide access to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;) because the Board of Directors (the &#8220;Board&#8221;) of X4 Pharmaceuticals, Inc. (sometimes referred to as the &#8220;Company&#8221; or &#8220;X4&#8221;) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;), including at any adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Will I receive any other proxy materials by mail&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We may elect, in our discretion, to send you a proxy card, along with a second Notice, on or after ten calendar days have passed since our first mailing of the Notice.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How do I attend the Annual Meeting&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Annual Meeting will be held in person on Monday, June 10, 2024 at 12&#58;00 p.m. Eastern Time at the offices of Goodwin Procter LLP, 100 Northern Avenue, 17th Floor, Boston, Massachusetts 02210. Directions to the Annual Meeting may be found at https&#58;&#47;&#47;materials.proxyvote.com. Information on how to vote in person at the Annual Meeting is discussed below.</font></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Who can vote at the Annual Meeting&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Only stockholders of record at the close of business on April&#160;15, 2024 will be entitled to vote at the Annual Meeting. On this record date, there were 167,937,781 shares of common stock outstanding and entitled to vote. A list of stockholders entitled to vote at the Annual Meeting will be available at our principal executive offices for examination during normal business hours by any stockholder for any purpose germane to the Annual Meeting for a period of ten days ending the day prior to the Annual Meeting.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Stockholder of Record&#58; Shares Registered in Your Name</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If on April 15, 2024, your shares were registered directly in your name with our transfer agent, Computershare Trust Company, N.A., then you are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy prior to the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy electronically through the Internet, over the telephone or by completing and returning a printed proxy card that you may request or that we may elect to deliver at a later time to ensure your vote is counted.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Beneficial Owner&#58; Shares Registered in the Name of a Broker or Bank</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If on April&#160;15, 2024,&#160;your shares were held not in your name but rather in an account at a brokerage firm, bank or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and the Notice is&#160;being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker, bank or other agent.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">What am I voting on&#63;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">There are three matters scheduled for a vote&#58;</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">Election of three (3) directors to hold office until the 2027 Annual Meeting of Stockholders (Proposal 1)&#59;</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">Ratification of selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2024 (Proposal 2)&#59; and</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">Non-binding advisory &#8220;say-on-pay&#8221; vote on our named executive officer compensation (Proposal 3)&#59;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">What if another matter is properly brought before the Annual Meeting&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How do I vote&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With respect to Proposal 1, you may either vote &#8220;FOR ALL&#8221;  the nominees to the Board, &#8220;WITHHOLD ALL&#8221; for the nominees, or you may vote &#8220;FOR ALL EXCEPT&#8221; any nominee you specify. With respect to Proposals 2 and 3, you may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or abstain from voting. </font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The procedures for voting are as follows&#58;</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Stockholder of Record&#58; Shares Registered in Your Name</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy through the Internet, vote by proxy over the telephone, or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person even if you have already voted by proxy.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive.</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">To vote through the Internet before the Annual Meeting, go to</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> www.proxyvote.com </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to complete an electronic proxy card. You will be asked to provide the</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> 16-digit c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ontrol number from the Notice. Your Internet vote must be received by 11&#58;59 p.m., Eastern Time, on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">June&#160;9, 2024 to be counted.</font></div><div style="margin-bottom:6.08pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">To vote over the telephone from a location in the United States, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the control number from the Notice. Your telephone vote must be received by 11&#58;59 p.m., Eastern Time, on June&#160;9, 2024 to be counted.</font></div><div style="margin-bottom:6.08pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">To vote by using a printed proxy card that may be delivered to you, simply complete, sign and date the proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Beneficial Owner&#58; Shares Registered in the Name of Broker or Bank</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from us. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact that organization to request a proxy form.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6.1pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from internet access providers and telephone companies.</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How many votes do I have&#63;</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On each matter to be voted upon, you have one vote for each share of common stock you own as of April&#160;15, 2024.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you are a stockholder of record and do not vote by completing a proxy card, by telephone, through the Internet&#160;or in person  at the Annual Meeting, your shares will not be voted.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;FOR&#8221; the election of each nominee for director, &#8220;FOR&#8221; the ratification of the selection of our independent registered public accounting firm, and &#8220;FOR&#8221; the non-binding advisory vote on &#8220;say-on-pay&#8221;. If any other matter is properly presented at the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you are a beneficial owner of shares held in street name and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion. In this regard, under the rules of the New York Stock Exchange (&#8220;NYSE&#8221;), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to&#160;&#8220;non-routine&#8221;&#160;matters. In this regard, each of Proposals 1 and 3 are considered to be&#160;&#8220;non-routine&#8221;&#160;under NYSE rules meaning that your broker may not vote your shares on this proposal in the absence of your voting instructions. However, Proposal 2 is considered to be a &#8220;routine&#8221; matter under NYSE rules, meaning that if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposal 2. Accordingly, if you own shares through a nominee, such as a broker, bank or other agent, please be sure to instruct your nominee how to vote to ensure that your vote is counted on all of the proposals.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">If you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%;text-decoration:underline">must</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">&#160;provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Who is paying for this proxy solicitation&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies.&#160;We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">What does it mean if I receive more than one Notice&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each of the Notices to ensure that all of your shares are voted.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Can I change my vote after submitting my proxy&#63;</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Stockholder of Record&#58; Shares Registered in Your Name</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">You may submit another properly completed proxy card with a later date (which automatically revokes the earlier proxy).</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">You may grant a subsequent proxy by telephone or through the Internet.</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">You may send a timely written notice that you are revoking your proxy to our Corporate Secretary at 61 North Beacon Street, 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;Floor, Boston, Massachusetts 02134.</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy.</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Your most current proxy card or telephone or Internet proxy is the one that is counted.</font></div><div style="margin-top:18pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Beneficial Owner&#58; Shares Registered in the Name of Broker or Bank</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">When are stockholder proposals and director nominations due for next year&#8217;s annual meeting&#63;</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To be considered for inclusion in next year&#8217;s proxy materials, your proposal must be submitted in writing by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> December&#160;30, 2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, to our Corporate Secretary, c&#47;o X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;Floor, Boston, Massachusetts 02134.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our bylaws also establish an advance notice procedure if you wish to present a proposal (including a director nomination) before an annual meeting of stockholders but you are not requesting that your proposal or nomination be included in next year&#8217;s proxy materials. To be timely for our 2025 Annual Meeting of Stockholders, our Corporate Secretary must receive the written notice at our principal executive offices not later than the close of business on March 12, 2025 nor earlier than the close of business on February 10, 2025. However, if we hold our 2025 Annual Meeting of Stockholders more than 30 days before or 60 days after June&#160;10, 2025 (the&#160;one-year&#160;anniversary date of the 2024 Annual Meeting of Stockholders), then timely notice of a stockholder proposal that is not intended to be included in our Proxy Statement must be received not earlier than the close of business on the 120th day prior to the 2025 Annual Meeting of Stockholders and not later than the close of business on the later of (a)&#160;the 90th day prior to the 2025 Annual Meeting of Stockholders and (b)&#160;the 10th day following the day on which the one of the following first occurs&#58; (i)&#160;mailing of notice of the date of the 2024 Annual Meeting of Stockholders and (ii)&#160;the first public announcement of the date of the 2025 Annual Meeting of Stockholders. You are also advised to review our bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. In addition, to comply with the SEC&#8217;s new universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice by the same deadline noted herein and also comply with the additional requirements of Rule 14a-19(b). </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How are votes counted&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each holder of common stock is entitled to one vote for each share held by such stockholder as of the record date on each matter to come before the Annual Meeting, including the election of a director. Votes cast during the Annual Meeting or by proxy by mail, via the Internet or by telephone will be tabulated by the inspector of election appointed for the Annual Meeting, who will also determine whether a quorum is present. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under our bylaws, any proposal, other than an election of directors, is decided by a majority of the votes properly cast for and against such proposal, except where a larger vote is required by law or by our certificate of incorporation or bylaws. Abstentions and broker &#8220;non-votes&#8221; are not included in the tabulation of the voting results on any such proposal and, therefore, do not have an impact on such proposals. A broker &#8220;non-vote&#8221; occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item, and has not received instructions from the beneficial owner.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, for the proposal to elect directors (Proposal 1), votes &#8220;For,&#8221; &#8220;Withhold&#8221; and broker&#160;non-vote,&#160;with respect to Proposals 2 and 3, votes &#8220;For,&#8221; &#8220;Against&#8221; and abstentions.&#160;Abstentions and broker non-votes for Proposals 2 and 3 will have no effect and will not be counted towards the vote total. Votes withheld and broker&#160;non-votes&#160;on Proposal 1 will have no effect and will not be counted towards the vote total for this proposal.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">What are &#8220;broker&#160;non-votes&#8221;&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed above, when a beneficial owner of shares held in &#8220;street name&#8221; does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be&#160;&#8220;non-routine&#8221;&#160;under NYSE rules, the broker, bank or other such agent cannot vote the shares. These&#160;unvoted&#160;shares are counted as &#8220;broker&#160;non-votes.&#8221;&#160;Each of Proposals 1 and 3 is considered to be&#160;&#8220;non-routine&#8221;&#160;under NYSE rules and we therefore expect broker&#160;non-votes&#160;to exist in connection with that proposal.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%;text-decoration:underline">must</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">&#160;provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How many votes are needed to approve each proposal&#63;</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker&#160;non-votes.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.660%"><tr><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.875%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Proposal<br>Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Proposal Description</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Vote Required for Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Effect of<br>Abstentions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Effect of Broker<br>Non-Votes</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Election of directors</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The three nominees receiving the most &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8221; votes from the holders of shares, either present at the meeting or represented by proxy, and entitled to vote on the election of directors will be elected&#59; withheld votes will have no effect.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Not applicable</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No effect</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December&#160;31, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8221; votes from the holders of shares representing a majority of the voting power of the shares of common stock of the Company, either present at the meeting or represented by proxy, and entitled to vote on the matter.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No effect</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Non-binding advisory &#8220;say-on-pay&#8221; vote on named executive officer compensation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8221; votes from the holders of shares representing a majority of the voting power of the shares of common stock of the Company, either present at the meeting or represented by proxy, and entitled to vote on the matter.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No effect</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No effect</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proposal 2 is considered to be a &#8220;routine&#8221; matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other agent has discretionary authority under NYSE rules to vote your shares on this proposal.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">What is the quorum requirement&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders&#160;holding&#160;at least a majority in voting power of the outstanding shares entitled to vote are present at the Annual Meeting in person or represented by proxy. On the record date, there were 167,937,781 shares&#160;outstanding and entitled to vote.&#160;Thus, the holders of&#160;83,968,892 shares must be present in person or represented by proxy at the Annual Meeting to have a quorum.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker&#160;non-votes&#160;will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">How can I find out the results of the voting at the Annual Meeting&#63;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form&#160;8-K&#160;that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a&#160;Form&#160;8-K&#160;within four business days after the Annual Meeting, we intend to file a&#160;Form&#160;8-K&#160;to publish preliminary results and, within four business days after the final results are known to us, file an additional&#160;Form&#160;8-K&#160;to publish the final results.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_16"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">PROPOSAL&#160;1</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">LECTION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Board is divided into three classes. Each class consists, as nearly as possible, of&#160;one-third&#160;of the total number of directors, and each class has a three-year term. Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors. A director elected by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#8217;s successor is duly elected and qualified.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board presently has eight members. There are three directors in the class whose term of office expires at our Annual Meeting&#58; David McGirr, M.B.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Paula Ragan, Ph.D., and Michael S. Wzyga.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> If elected at the Annual Meeting, each of these nominees would serve until the 2027 annual meeting and until his or her successor has been duly elected and qualified, or, if sooner, until the director&#8217;s death, resignation or removal. It is our policy that all directors and nominees for director make every effort to attend the Annual Meeting. All of the then-serving directors</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">attended the 2023 Annual Meeting of stockholders. </font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Vote Required</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Directors are elected by a plurality of the votes of the holders of shares present in person or by remote communication, as applicable, or represented by proxy and entitled to vote on the election of directors. Accordingly, the three nominees receiving the highest number of affirmative votes will be elected.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the three nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election of a substitute nominee proposed by us. Each person nominated for election has agreed to serve if elected. We have no reason to believe that any nominee will be unable to serve.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Director Nominees and Continuing Directors</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following is a brief biography and the ages of each nominee and each director whose term will continue after the Annual Meeting, and a discussion of the specific experience, qualifications, attributes or skills of each nominee that led the Nominating and Corporate Governance Committee to recommend that person as a nominee for director, as of the date of this Proxy Statement.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">There are no family relationships between or among any of our directors or nominees. There is no arrangement or understanding between any of our directors or nominees and any other person or persons pursuant to which he or she is to be selected as a director or nominee.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">There are no legal proceedings to which any of our directors is a party adverse to us or any of our subsidiaries or in which any such person has a material interest adverse to us or any of our subsidiaries.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Nominees for Election as a Class&#160;I Directors Continuing in Office Until the 2027 Annual Meeting of Stockholders</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">David McGirr, M.B.A.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">age 69, became a member of the board of directors of Arsanis, Inc. in September 2017 and continues to serve as a member of our Board upon the completion of our merger, between Arsanis, Inc. and the Company, in March 2019. From March 2013 until June 2014, Mr.&#160;McGirr was Senior Advisor to the chief executive officer of Cubist Pharmaceuticals, Inc., a biopharmaceutical company where he also served as Senior Vice President and Chief Financial Officer from November 2002 to March 2013. Prior to joining Cubist in 2002, Mr.&#160;McGirr was the President and Chief Operating Officer of Hippo Inc., a venture-financed internet technology company. From 1996 to 1999, he was the President of GAB Robins North America, Inc., a risk management company, serving also as Chief Executive Officer from 1997 to 1999. Mr.&#160;McGirr was a private equity investor from 1995 to 1996. From 1978 to 1995, Mr.&#160;McGirr served in various positions within the S.G. Warburg Group, ultimately as Chief Financial Officer, Chief Administrative Officer and Managing Director of S.G. Warburg&#160;&#38; Co., Inc., a position held from 1992 to 1995. Mr.&#160;McGirr is currently a member of the board of directors of Insmed Incorporated, a publicly traded biopharmaceutical company, where he has served since October 2013, and Rhythm Pharmaceuticals, Inc., a publicly traded biopharmaceutical company, where he has served since November 2015. Mr.&#160;McGirr previously served on the board of directors of Roka Bioscience, Inc., a molecular diagnostics company, from </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">December 2013 to January 2018 and Menlo Therapeutics Inc., a publicly traded biopharmaceutical company, from November 2017 until its merger with Foamix Pharmaceuticals, Ltd., another publicly traded biopharmaceutical company, in March 2019. Mr.&#160;McGirr received a B.Sc. in Civil Engineering from the University of Glasgow and received an M.B.A. from The Wharton School at the University of Pennsylvania. We believe that Mr.&#160;McGirr&#8217;s extensive experience with public and private pharmaceutical companies provides him with the qualifications and skills to serve on our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Paula Ragan, Ph.D.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, age 54, has served as our President, Chief Executive Officer, Secretary and a member of our Board since July 2014. Prior to joining us, from August 2012 to September 2014, Dr.&#160;Ragan consulted as Chief Business Officer at Lysosomal Therapeutics Inc., a private biopharmaceutical company, where she led the company&#8217;s business development activities.&#160;Prior to then, from January 2007 to August 2012, Dr.&#160;Ragan held leadership roles in corporate development and operations at Genzyme Corporation, a Sanofi company, where she led strategic partnering efforts for Genzyme&#8217;s Rare Disease business and headed the supply chain planning for Genzyme&#8217;s flagship commercial products. Other professional roles include business roles at Hydra Biosciences, Oscient Corporation and Celera Corporation. Dr.&#160;Ragan received her B.S. from Tufts University and her Ph.D. from Massachusetts Institute of Technology and completed post-doctoral studies at Harvard Medical School.&#160;We believe that Dr.&#160;Ragan&#8217;s perspective and experience as our President and Chief Executive Officer, which provides the Board with historic knowledge, operational expertise and continuity, provides her with the qualifications and skills to serve on our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Michael S. Wyzga</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, age 69, became a member of the board of directors of X4 Pharmaceuticals, Inc., a private company, in July 2018 and continues to serve as a member of our Board and our Chairman following the completion of the Merger in March 2019. Mr.&#160;Wyzga is currently the President of MSW Consulting Inc., a strategic consulting group focused in the life sciences area. From December 2011 until November 2013, Mr.&#160;Wyzga served as President and Chief Executive Officer and a member of the board of directors of Radius Health, Inc., a publicly traded biopharmaceutical company. Prior to that, Mr.&#160;Wyzga served in various senior management positions at Genzyme Corporation, a publicly traded global biotechnology company. Mr.&#160;Wyzga joined Genzyme in February 1998 and most recently served as Executive Vice President, Finance from May 2003 until November 2011 and as Chief Financial Officer from July 1999 until November 2011. Mr.&#160;Wyzga is also a member of the boards of directors of Exact Sciences Corporation, a publicly traded medical technology company, where he has served since February 2015&#59; LogicBio Therapeutics, Inc., a publicly traded genetic medicines company, where he has served since September 2018&#59; GenSight Biologics S.A., a Euronext traded biopharmaceutical company, where he has served since February 2016 and currently holds the position as Chairman of the Board of Directors&#59; and Invivyd, Inc. a publicly traded biopharmaceutical company since June 2022 and currently holds the position of chair of the audit committee and member of the compensation committee. He previously served at Mereo BioPharma Group plc (formerly Oncomed Pharmaceuticals, Inc.), where he served from October 2013 through the business combination in April 2019 and Akebia Therapeutics, Inc., a publicly traded biopharmaceutical company, from February 2014 to December 2018. He received an M.B.A. from Providence College and a B.S. from Suffolk University. We believe that Mr.&#160;Wyzga&#8217;s senior management experience at biopharmaceutical and biotechnology companies, his current and past experience on boards of directors of public companies, and his financial expertise qualify him to serve as a member of our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A V</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OTE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AVOR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ACH</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AMED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMINEE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Class&#160;II Directors Continuing in Office Until the 2025 Annual Meeting of Stockholders</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">William E. Aliski, MPA</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 76, has served as a member of our Board since September 2019. Since 2011, Mr.&#160;Aliski has served as an independent consultant to life sciences companies focused on orphan diseases. Prior to 2011, he served as Chief Commercial Officer for FoldRX Pharmaceuticals, an early stage company purchased by Pfizer in 2011, served as General Manager for Biomarin Europe, a biopharmaceutical company focused on rare diseases with genetic causes, and held executive level positions at Transkaryotic Therapies (TKT)&#47;Shire and Genzyme Corp., both biopharmaceutical companies. Previously, Mr.&#160;Aliski served as a member of the boards of directors of Ultragenyx Pharmaceutical, Inc. from January 2011 until June 2022 and Applied Genetic Therapies Corporation from November 2018 until 2023. Mr.&#160;Aliski holds a M.P.A. from Harvard University and a Master of Social Planning from Boston College. We believe that Mr.&#160;Aliski&#8217;s experience, in both consulting and operational roles, with life sciences companies focused on orphan diseases, as well as his public company board experience, qualify him to serve on our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Alison Lawton</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 62, has served as a member of our Board since October 5, 2020. Ms. Lawton is an executive leader with more than 35 years of experience in biopharma and most recently served as the President and Chief Executive Officer of Kaleido Biosciences from August 2018 to June 2020, and prior to then as its President and Chief Operating Officer from December 2017 to August 2018. Prior to joining Kaleido Biosciences, Ms. Lawton served as Chief Operating Officer at Aura Biosciences, Inc., an oncology therapeutics company, from January 2015 until December 2017, and, prior to joining Aura, served as a consultant to Aura from March 2014 to December 2014. Before that, Ms. Lawton served as Chief Operating Officer at OvaScience, Inc., a life sciences company, from January 2013 to January 2014. In addition, from 2014 to 2017, Ms. Lawton served as a biotech consultant for various companies, including as a part-time Chief Operating Officer consultant to the Company from 2014 to 2016. Prior to that, Ms. Lawton spent more than 20 years in various positions of increasing responsibility at Genzyme Corporation, a global biopharmaceutical company, and subsequently at Sanofi S.A., also a global biopharmaceutical company, following the acquisition of Genzyme by Sanofi in 2011. Ms. Lawton currently serves as a member of the board of directors of ProQR Therapeutics N.V., a publicly traded biotechnology company, Dianthus Therapeutics (formerly Magenta Therapeutics), a publicly traded biotechnology company and three other nonpublic companies. Ms. Lawton previously served as a member of the board of directors of Verastem Inc., from 2012 to 2020, CoLucid Pharmaceuticals, Inc. from 2016 until its acquisition by Eli Lilly in 2017, Cubist Pharmaceuticals until its acquisition by Merck &#38; Co and Spyre Therapeutics (formerly Aeglea Biotherapeutics) from November 2023 to January 2024. She holds a B.Sc. in pharmacology from Kings College, University of London. We believe that Ms. Lawton&#8217;s experience as a senior executive in the pharmaceutical and biotechnology industries qualify her to serve on our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">R. Keith Woods,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> age 56, has served as a member of our Board since September 2023. From 2018 to 2022, Mr. Woods served as Chief Operating Officer of argenx, a company focused on rare diseases, where he helped lead argenx through its transition from a research and development organization to a global commercial organization. Following his retirement from argenx, Mr. Woods continues to serve as an advisor to the argenx Board of Directors. Beginning in December 2023, Mr. Woods still currently serves as a member of the Board of Directors of Neurogene, a publicly traded biotechnology company, Rocket Pharmaceuticals, a publicly traded biotechnology company, and TScan Therapeutics, a publicly traded biopharmaceutical&#160;&#160;&#160;&#160; company. Mr. Woods previously served in a variety of roles at Alexion Pharmaceuticals, including Vice President and Managing Director of Alexion UK, overseeing all aspects of Alexion&#8217;s UK business, and Vice President, U.S. operations, ending his tenure there as Senior Vice President of North America Business Operations. Prior to that, he spent more than two decades in roles of increasing responsibility at Roche, Amgen, and Eisai. Mr. Woods a Bachelor of Science degree from Florida State University. We believe that Mr. Woods&#8217;s experience with research and development and commercialization efforts as well as his focus on rare diseases qualifies him to serve on our Board.   </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Class&#160;III Directors Continuing In Office Until the 2026 Annual Meeting of Stockholders</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gary J. Bridger, Ph.D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 61, became a member of the board of directors of X4 Pharmaceuticals, Inc., a private company, in October 2018 and continues to serve as a member of our Board upon the completion of our merger, between Arsanis, Inc. and the Company, in March 2019. From February 2015 to December 2017, Dr.&#160;Bridger served as a consultant to Xenon Pharmaceuticals Inc., a biopharmaceutical company, where he previously served as the Executive Vice President of Research and Development from January 2013 to February 2015. From October 2013 to October 2015, Dr.&#160;Bridger served as a Managing Director at Five Corners Capital Inc. From June 2010 to June 2012, Dr.&#160;Bridger served as a venture partner at Venture West Capital Management, a venture capital firm. From November 2006 to December 2007, Dr.&#160;Bridger served as Senior Vice President of Research and Development of Genzyme Corporation, a biotechnology company, which was acquired by Sanofi, S.A. In June 1996, Dr.&#160;Bridger co-founded&#160;AnorMED Inc., a biopharmaceutical company, and was its Vice President of Research and Development and Chief Scientific Officer from 2000 until its acquisition by Genzyme in November 2006. Dr.&#160;Bridger has served on the board of directors of Liminal BioSciences Inc., a biotechnology company, from May 2019 until September 2023, and previously served on the board of directors of Alder BioPharmaceuticals, Inc., a biopharmaceutical company, from 2013 to 2016 and Aquinox Pharmaceuticals Inc., a pharmaceuticals company, from 2015 until 2019. Dr.&#160;Bridger serves on the board of directors of Expansion Therapeutics and on the scientific advisory board of Alectos Therapeutics Inc., a biopharmaceutical company. Dr.&#160;Bridger holds a Ph.D. in Organic Chemistry from the University of Manchester Institute of Science and Technology. We believe that Dr.&#160;Bridger&#8217;s experience as an executive officer or director of several public and private life sciences companies provides him with the qualifications and skills to serve on our Board.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Francoise de Craecker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 62, has served as a member of our Board since October 14, 2021. Ms. de Craecker has served as an Independent Director of Gensight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, since May 2021.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Previously, from January 2018 to August 2019, Ms. de Craecker was the General Manager of the Europe, Middle East &#38; Africa region at AveXis (now Novartis Gene Therapies), a biotechnology company that develops and commercializes gene therapies for rare and life-threatening neurological genetic disorders. From August 2014 to December 2017, Ms. de Craecker served as Senior Vice President and General Manager of the Europe, Middle East &#38; Africa region at Raptor Pharmaceuticals, a biopharmaceutical company since acquired by Horizon Pharmaceuticals and after by Chiesi Farmaceutici. Earlier in her </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">career, Ms. de Craecker held multiple positions of increasing responsibility and in diverse geographies at Shire Human Genetics Rare Disease Business Unit (previously Transkaryotic Therapies), from October 2000 to March 2014, including Vice President and General Manager of Europe, Vice President and General Manager of Northern Europe, Senior Director European Mid-Sized Countries and Global Fabry Disease Franchise Lead. Ms. de Craecker received her Masters in Nutrition Science from Faculty of Medicine of the University of Leuven (Belgium). We believe that Ms. De Craecker&#8217;s experience with and knowledge of life sciences companies in the development and commercialization space provide her with the qualifications and skills to serve on our Board. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Murray W. Stewart, M.D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 63, has served as a member of our Board since March 2019 and as our interim Chief Medical Officer from November 2022 to September 2023. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From July 2021 to May 2023, Dr. Stewart served on the Board of Directors of VectivBio Holding AG (Nasdaq&#58; VECT) and was a member of the compensation committee. Additionally, from January 2023 to March 2023, Dr. Stewart served as a member of the Board of Directors of Amarin Corporation plc (NASDAQ&#58; AMRN). Dr.&#160;Stewart has served as Chief Medical Officer of Rhythm Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing therapies for the treatment of rare genetic disorders of obesity, since October 2018. He previously served as Head of Research and Development for Novelion Therapeutics Inc., a biopharmaceutical company focused on developing new standards of care for individuals living with rare disease, from November 2017 to October 2018. Prior to that, Dr.&#160;Stewart held various positions of increasing responsibility at GlaxoSmithKline, including serving as Chief Medical Officer from April 2014 to November 2017, with global responsibility for patient well-being across the vaccine, pharmaceutical, and consumer business units. He also held multiple research and development leadership roles, including Chief Medical Officer for the pharmaceutical business, Clinical Head of the Biopharma Unit, and Therapy Area Head for metabolic and cardiovascular diseases. Prior to his tenure to joining GlaxoSmithKline, he worked as a consultant physician and honorary senior lecturer at the Diabetes Center in Newcastle upon Tyne in the United Kingdom. Dr.&#160;Stewart holds an M.D. from Southampton Medical School and is a Fellow of the Royal College of Physicians. We believe that Dr.&#160;Stewart&#8217;s extensive biopharmaceutical leadership experience, including experience in research, clinical development and regulatory strategy, provide him with the qualifications and skills to serve on our Board.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OARD </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">IVERSITY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The composition of our Board of Directors currently includes three individuals who are diverse under Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) listing rule regarding board diversity, representing gender diversity of 33%, as presented in the below Board Diversity Matrix. Under the Nasdaq listing rule, directors who self-identify as (i) female, (ii) an underrepresented minority or (iii) LGBTQ+ are defined as being diverse. The following table provides certain self-identified personal characteristics of our directors, in accordance with Rule 5605(f) of the Nasdaq listing standards&#58;   </font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.470%"><tr><td style="width:1.0%"></td><td style="width:42.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix (As of April 15, 2024)</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Number of Directors</font></div></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Female</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Male</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Non-</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Binary</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Did Not</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Disclose</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Gender</font></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part I&#58; Gender Identity</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Directors</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part II&#58; Demographic Background</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">African American or Black</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alaskan Native or Native American</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Asian</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hispanic or Latinx</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Native Hawaiian or Pacific Islander</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">White</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">6</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Two or More Races or Ethnicities</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LGBTQ+</font></div></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Did Not Disclose Demographic Background</font></div></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8212;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_19"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_22"></div><div style="margin-bottom:0.08pt;margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">NDEPENDENCE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">HE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">IRECTORS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As required under the Nasdaq</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">listing standards, a majority of the members of a listed company&#8217;s board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the Board of Directors. The Board consults with its counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and the Company, its senior management and its independent auditors, the Board has affirmatively determined that the following six directors are independent directors within the meaning of the applicable Nasdaq listing standards&#58; Mr.&#160;Aliski, Ms. de Craecker, Ms. Lawton, Mr.&#160;McGirr, Mr.&#160;Wyzga and R. Keith Woods. In making this determination, the Board found that none of these directors or nominees for director had a material or other disqualifying relationship with the Company. Dr.&#160;Ragan is employed by us and is therefore not independent under Nasdaq listing standards. Dr. Bridger has previously provided us with consulting services in the past pursuant to a consulting agreement that was terminated in January 2023 and Dr. Stewart is currently providing consulting services to us pursuant to a consulting agreement. Therefore, neither Dr. Bridger nor Dr. Stewart are independent under the Nasdaq listing standards. See &#8220;Transactions with Related Persons and Indemnification &#8211; Certain Related-Person Transactions.&#8221; </font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_25"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;L</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EADERSHIP</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">TRUCTURE</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board has an independent Chairman, Mr.&#160;Wyzga, who has authority, among other things, to call and preside over Board meetings, including meetings of the independent directors, to set meeting agendas and to determine materials to be distributed to the Board. Accordingly, the Chairman has substantial ability to shape the work of the Board. We believe that separation of the positions of Chairman and Chief Executive Officer reinforces the independence of the Board in its oversight of our business and affairs. Our Board also recognizes the full-time, effort and energy that our Chief Executive Officer devotes to her position in the current business environment. In addition, we believe that having an independent Chairman creates an environment that is more conducive to objective evaluation, increasing management accountability and improving the ability of the Board to assess management&#8217;s capacity to act in the best interests of our Company and our stockholders. As a result, we believe that having an independent Chairman can enhance the effectiveness of the Board as a whole.</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_28"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OLE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">THE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IN</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ISK</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">VERSIGHT</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">One of the Board&#8217;s key functions is informed oversight of our risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. For example, in determining whether and under what circumstances we will engage in financing transactions or enter into licensing, collaboration or similar arrangements, the Board is involved in our management of risks related to our financial condition or of the risks inherent in drug development and commercialization. As part of its oversight, our Board receives reports by each committee chair regarding the committee&#8217;s considerations and actions. In particular, the Audit Committee is responsible for discussing the adequacy of our risk management activities with management and our independent registered public accounting firm. The Audit Committee&#8217;s primary emphasis is managing our financial risk exposures, including our internal control over financial reporting. The Audit Committee also monitors compliance with legal and regulatory requirements and considers and approves or disapproves any related person transactions. In addition, the Compensation Committee is responsible for considering whether our compensation programs and practices are reasonably likely to have a material adverse effect on us. The Nominating and Corporate Governance Committee assists the Board by overseeing and evaluating programs and risks associated with Board organization, membership and structure, and corporate governance. </font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At each of its meetings, the Board receives business updates from various members of management. These updates may identify matters that have emerged within that member of management&#8217;s scope of responsibility that involve operational, financial, legal or regulatory risks and, in these cases, the Board provides guidance to management. Our Board believes that full and open communication between management and the Board is essential for effective risk management and oversight.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In carrying out their risk oversight functions, the Board and its committees routinely request and review management updates, reports from the independent auditors and legal and regulatory advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by us. The Board is committed to continuing to ensure and evolve its risk oversight practices as appropriate given the stage of our evolution as a late-stage clinical biopharmaceutical company and the fast-paced changes of the life sciences industry. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_31"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">M</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EETINGS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board met 8 times during the last fiscal year. Each of our incumbent Board members attended 75% or more of the aggregate number of meetings of the Board and of the committees on which he or she</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">served, held during the portion of the last fiscal year for which he or she</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">was a director or committee member.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_34"></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">NFORMATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">EGARDING</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OMMITTEES</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">THE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">IRECTORS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board has three standing committees&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each of these committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The composition and function of each of these committees are described below.</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_37"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee is currently composed of three</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">members&#58; Mr.&#160;McGirr (chair), Ms. Lawton and Mr.&#160;Wyzga. The Audit Committee met four times during 2023. The Board has adopted a written Audit Committee charter that is available to stockholders on our website at http&#58;&#47;&#47;investors.x4pharma.com&#47;.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee established by the Board in accordance with Section&#160;3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), to oversee our corporate accounting and financial reporting processes and audits of our financial statements. For this purpose, the Audit Committee performs several functions. The Audit Committee&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">appoints, evaluates, retains, and when necessary, terminates the engagement of the independent auditors&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">oversees the independent auditor and approves the compensation of the independence auditor&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reviews and approves the retention of the independent auditors to perform any proposed permissible&#160;non-audit&#160;services&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">oversees the work of the independent auditor, including resolution of disagreements between our management and the independent auditor regarding financial reporting&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reviews our annual audited financial statements and quarterly financial statements with management and the independent auditor, including our disclosures under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#59;&#8221;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">discusses the type and presentation of information to be disclosed in our earnings releases&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">coordinates the Board&#8217;s oversight of our internal control over financial reporting, disclosure procedures, cybersecurity and technology planning, and code of business conduct and ethics&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">discusses our policies with respect to risk assessment and risk management, including guidelines and policies to govern the process by which our exposure to risk is handled&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">establishes procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters&#59; </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reviews our policies and procedures for reviewing and approving related person transactions&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">oversees the work of the internal auditors and internal audit functions, including evaluating whether the Company requires an internal audit function in order to improve in the oversight of the integrity of the Company&#8217;s financial statements, the Company&#8217;s compliance with legal and regulatory requirements, and the Company&#8217;s overall audit function&#59; and</font></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">oversees and controls the Company&#8217;s cybersecurity policies and guidelines to prevent, detect, and respond to cyber incidents or data breaches involving the Company&#8217;s products, services, data, information systems, and business operations and reviews the effectiveness of the Company&#8217;s cybersecurity programs and its practices for identifying, assessing, and mitigating cybersecurity risks across the Company&#8217;s products, services, and business operations.</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board reviews the Nasdaq listing standards definition of independence for Audit Committee members on an annual basis and has determined that all members of the Company&#8217;s Audit Committee are independent (as independence is currently defined in Rule 5605(c)(2)(A)(i) and (ii)&#160;of the Nasdaq listing standards).</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Board has also determined that each of Mr.&#160;McGirr and Mr.&#160;Wyzga qualifies as an &#8220;audit committee financial expert,&#8221; as defined in applicable Security and Exchange Commission (&#8220;SEC&#8221;) rules.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of the Audit Committee of the Board of Directors</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">The material in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee is appointed by our Board to assist our Board in fulfilling its oversight responsibilities with respect to (1) the integrity of the Company&#8217;s financial statements and financial reporting process and systems of internal controls regarding finance, accounting, and compliance with legal and regulatory requirements, (2) the qualifications, independence, and performance of the Company&#8217;s independent registered public accounting firm, (3) the performance of the Company&#8217;s internal audit function, if any, and (4) other matters as set forth in the charter of the audit committee approved by our board of directors.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Management is responsible for the preparation of the Company&#8217;s financial statements and the financial reporting process, including its system of internal control over financial reporting and its disclosure controls and procedures. The independent registered public accounting firm is responsible for performing an audit of the Company&#8217;s financial statements in accordance with the standards of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;), and issuing a report thereon. The Audit Committee&#8217;s responsibility is to monitor and oversee these processes.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December&#160;31, 2023 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the PCAOB and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the Company&#8217;s Annual Report on&#160;Form&#160;10-K&#160;for the fiscal year ended December&#160;31, 2023.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respectfully submitted,</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David McGirr, M.B.A (Chairman)</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alison Lawton</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael S. Wyzga</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_40"></div><div style="margin-bottom:0.08pt;margin-top:16pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Compensation Committee is currently composed of three</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">directors&#58;  Mr.&#160;Aliski (chair), Ms. de Craecker and Mr. Wyzga. All members of our Compensation Committee are independent (as independence is currently defined in Rule 5605(d)(2) of the Nasdaq Listing Rules.) The Compensation Committee met seven times during 2023. The Board has adopted a written Compensation Committee charter that is available to stockholders on our website at http&#58;&#47;&#47;investors.x4pharma.com.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Compensation Committee acts on behalf of the Board to review, approve or recommend for approval by the Board and oversee our compensation strategy, policies, plans and programs, including&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">review and approval, or review and recommendation to the Board for approval,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the compensation and other terms of employment or service, including salary, bonus and incentive compensation levels, deferred compensation, executive perquisites, equity compensation, severance arrangements and&#160;change-in-control&#160;benefits, of our Chief Executive Officer and the other executive officers&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">oversight of the evaluation of our senior executives, including determining the nature and frequency of the evaluation and the persons subject to the evaluation, supervising the conduct of the evaluation, and preparing assessments of the senior executives&#8217; performance&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">review and approval or review and recommendation to the Board of our incentive-compensation and equity-based plans and approval of any&#160;tax-qualified,&#160;non-discriminatory&#160;employee benefit plans for which stockholder approval is not sought and pursuant to which options or stock may be acquired by our officers, directors, employees or consultants&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">administration of our equity compensation plans&#59; </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">review and recommendation to the Board with respect to director compensation&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">adopt and administer a compensation recovery policy including, without limitation, a policy designed to comply with any rules or regulations adopted by the SEC and Nasdaq pursuant to Section 10D of the Exchange Act.</font></td></tr></table></div><div style="margin-top:13pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Compensation Committee Processes and Procedures</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Compensation Committee is primarily responsible for determining the compensation for our executive officers. In setting base salaries and bonuses and granting equity incentive awards for our executive officers, including our NEOs, our Compensation Committee considers compensation for comparable positions in the market, the historical compensation levels of our executives, individual and corporate performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term commitment to our company. As part of this process, Dr.&#160;Ragan, as our president and chief executive officer, prepares performance evaluations for the other executive officers and recommends annual salary increases, annual equity awards and cash bonuses to the Compensation Committee, which is ultimately approved by the Compensation Committee. The Compensation Committee also conducts a performance evaluation of Dr.&#160;Ragan and reviews and approves, or recommends for approval by the Board, the compensation of Dr. Ragan, including salary, bonus and incentive compensation levels&#59; deferred compensation&#59; executive perquisites&#59; equity compensation&#59; severance arrangements&#59; change-in-control benefits and&#47;or other forms of executive officer compensation. Dr. Ragan may not be present during voting or deliberations on her compensation or evaluation. As necessary, the Compensation Committee consults with the Board as to the achievement of corporate objectives that drive contingent compensation awards.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Compensation Committee has the authority to delegate authority to one or more subcommittees as it deems appropriate from time to time under the circumstances. Additionally, our Compensation Committee may delegate to one or more executive officers of the Company the power to grant options or other stock awards pursuant to our equity-based plan to employees of the Company or any subsidiary of the Company who are not directors or executive officers of the Company. Our Compensation Committee has delegated Dr. Ragan such authority, subject to certain parameters.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Compensation Committee has the authority to engage the services of a consulting firm or other outside advisors to assist it in designing our executive compensation programs and in making compensation decisions. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have utilized a compensation consultant, Arnosti Consulting, with expertise in the biotechnology market, to help assess executive and employee compensation and to help inform our compensation strategy. Arnosti Consulting reports directly to our Compensation Committee. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Compensation Committee annually assesses its independence consistent with Nasdaq listing standards and concluded that the engagement of Arnosti Consulting did not raise any conflict of interest. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_43"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Nominating and Corporate Governance Committee</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">is current composed of three directors&#58; Mr. Aliski (chair), Mr.&#160;McGirr, and Mr.&#160;Wyzga. All members of the Nominating and Corporate Governance Committee are independent (as independence is currently defined in Rule 5605(a)(2) of the Nasdaq Listing Rules). The Nominating and Corporate Governance Committee met three times during 2023. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to our stockholders on our website at http&#58;&#47;&#47;investors.x4pharma.com&#47;.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Nominating and Corporate Governance Committee of the Board is responsible for identifying, reviewing and evaluating candidates to serve as directors of the Company (consistent with criteria approved by the Board), reviewing and evaluating incumbent directors, recommending to the Board</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">candidates for election to the Board, making recommendations to the Board regarding the membership of the committees of the Board (including with respect to making changes or rotation of members, the creation of additional Board committees, or changes in Committee charters), overseeing an annual self-assessment of the Board, overseeing succession planning for senior executives of the Company, and developing and recommending to the Board a set of corporate governance principles for the Company.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including a reputation for integrity, honesty and adherence to high ethical standards&#59; demonstrated business acumen, experience and the ability to exercise sound judgements in matters that relate to the current and long-term objectives of the Company and a willingness and ability to contribute positively to the decision-making process of the Company&#59; a commitment to understand the Company and its industry and to regularly attend and participate in meetings of the Board and its committees&#59; the interest and ability to understand the sometimes conflicting interests of the various constituencies of the Company, which include stockholders, employees, customers, governmental units, creditors and the general public, and to act in the interests of all stockholders&#59; and the ability to serve for at least three years before reaching the age of 75. The Nominating and Corporate Governance Committee also believes that candidates for director should not have, nor appear to have, a conflict of interest that would impair the candidate&#8217;s ability to represent the interests of all the Company&#8217;s stockholders and to fulfill the responsibilities of a director. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the context of the current composition of the Board, the operating requirements of the Company and the long-term interests of stockholders, and the Nominating and Corporate Governance Committee has direct input from the Chairman of the Board and the Chief Executive Officer.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Nominating and Corporate Governance Committee has not adopted a formal diversity policy in connection with the consideration of director nominations or the selection of nominees but believes that our Board, taken as a whole, should embody a diverse set of skills, experiences and backgrounds. In this regard, the Nominating and Corporate Governance Committee will consider issues of diversity among its members in identifying and considering nominees for director, and strive where appropriate to achieve a diverse balance of backgrounds, perspectives, experience, age, gender, ethnicity and country of citizenship on our Board and its committees. The Nominating and Corporate Governance Committee does not make any particular weighting of diversity or any other characteristic in evaluating nominees and directors.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Nominating and Corporate Governance Committee appreciates the value of thoughtful Board refreshment, and regularly identifies and considers qualities, skills and other director attributes that would enhance the composition of the Board. In the case of incumbent directors whose terms of office are set to expire, the Committee reviews these directors&#8217; overall service to the Company during their terms, including the number of meetings attended, level of participation, quality of performance and any other relationships and transactions that might impair the directors&#8217; independence. The Nominating and Corporate Governance Committee also takes into account the results of the Board&#8217;s self-evaluation, conducted annually on a group and individual basis. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee is independent for Nasdaq purposes, which determination is based upon applicable Nasdaq listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee then uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#8217; qualifications and then selects a nominee for recommendation to the Board by majority vote.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the </font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nominating and Corporate Governance Committee at the following address&#58; c&#47;o X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;Floor, Boston, Massachusetts 02134 at least 120 days prior to the anniversary date of the mailing of our Proxy Statement for the last Annual Meeting of Stockholders. Submissions must include the full name of the proposed nominee, a description of the proposed nominee&#8217;s business experience for at least the previous five years, complete biographical information, a description of the proposed nominee&#8217;s qualifications as a director and a representation that the nominating stockholder is a beneficial or record holder of our common stock and has been a holder for at least one year. Any such submission must be accompanied by the written consent of the proposed nominee to be named as a nominee and to serve as a director if elected.</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_46"></div><div style="margin-bottom:0.08pt;margin-top:16pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">TOCKHOLDER</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMMUNICATIONS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITH</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">THE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These communications will be reviewed by one or more employees of the Company designated by the Board, who will determine whether the communication should be presented to the Board. Stockholders who wish to communicate with our Board, or any individual director, may do so by sending written communications addressed to our Corporate Secretary at 61 North Beacon Street,</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4th Floor, Boston, Massachusetts 02134.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Communications will be distributed to the Board, or to any individual director or directors as appropriate, depending on the facts and circumstances outlined in the communications. Items that are unrelated to the duties and responsibilities of our Board of Directors may be excluded, such as&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">junk mail and mass mailings&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">resumes and other forms of job inquiries&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">surveys&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">solicitations or advertisements.</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any material that is unduly hostile, threatening, or illegal in nature may be excluded, in which case it will be made available to any outside director upon request.</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_49"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ODE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">THICS</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have adopted a</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Code of Business Conduct and Ethics that applies to all of our officers, directors and employees. The Code of Business Conduct and Ethics is available on our website at http&#58;&#47;&#47;investors.x4pharma.com.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If the Company makes any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the Code of Business Conduct and Ethics to any executive officer or director, the Company will promptly disclose the nature of the amendment or waiver on its website.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EDGING </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OLICY</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Board has adopted an insider trading policy, which prohibits our employees, directors and certain consultants from engaging in hedging or monetization transactions with respect to our securities, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars, and exchange funds. In addition, our insider trading policy prohibits trading in derivative securities related to our securities, which include publicly traded call and put options, engaging in short selling of our common stock, purchasing our common stock on margin or holding it in a margin account and pledging our shares as collateral for a loan.</font></div><div style="margin-top:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">NCENTIVE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">OMPENSATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">ECOUPMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">OLICY</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our board of directors adopted an Incentive Compensation Recoupment Policy effective as of October 2, 2023 (the &#8220;Incentive Compensation Recoupment Policy&#8221;), in compliance with the Nasdaq listing rules, which requires recovery from executive officers of incentive-based compensation that is earned, granted or vested based on the achievement of a financial reporting measure in the event of a required accounting restatement of previously issued financial statements. The recoverable compensation includes any compensation received after the effective date of the Incentive Compensation Recoupment Policy and in the three-year fiscal period preceding the date we were required to prepare the accounting restatement that is in excess of the amount that would have been earned, paid or vested had it been calculated based on the restated financial statements. Recovery is required regardless of fault or a covered officer&#8217;s role in the financial reporting process. The Incentive Compensation Recoupment Policy has been filed as Exhibit 97.1 to our Annual Report on Form 10-K for the year ended December 31, 2023. At no time during or after the year ended December 31, 2023, was the Company required to prepare an accounting restatement that required recovery of erroneously awarded compensation pursuant to the Incentive Compensation Recoupment Policy, nor was there, on December 31, 2023, an outstanding balance of erroneously awarded compensation to be recovered from the application of the policy to a prior restatement.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_52"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ROPOSAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;2</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ATIFICATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ELECTION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">NDEPENDENT</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EGISTERED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">UBLIC</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CCOUNTING</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRM</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee of the Board has selected PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2024 and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. PricewaterhouseCoopers LLP has audited our financial statements since 2016 and also served as our auditor when we were a private company since 2016. Representatives of</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PricewaterhouseCoopers LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm. However, the Audit Committee of the Board is submitting the selection of PricewaterhouseCoopers LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in our best interests and our stockholders.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">RINCIPAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">CCOUNTANT</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EES</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AND</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ERVICES</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table represents aggregate fees billed to us for the fiscal years ended December&#160;31, 2023 and December&#160;31, 2022 by PricewaterhouseCoopers LLP, our principal accountant.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:68.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.324%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">For the year ended</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit Fees </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">943,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">960,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related Fees </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax Fees</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All Other Fees&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,250&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,038&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total Fees</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">947,250&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">964,038&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Consists of fees billed for professional services provided to us in connection with the annual audit of our consolidated financial statements, the review of our quarterly condensed consolidated financial statements, as well as audit services that are normally provided by an independent registered public accounting firm in connection with statutory and regulatory filings or engagements for those fiscal years, such as statutory audits. Included in 2023 and 2022 Audit Fees are fees of $158,000 and $255,000, respectively, in connection with the filing of registration statements and issuance of comfort letters. </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Consists of subscription fees paid for access to online accounting research software applications and data.</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All fees described above were&#160;pre-approved&#160;by the Audit Committee. There were no services that were approved by the Audit Committee pursuant to Rule&#160;2-01(c)(7)(i)(C)&#160;(relating to the approval of a&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;amount of&#160;non-audit&#160;services after the fact but before completion of the audit).</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee has adopted a policy and procedures for the&#160;pre-approval&#160;of audit and&#160;non-audit&#160;services rendered by our independent registered public accounting firm, PricewaterhouseCoopers LLP. Prior to engagement of an independent registered public accounting firm for the next year&#8217;s audit, management will submit an aggregate of services expected to be rendered during that year for each of four categories of services (audit services, audit-related services, tax services and other fees) to the Audit Committee for approval. Prior to engagement, the Audit Committee&#160;pre-approves&#160;these services by category of service. The fees are budgeted, and the Audit Committee requires our independent registered public accounting firm and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances may arise when it may become necessary to engage our independent registered public accounting firm for additional services not contemplated in the original&#160;pre-approval.&#160;In those instances, the Audit Committee requires </font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">specific&#160;pre-approval&#160;before engaging our independent registered public accounting firm. The&#160;pre-approval&#160;of services may be delegated to one or more of the Audit Committee&#8217;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Audit Committee has determined that the rendering of services other than audit services by PricewaterhouseCoopers LLP is compatible with maintaining the principal accountant&#8217;s independence.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of shares representing a majority of the shares present in person or by proxy and entitled to vote on this matter at the Annual Meeting will be required to ratify the selection of PricewaterhouseCoopers LLP.</font></div><div style="margin-top:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;V</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OTE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IN</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AVOR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ROPOSAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;2.</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">17</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_55"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ROPOSAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;3</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ON</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">-B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">INDING</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">DVISORY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> V</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OTE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">AMED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">XECUTIVE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">FFICER</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OMPENSATION</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In accordance with the requirements of Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer Protection Act, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">we are providing our stockholders with an opportunity to make a non-binding advisory vote on the compensation of our named executive officers, as disclosed in this Proxy Statement. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This non-binding advisory vote is commonly known as a &#8220;say-on-pay&#8221; vote and provides our stockholders with the opportunity to express their views on our executive compensation for our named executive officers for fiscal year 2023.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We urge stockholders to read the &#8220;Executive Compensation&#8221; section of this Proxy Statement, which discusses our executive compensation policies and procedures and contains tabular information and narrative discussion about our executive compensation policies and procedures and the compensation of our named executive officers. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Advisory Vote and Board Recommendation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We request stockholder approval, on a non-binding and advisory basis, of the compensation of our named executive officers as disclosed in this Proxy Statement pursuant to the SEC&#8217;s compensation disclosure rules (which disclosure includes the compensation tables and narrative disclosures that accompany the compensation tables within the Executive Compensation section of this Proxy Statement). This vote is not intended to address any specific element of compensation, but rather the overall compensation of our named executives and the compensation philosophy, policies, and practices described in this Proxy Statement. Accordingly, we ask our stockholders to vote &#8220;FOR&#8221; on the following resolution at the Annual Meeting&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;RESOLVED, that the Company&#8217;s stockholders approve, on a non-binding and advisory basis, the compensation of the named executive officers, as disclosed in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and narrative discussions that accompany the compensation tables within the Executive Compensation section of this Proxy Statement.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The say-on-pay vote is advisory, and therefore not binding on the corporation or our Board of Directors. Although non-binding, our Board of Directors and the Compensation Committee value the opinions of our stockholders, and will carefully review and consider the voting results when making future decisions regarding our executive compensation program.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of shares representing a majority of the shares present in person or by proxy and entitled to vote on this matter at the Annual Meeting will be required to ratify the advisory &#8220;say-on-pay&#8221; vote on executive compensation.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-top:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;B</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">A V</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OTE </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#8220;FOR&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ROPOSAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> 3.</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_64"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EXECUTIVE OFFICERS</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table sets forth information with respect to our executive officers and their ages as of the date of this Proxy Statement. There are no family relationships between any of our executive officers, and there is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was selected.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.282%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Age</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Position</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Paula Ragan, Ph.D.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">54</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">President, Chief Executive Officer and Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Adam S. Mostafa</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">44</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer, Treasurer and Corporate Secretary</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Christophe Arbet-Engels, Ph.D., M.D.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">62</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Medical Officer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mark Baldy</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">60</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Commercial Officer</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mary DiBiase, Ph.D.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">63</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Operating Officer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arthur Taveras, Ph.D.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">60</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Scientific Officer</font></td></tr></table></div><div style="margin-top:7pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Paula Ragan, Ph.D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Biographical information for Dr.&#160;Ragan is presented above under the caption &#8220;Nominees for Election as a Class&#160;I Directors Continuing in Office Until the 2027 Annual Meeting of Stockholders&#8221;.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Adam S. Mostafa. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mr. Mostafa has served as our Chief Financial Officer and Treasurer since the completion of our merger, between Arsanis, Inc. and the Company, in March 2019. Prior to that, Mr. Mostafa served as X4&#8217;s Chief Financial Officer since September 2018. Prior to joining X4, Mr. Mostafa served as chief financial officer of Abpro Corporation, a biotechnology company focused on antibody therapeutics, from June 2016 to August 2018. Prior to that, Mr. Mostafa was a managing director in the healthcare investment banking group at Cantor Fitzgerald from January 2015 to May 2016, and from June 2011 to January 2015, Mr. Mostafa was a senior banker in the healthcare investment banking group at Needham &#38; Company. Prior to that, Mr. Mostafa was a vice president in the investment banking group at CRT Capital Group from March 2007 to May 2011, and from September 2003 to March 2007, Mr. Mostafa was a portfolio management associate in the global stock selection group at AQR Capital. Mr. Mostafa began his career as an analyst in the healthcare investment banking group at Salomon Smith Barney. Mr. Mostafa earned an A.B. in Economics from Brown University.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Christophe Arbet-Engels, Ph.D., M.D. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr. Arbet-Engels joined X4 in August 2023 as Chief Medical Officer. He brings to X4 more than 25 years of experience in strategic global drug discovery, development, and commercialization across a broad range of therapeutic areas including gastroenterology, cardiovascular-metabolism, neurology, oncology, and rare and orphan diseases. Dr. Arbet-Engels previously served as Chief Medical Officer at several life science companies, including Neurogastrx, Millendo Therapeutics, and Poxel Pharmaceuticals, where he provided research and development leadership, advancing multiple candidates from pre-clinical through to late-stage clinical trials and assisting with both financial and strategic partnering transactions. Prior to these roles, he held a variety of senior medical and clinical positions at Biogen, Boehringer-Ingelheim Pharmaceuticals, Hoffmann-La Roche, Merck Research Laboratories, Aventis Pharmaceuticals, and Ligand Pharmaceuticals, where he led clinical development and registration, launch, and lifecycle management efforts for several new medicines, including the blockbuster therapies LANTUS&#174; and JARDIANCE&#174;. Dr. Arbet-Engels has also served in educational roles at The Salk Institute for Biological Studies, University of Paris VI, and the Assistance Publique, Hospitals of Paris, and currently serves as a Member of the Board of Tutors in Biochemical Sciences at Harvard University. He received his MD and PhD in internal medicine&#47;endocrinology-metabolism from the University of Paris, France, and completed his MBA at Rutgers University.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Mark Baldry.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;Mr. Baldry has served as our Chief Commercial Officer since November 2022. Previously, from November 2020 to October 2022, Mr. Baldry served as Chief Commercial Officer at Freeline Therapeutics Holdings Limited, a clinical-stage biotechnology company developing AAV gene therapies. From August 2019 to February 2020, Mr. Baldry served as Chief Commercial Officer of Wave Life Sciences USA, Inc., a clinical-stage genetic medicines company. From June 2015 to July 2019, Mr. Baldry held multiple positions of increasing responsibility at Amicus Therapeutics, Inc., a global biotechnology company focused on medicines for people living with rare metabolic diseases, including VP Global Marketing and SVP Global Marketing and Commercial Operations. Mr. Baldry received his B.Sc. in Genetics from York University (U.K.) and an M.B.A. from Concordia University (Canada).</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Mary DiBiase, Ph.D. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr. DiBiase has served as our Chief Operating Officer since September 2021. Prior to her promotion, Dr. DiBiase served as our Senior Vice President and previously Vice President of Technical Operations and Quality from June 2017 to September 2021. From February 2013 to July 2016, Dr. DiBiase was VP Technical Operations and Program Management, previously VP Program Management at Epirus Biopharmaceuticals, a small biosimilar company working to expand access to biosimilar products across the globe. From June 2011 to May 2012, Dr. DiBiase served as VP Product Operations, Specialty Care Business Unit for Pfizer Global Supply. From 1995 to 2011, she held multiple positions of increasing responsibility at Biogen, including Sr Director CMC Management, Program Executive for Avonex</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and Associate Director Pharmaceutical Science and Technology. Dr. DiBiase received her Ph.D. from University of Rhode Island and her B.Pharm. from the University of London.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Arthur Taveras, Ph.D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> Dr. Taveras has served as our Chief Scientific Officer since November 2020. Previously, from August 2018 to July 2020, Dr. Taveras served as Chief Scientific Officer of Comet Therapeutics, Inc., a private biotechnology company. From May 2015 to the present, Dr. Taveras has served in various capacities as Chief Scientific Officer, Head of Drug Discovery and&#47;or Owner of Transform Therapeutics, a private company he founded that is focused on developing novel therapeutics for cancer, neurodegenerative diseases and immunologic disorders. Dr. Taveras also served as President &#38; Chief Scientific Officer of Shanghai ChemPartner Co., Ltd., a research organization serving the pharmaceutical and biotechnology industry, from October 2013 to December 2014. Earlier in his career, he held leadership positions at Biogen, Atlantos Pharmaceuticals (later acquired by Amgen), and Schering-Plough Research Institute (later acquired by Merck). Dr. Taveras received his Ph.D., M.S and B.S. degrees from Rensselaer Polytechnical Institute.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">20</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_67"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL STOCKHOLDERS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our common stock as of March 31, 2024 by&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">each of our directors&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">each of our named executive officers&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">all of our directors and executive officers as a group&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">each person, or group of affiliated persons, who is known by us to beneficially own greater-than-5% of our common stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The column entitled &#8220;Percentage Beneficially Owned&#8221; is based on 167,937,781 shares of our common stock outstanding as of March 31, 2024.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our common stock. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days of March 31, 2024 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable.  Except as otherwise indicated in the table below, addresses of named beneficial owners are in care of X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Floor, Boston, Massachusetts 02134.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"></td><td style="width:57.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.453%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Beneficial Ownership&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Beneficial Owner</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Number&#160;of&#160;Shares</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Percent&#160;of&#160;Total</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">5% Stockholders</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Entities affiliated with Bain Capital&#160;Life Sciences Investors, LLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,987,546</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.99&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Entities affiliated with Growth Equity Opportunities 18 VGE, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,994,493</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.99&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Entities affiliated with Acorn&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">17,845,650</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.99&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Entities affiliated with OrbiMed </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,494,437</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.67&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Named Executive Officers, Directors and Director Nominees</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Paula Ragan, Ph.D.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,095,280</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adam S. Mostafa&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">78,480</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">William E. Aliski</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">  (7)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">67,948</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gary J. Bridger, Ph.D&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">119,518</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Francoise de Craecker </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">62,556&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Alison Lawton </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">64,521&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">David McGirr, M.B.A&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">70,353</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Murray W. Stewart, M.D.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">176,119</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Michael S. Wyzga&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">163,272</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-12pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Christophe Arbet-Engels, Ph.D. M.D.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-12pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">R. Keith Woods</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All directors and current executive officers as a group (14 people)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,739,034</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.62&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Less than one percent.</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1)   Based on a Schedule 13G&#47;A filed by Bain Capital Life Sciences Fund, L.P. (&#8220;BCLS Fund I&#8221;), Bain Capital Life Sciences Fund II, L.P. (&#8220;BCLS Fund II&#8221;), BCIP Life Sciences Associates, LP (&#8220;BCIP LS&#8221;), BCLS I Investco, LP (&#8220;BCLS I Investco&#8221;) and BCLS II Investco, LP (&#8220;BCLS II Investco&#8221; and collectively, the &#8220;Bain Capital Life Sciences Holders&#8221;) on February 13, 2024. As of the close of business on December 31, 2023, (i) BCLS Fund I held 566,966 shares of our common stock and pre-funded warrants to purchase 566,966 shares of our common stock&#59; (ii) BCLS Fund II held 1,332,276 shares of our common stock and pre-funded warrants to purchase 601,714 shares of our common stock&#59; (iii) BCIP LS held 220,298 shares of our common stock and pre-funded warrants to purchase 131,320 shares of our common stock&#59; (iv) BCLS II Investco held 9,270,081 shares of our common stock, warrants to purchase 6,448,689 shares of our common stock, Class C warrants to purchase 2,064,561 shares of common stock and pre-funded warrants to purchase 7,303,890 shares of common stock&#59; and (v) BCLS I Investco held 3,490,188 shares of our common stock, warrants to purchase 2,688,998 shares of common stock, Class C warrants to purchase 860,888 shares of common stock and pre-funded warrants to purchase 1,888,599 shares of common stock. The Bain Capital Life Sciences Holders are (i) prohibited from exercising warrants to purchase common stock or pre-funded warrants to purchase common stock if, as a result of such exercise, the Bain Capital Life Sciences Holders would beneficially own more than 9.99% of the total number of shares of common stock then issued and outstanding immediately after giving effect to the exercise and (ii) prohibited from exercising Class C warrants to purchase common stock if, as a result of such exercise, the Bain Capital Life Sciences Holders would beneficially own more than 4.99% of the total number of shares of common stock then issued and outstanding immediately after giving effect to the exercise (collectively, the &#8220;BCLS Bain Beneficial </font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ownership Blockers&#8221;). As a result of the BCLS Bain Beneficial Ownership Blockers, the amount reported above as beneficially owned consists of&#58; (a) an aggregate of 14,879,809 shares of common stock held directly by the Bain Capital Life Sciences Holders and (b) an aggregate of 2,107,737 shares of common stock issuable upon exercise of pre-funded warrants, warrants and&#47;or Class C warrants held directly by the Bain Capital Life Sciences Holders. Bain Capital Life Sciences Investors, LLC, (&#8220;BCLSI&#8221;), is (i) the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of BCLS Fund I and (ii) the manager of Bain Capital Life Sciences Investors II, LLC, which is the general partner of BCLS Fund II. Boylston Coinvestors, LLC, is the general partner of BCIP LS. BCLSI governs the investment strategy and decision-making process with respect to investments held by BCIP LS. BCLS II Investco (GP), LLC, whose manager is BCLS Fund II, is the general partner of BCLS II Investco and BCLS I Investco GP, LLC, whose manager is BCLS Fund I, is the general partner of BCLS I Investco. As a result, BCLSI  may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Holders. The address of each of the Bain Capital Life Sciences Holders is c&#47;o Bain Capital Life Sciences, 200 Clarendon Street, Boston, MA 02116.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(2)&#160;&#160;&#160;&#160;Based on a Schedule 13D&#47;A filed by Growth Equity Opportunities 18 VGE, LLC (&#8220;GEO&#8221;) on May 26, 2023. As of May 15, 2023, GEO in connection with a private placement purchased (i) 3,250,000 shares of common stock and (ii) pre-funded warrants to purchase 4,973,684 shares of common stock. The pre-funded warrants carry a limitation on exercise preventing GEO from exercise if such exercise results in GEO beneficially owning in excess of 9.99% of the number of shares of our common stock, which percentage can be increased or decreased at the option of GEO upon 61 days prior notice however not to exceed 19.99%. Additionally, as previously disclosed, in connection with our underwritten offering in December 2022, GEO purchased (i) 5,213,636 shares of our common stock, (ii) pre-funded warrants to purchase 6,150,000 shares of our common stock and (iii) Class C warrants to purchase 5,681,818 shares of common stock. The pre-funded warrants carry a limitation on exercise preventing GEO from exercise if such exercise results in GEO beneficially owning in excess of 9.99% of the number of shares of our common stock, which percentage can be increased or decreased at the option of GEO upon 61 days prior notice however not to exceed 19.99%, and the Class C warrants carry a limitation on exercise preventing GEO from exercise if such exercise results in GEO beneficially owning in excess of 4.99% of the number of shares of our common stock, which percentage can be increased or decreased at the option of GEO upon 61 days prior notice however not to exceed 9.99% (the &#8220;GEO Beneficial Ownership Blockers&#8221;). As previously disclosed, in connection with a private placement closed in July 2022, GEO purchased (i) 6,523,157 shares of our common stock, (ii) pre-funded warrants to purchase 7,182,032 shares of our common stock and (iii) warrants to purchase 13,705,189 shares of our common stock. As a result of the GEO Beneficial Ownership Blockers, the amount reported above as beneficially owned consists of 14,986,793 shares of common stock held by GEO and up to 2,007,700 shares of common stock issuable upon exercise of pre-funded warrants and&#47;or warrants, including Class C warrants held by GEO. NEA 18 Venture Growth Equity, L.P. (&#8220;NEA 18 VGE&#8221;) is the sole member of GEO and NEA Partners 18 VGE, L.P. (&#8220;NEA Partners 18 VGE&#8221;) is the sole general partner of NEA 18 VGE. NEA 18 VGE GP, LLC (&#8220;NEA 18 VGE LLC&#8221; and, together with NEA Partners 18 VGE, the &#8220;Control Entities&#8221;) is the sole general partner of NEA Partners 18 VGE. Ali Behbahani (&#8220;Behbahani&#8221;), Carmen Chang (&#8220;Chang&#8221;), Anthony A. Florence, Jr. (&#8220;Florence&#8221;), Mohamad H. Makhzoumi (&#8220;Makhzoumi&#8221;), Edward T. Mathers (&#8220;Mathers&#8221;), Scott D. Sandell (&#8220;Sandell&#8221;), Paul Walker (&#8220;Walker&#8221;) and Rick Yang (&#8220;Yang&#8221;) are the managers of NEA 18 VGE LLC. The address of the principal business office of GEO, NEA 18 VGE, each Control Entity and Sandell is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Behbahani, Chang, Makhzoumi, Walker and Yang is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, California 94025. The address of the principal business office of Florence and Mathers is New Enterprise Associates, 104 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Avenue, 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Floor, New York, NY 10001.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(3)&#160;&#160;&#160;&#160;Based on a Schedule 13G filed by Acorn Bioventures, L.P. (&#8220;Acorn&#8221;)&#59;  Acorn Capital Advisors GP, LLC (&#8220;Acorn GP&#8221;), which is the sole general partner of Acorn&#59; Acorn Bioventures 2, L.P. (&#8220;Acorn 2&#8221;)&#59; Acorn Capital Advisors GP 2, LLC (&#8220;Acorn GP 2&#8221;), which is the sole general partner of Acorn 2&#59; and Anders Hove (&#8220;Hove&#8221; or &#8220;Manager&#8221;, and collectively with Acorn, Acorn GP, Acorn 2, Acorn GP2, the &#8220;Acorn Reporting Persons&#8221;) on February 14, 2024. As of the close of business on December 31, 2023, the Acorn Reporting Persons held (i) 7,310,650 shares of common stock and (ii) 10,535,000 warrants to purchase 10,535,000 shares of our common stock. The Acorn Reporting Persons are (i) prohibited from exercising warrants to purchase common stock or pre-funded warrants to purchase common stock if, as a result of such exercise, the Acorn Reporting Persons would beneficially own more than 9.99% of the total number of shares of common stock then issued and outstanding immediately after giving effect to the exercise and (ii) prohibited from exercising Class C warrants to purchase common stock if, as a result of such exercise, the Acorn Reporting Persons would beneficially own more than 4.99% of the total number of shares of common stock then issued and outstanding immediately after giving effect to the exercise (collectively, the &#8220;Acorn Beneficial Ownership Blockers&#8221;). As a result of the Acorn Beneficial Ownership Blockers, any warrants held in excess of the Acorn Beneficial Ownership Blockers are not included in the above amounts. The address of the principal business office of each of the Acorn Reporting Persons is 420 Lexington Avenue, Suite 2626, New York, New York 10170. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(4)   Based on a Schedule 13G filed by OrbiMed Advisors LLC (&#8220;OrbiMed Advisors&#8221;) and OrbiMed Capital GP IV LLC (&#8220;GP IV&#8221;) on February 14, 2024. Consists of (i) 7,133,515 shares of common stock and (ii) 4,360,922 shares issuable upon the exercise of warrants to purchase common stock held by OrbiMed Private Investments IV, LP (&#8220;OPI IV&#8221;). GP IV is the general partner of OPI IV. OrbiMed Advisors is the managing member of GP IV. By virtue of such relationships, GP IV and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI IV and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI IV. The&#8239;address of each of the aforementioned entities is c&#47;o OrbiMed Advisors LLC, 601 Lexington Avenue, 54th Floor, New York, New York 10022.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)   Consists of 765,068 shares of common stock and 330,012 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)   Consists of 78,480 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(7)&#160;&#160;&#160;&#160;Consists of 3,334 shares of common stock, 16,281 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)&#160;&#160;&#160;&#160;Consists of 3,334 shares of common stock, 67,851 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(9)&#160;&#160;&#160;&#160;Consists of 3,334 shares of common stock, 10,889 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(10)&#160;&#160;&#160;&#160;Consists of 3,334 shares of common stock, 12,854 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48.333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(11)&#160;&#160;&#160;&#160;Consists of 3,334 shares of common stock, 18,686 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(12)&#160;&#160;&#160;&#160;Consists of 146,505 shares of common stock, 26,281 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 3,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(13)&#160;&#160;&#160;&#160;Consists of 28,334 shares of common stock, 86,605 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date and 48,333 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)&#160;&#160;&#160;&#160;Consists of 1,507,320 shares of common stock, 937,022 shares of common stock underlying options that were exercisable as of April 15, 2024 or will become exercisable within 60 days after such date, and 293,331 shares of common stock underlying restricted stock units that were vested as of April 15, 2024 or will become exercisable within 60 days after such date.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">23</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_70"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EXECUTIVE COMPENSATION</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Compensation Committee is primarily responsible for establishing and reviewing our general compensation strategy. See the section captioned &#8220;Compensation Committee Processes and Procedures.&#8221; </font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_73"></div><div style="margin-bottom:0.08pt;margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">UMMARY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMPENSATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ABLE </font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table shows the total compensation awarded to, earned by or paid to, during the fiscal years ended December&#160;31, 2023 and December&#160;31, 2022, the following individuals, for all services rendered in all capacities&#58; (1)&#160;each individual who served as our Chief Executive Officer during the fiscal year ended December&#160;31, 2023, and (2)&#160;our two next most highly compensated executive officers who earned more than $100,000 during the fiscal year ended December&#160;31, 2023 and were serving as executive officers as of such date. We refer to these three individuals in this Proxy Statement as our named executive officers.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our named executive officers for 2023 who appear in the Summary Compensation Table are&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Paula Ragan, Ph.D., our President and Chief Executive Officer&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Adam S. Mostafa, our Chief Financial Officer, Treasurer and Corporate Secretary&#59; and</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Christophe Arbet-Engels, Ph.D. M.D., our Chief Medical Officer.</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.579%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">Name and Principal Position</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">Year</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">Salary ($)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Bonus</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">($)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stock</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Awards</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">Option Awards ($)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Non-Equity</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Incentive Plan</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Compensation</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">($)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">All Other<br>Compensation<br>($)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:125%">Total ($)</font></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Paula Ragan, Ph.D.</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">President and Chief Executive Officer</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">620,053&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,035,784&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">375,132&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">13,792&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,044,761&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">583,481&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">58,773&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">476,904&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,432,049&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">308,557&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">12,769&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">3,872,533&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adam S. Mostafa</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Chief Financial Officer, Treasurer and Secretary</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">486,192&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">452,064&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">214,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">592&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,152,848&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">458,973&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">46,085&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">226,800&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">954,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">193,555&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">569&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,880,882&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Christophe Arbet-Engels, Ph.D M.D. Chief Medical Officer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">179,590&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">200,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,257,135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">205&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,636,930&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The amounts reported in the &#8220;Stock Awards&#8221; column reflect the aggregate grant date fair value of  restricted stock units awarded during the applicable fiscal year, computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (&#8220;ASC 718&#8221;), but excluding any estimated forfeitures related to service-based vesting conditions. See Note 12 to the X4 Pharmaceuticals Inc. Annual Report on Form&#160;10-K&#160;for the year ended December&#160;31, 2023 filed with the SEC on March&#160;21, 2024, regarding assumptions underlying the valuation of equity awards. The amounts reported in this column reflect the total accounting expense for these restricted stock units and do not correspond to the actual economic value that may be received by our named executive officers upon the vesting and settlement of the restricted stock units or any sale of the underlying shares of common stock. For 2023, the amounts are for performance-based restricted stock units and the aggregate grant date fair value is reported based on probable achievement of performance outcomes. The aggregate grant date fair value of such awards assuming the maximum achievement of performance outcomes are the same as the aggregate grant date fair values of the awards assuming probable achievement of the performance outcomes. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The amounts reported in the &#8220;Options Awards&#8221; column reflect the aggregate grant date fair value of stock appreciation rights (&#8220;SARs&#8221;) and&#47;or stock options awarded during the applicable fiscal year, computed in accordance with the provisions of ASC 718 but disregarding any estimate of forfeitures related to service-based vesting conditions for this purpose. See Note 12 to the X4 Pharmaceuticals Inc. Annual Report on Form&#160;10-K&#160;for the year ended December&#160;31, 2023 filed with the SEC on March&#160;21, 2024, regarding assumptions underlying the valuation of equity awards. The amounts reported in this column reflect the accounting expense for these options and&#47;or SARs and do not correspond to the actual economic value that may be received by our named executive officers upon the exercise of the options or SARs, as applicable, or any sale of the underlying shares of common stock.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The amounts reported in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column represent amounts earned pursuant to our annual bonus program, which is based upon our named executive officer&#8217;s achievement of predetermined individual and&#47;or company-wide performance goals. Amounts listed for fiscal year 2023, represents amounts earned for the 12-month period from January 1, 2023  to December 31, 2023 and paid in 2024. See &#8220;Narrative to Summary Compensation Table&#8212;Non-Equity Incentive Plan Compensation&#8221; below for more information. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The amounts reported in the &#8220;All Other Compensation&#8221; column for fiscal years 2023 reflect 401(k) matching contributions of $13,200 for Dr. Ragan and the value of group term life insurance provided to each named executive officer. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Dr. Arbet-Engels commenced employment with us on August 16, 2023 and was not a named executive officer for 2022.</font></td></tr></table></div><div><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.107%"><tr><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The amount reported represents the pro-rated salary that Dr. Arbet-Engels received for 2023 due to his commencement of employment on August 16, 2023 . </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(7)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The amount reported represents (i) a guaranteed annual bonus for the 2023 calendar year equal to 20% of Dr. Arbet-Engels&#8217;s annual base salary (i.e., $100,000) (the &#8220;Arbet-Engels 2023 Bonus&#8221;) and (ii) a signing bonus equal to $100,000 (the &#8220;Signing Bonus&#8221;), in each case subject to the terms of Dr. Arbet-Engels&#8217;s employment agreement. With respect to the Arbet-Engels 2023 Bonus, if Dr. Arbet-Engels is terminated for cause, (other than as a result of death or disability), or if he terminates his employment without good reason (each, as defined in his employment agreement), within the first 12 months following the commencement of his employment with us, Dr. Arbet-Engels will be required to repay a pro-rata amount of the after-tax value of the Arbet-Engels 2023 Bonus, based on the number of days Dr. Arbet-Engels is not actually employed during such 12-month period. With respect to the Signing Bonus, if Dr. Arbet-Engels is terminated for cause, (other than as a result of death or disability), or if he terminates his employment without good reason, before the two-year anniversary following the commencement of his employment with us, Dr. Arbet-Engels will be required to repay a pro-rata amount of the after-tax value of the Signing Bonus based on the following&#58; (A) if such termination occurs on or before the one-year anniversary following Dr. Arbet-Engels&#8217;s commencement of employment with us, Dr. Arbet-Engels will be required to repay 100% of the after-tax value of the Signing Bonus&#59; and (ii) if such termination occurs after the one-year anniversary following Dr. Arbet-Engels&#8217;s commencement of employment with us but before the two-year anniversary following his commencement of employment with us, Dr. Arbet-Engels will be required to repay 50% of the after-tax value of the Signing Bonus.</font></td></tr></table></div><div id="if48504d5cdfb4b02afccfa7e833b9374_76"></div><div style="margin-bottom:0.08pt;margin-top:18pt;text-align:center"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">UTSTANDING</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">QUITY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">WARDS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ISCAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> 2023 Y</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">EAR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">ND</font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table shows for the fiscal year ended December&#160;31, 2023, certain information regarding outstanding equity awards at fiscal year-end for the named executive officers. The equity awards described below are subject to certain acceleration of vesting benefits pursuant to the named executive officers&#8217; employment agreements. </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Option and Stock Appreciation Rights (SARs) Awards</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Stock Awards</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Grant Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Securities</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Underlying</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Unexercised</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Options</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">(#)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Exercisable</font></div></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Securities</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Underlying</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Unexercised</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Options</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">(#)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Unexercisable</font></div></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="6" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Option</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Exercise</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Price</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">($)</font></div></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Option<br>Expiration<br>Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Number of Shares or Units of Stock That Have Not Vested (#)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Market Value of Shares or Units of Stock That Have Not Vested ($) (9)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Equity<br>incentive<br>plan&#160;awards&#58;<br>number of<br>unearned<br>shares, units<br>or other<br>rights that<br>have not<br>vested<br>(#)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Equity<br>incentive<br>plan&#160;awards&#58;<br>market or<br>payout&#160;value<br>of unearned<br>shares, units<br>or other<br>rights that<br>have not<br>vested<br>($) (9)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">Paula Ragan, Ph.D.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;19&#47;2016</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">100,729</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="5" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">6.84&#160;</font></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;18&#47;2026</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;24&#47;2017</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">65,430</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="5" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">6.84&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;23&#47;2027</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;31&#47;2018</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">80,160</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="5" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">7.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">1&#47;30&#47;2028</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">6&#47;17&#47;2019</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">83,893</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="5" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">14.75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">6&#47;16&#47;2029</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">3&#47;24&#47;2021</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">48,210</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">40,448</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">3&#47;10&#47;2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">110,394</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">92,621</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">11&#47;7&#47;2022</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,146,112</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,292,223</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="5" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1.80&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">11&#47;6&#47;2032</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">2&#47;17&#47;2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(7)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">443,401</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">372,013&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">3&#47;2&#47;2023</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(7)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">88,680</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">74,403&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="60" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">Adam S. Mostafa</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">10&#47;4&#47;2018</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">62,633</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="5" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">10.44&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">10&#47;3&#47;2028</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">6&#47;17&#47;2019</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">15,847</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="5" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">14.75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">6&#47;16&#47;2029</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">3&#47;24&#47;2021</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">27,721</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">23,258</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">3&#47;10&#47;2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">52,500</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">44,048</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">11&#47;7&#47;2022</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">450,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">900,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="5" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1.80&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">11&#47;6&#47;2032</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">2&#47;17&#47;2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2),(7)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">230,645</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">193,511&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">Christophe Arbet-Engels, Ph.D. M.D.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">8&#47;31&#47;2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,250,000</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(8)</font></div></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1.28</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">8&#47;30&#47;2033</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">This award was granted pursuant to the Company&#8217;s 2015 Employee, Director and Consultant Equity Incentive Plan, as amended from time to time. (&#8220;2015 Plan&#8221;).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">This award was granted pursuant to the Company&#8217;s Amended and Restated 2017 Equity Incentive Plan, as amended from time to time (the &#8220;2017 Plan&#8221;).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">This award was granted pursuant to the Company&#8217;s 2019 Inducement Equity Incentive Plan, as amended from time to time (the &#8220;Inducement Plan&#8221;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Represents restricted stock units, with each restricted stock unit representing the contingent right to receive one share of common stock on the applicable vesting date. No amount was paid upon grant of the restricted stock units. The restricted stock units vest in three substantially equal annual installments on February 11, 2022, February 11, 2023 and February 11, 2024, subject to the applicable named executive officer&#8217;s continued service through each such date. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Represents restricted stock units, with each restricted stock unit representing the contingent right to receive one share of common stock on the applicable vesting date. No amount was paid upon grant of the restricted stock units. The restricted stock units vest in two substantially equal annual installments on March 10, 2023 and March 10, 2024, subject to the applicable named executive officer&#8217;s continued service through each such date. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Represents SARs that are settled in cash upon exercise. The SARs vest and become exercisable in three equal annual installments on the first, second, and third anniversaries of grant date, in each case, subject to the applicable named executive officer&#8217;s continued service through each such date.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(7)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Represents performance-based restricted stock units for which the performance criteria has not been met. These performance-based restricted stock units vest based on the Company&#8217;s achievement of certain operational milestones, subject to the named executive officer&#8217;s continued service through the date that the applicable performance milestone is achieved.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(8)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">25% of the shares subject to the option vest on August 31, 2024, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option on the last day of each month thereafter for a period of 36 months, subject to the applicable named executive officer&#8217;s continued service through each such date  .</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(9)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">The market value of outstanding restricted stock units is based on the market price of the Company&#8217;s common stock of $0.839 as of December 29, 2023 (the last trading day of fiscal year 2023)  multiplied by the number of units that have not vested as of December 31, 2023.  </font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_79"></div><div style="margin-bottom:0.08pt;margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ARRATIVE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">TO</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;S</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">UMMARY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMPENSATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ABLE</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material terms of the elements of our executive compensation program are described below.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each named executive officer&#8217;s base salary is a fixed component of annual compensation for performing specific duties and functions, and has been established by our Board taking into account each individual&#8217;s role, responsibilities, skills, and experience. Effective January 1, 2023, our Board, upon the recommendation of the Compensation Committee increased Dr. Ragan&#8217;s base salary to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> $620,053</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, and increased Mr. Mostafa&#8217;s base salary to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$486,192</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. The Compensation Committee set Dr. Arbet-Engels&#8217;s salary to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$500,000</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> upon his commencement of employment on August 16, 2023. &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Bonus Compensation</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our annual bonus program is intended to reward our named executive officers for meeting objective or subjective individual and&#47;or company-wide performance goals for a fiscal year. For 2023, our named executive officers received incentive compensation based upon the Board&#8217;s determination (following the recommendation of the Compensation Committee) of their respective achievement of and performance with respect to corporate objectives, which are described below, as well as their respective individual performance. Dr. Ragan&#8217;s and Mr. Mostafa&#8217;s bonus targets were 55%, and 40%, respectively, of their annual base salaries. Pursuant to Dr. Arbet-Engels&#8217;s employment agreement, he received the Arbet-Engels 2023 Bonus and the Signing Bonus, in each case subject to repayment in certain conditions, as further described above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the Summary Compensation Table</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In February 2024, the Compensation Committee completed an evaluation of the Company&#8217;s overall performance for 2023 and the named executive officers&#8217; respective contributions in achieving this performance. The Compensation Committee&#8217;s review was based on company performance against corporate objectives, as well as individual performance against individual goals established by the Compensation Committee. Following such review, our Board (following the recommendation of the Compensation Committee) determined that the corporate performance objectives were achieved at the 110% level. Our Board also determined that Dr. Ragan had earned 110% of her target bonus for 2023, equal to a bonus of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$375,132, and</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> Mr. Mostafa had earned approximately 110% of his target bonus for 2023, equal to a bonus of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$214,000.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Equity Incentives</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our equity grant program is intended to align the interests of our named executive officers with those of our stockholders and to motivate them to make important contributions to our performance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During the fiscal year ended December 31, 2023, we granted a stock option award to Dr. Arbet-Engels as an inducement to his commencement of employment with the Company and restricted stock units as annual refresh grants to Dr. Ragan and Mr. Mostafa, as described in more detail in the &#8220;Outstanding Equity Awards at Fiscal 2023 Year-End&#8221; table above. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment and Change in Control Arrangements</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paula Ragan, Ph.D.</font></div><div style="margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On March&#160;13, 2019, we entered into an amended and restated executive employment agreement with Dr.&#160;Ragan, which was subsequently amended on February 10, 2020 and April 15, 2020, pursuant to which Dr.&#160;Ragan agreed to continue serving as our Chief Executive Officer. Pursuant to the employment agreement, Dr.&#160;Ragan&#8217;s compensation consists of base salary at an annual rate approved by our Board or an appropriate committee thereof, an annual performance bonus as determined by our Board (provided that the target for such bonus shall be no less than 25% of Dr.&#160;Ragan&#8217;s annual base salary), employee benefits, vacation, reimbursement of ordinary and reasonable&#160;out-of-pocket&#160;expenses and coverage under our Directors&#8217; and Officers&#8217;, or D&#38;O, insurance policies, subject to the terms and conditions of such policies. Dr.&#160;Ragan&#8217;s 2022 base salary was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$587,728</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, and in March 2023, Dr. Ragan&#8217;s 2023 annual base salary was retroactively increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$620,053 (effective January 1, 2023)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. Subsequently, in February 2024, Dr. Ragan&#8217;s 2024 annual base salary was retroactively increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$654,156 (effective January 1, 2024). </font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to her employment agreement, if Dr.&#160;Ragan&#8217;s employment is terminated for any reason, Dr.&#160;Ragan will be entitled to receive her accrued but unpaid salary, accrued but unused vacation days, and the amount of any properly incurred expenses prior to termination not yet reimbursed and other benefits. In addition to the foregoing, if Dr.&#160;Ragan&#8217;s employment is terminated by us without cause or if Dr.&#160;Ragan resigns for good reason, each term as defined in her employment agreement, Dr.&#160;Ragan will be entitled to the following&#58; (a)&#160;her base salary for a period of 12 months following such termination, (b)&#160;a&#160;pro-rated&#160;portion of her&#160;target&#160;annual bonus for the calendar year in which the termination occurs, payable in a lump sum, (c)&#160;so long as Dr.&#160;Ragan is eligible for coverage under our health insurance plan, elects coverage, was covered prior to termination, and elects to exercise her rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly employer contribution we pay for current employees under such plan until the earlier of 12&#160;months from the date of Dr.&#160;Ragan&#8217;s termination, or the date Dr.&#160;Ragan is eligible to receive health benefits through another employer, and (d)&#160;Dr.&#160;Ragan will become vested in the additional number of outstanding time-based equity awards granted to Dr.&#160;Ragan by us that would have otherwise vested had Dr.&#160;Ragan remained employed for an additional 12&#160;months after her termination date. In lieu of the foregoing, if Dr.&#160;Ragan&#8217;s employment is terminated without cause or if Dr.&#160;Ragan resigns for good reason, in either case within the&#160;one-year&#160;period following a change of control, as that term is defined in the employment agreement, Dr.&#160;Ragan will be entitled to the following, in addition to her accrued but unpaid benefits&#58; (a)&#160;her base salary for a period of 18&#160;months following such termination, (b)&#160;100% of her annual bonus for the calendar year in which the termination occurs, payable in a lump sum, (c)&#160;so long as Dr.&#160;Ragan is eligible for coverage under our health insurance plan, elects coverage, was covered prior to termination, and elects to exercise her rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly employer contribution we pay for current employees under such plan until the earlier of 12&#160;months from the date of Dr.&#160;Ragan&#8217;s termination, or the date Dr.&#160;Ragan is eligible to receive health benefits through another employer, and (d)&#160;automatic vesting in all outstanding time-based equity awards granted to Dr.&#160;Ragan by us. As a condition to receiving the foregoing severance benefits, Dr.&#160;Ragan must execute and not revoke a separation agreement in a form acceptable to us and which will include a complete release of claims and terms related to&#160;non-disparagement,&#160;non-competition,&#160;confidentiality and cooperation.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr.&#160;Ragan&#8217;s employment agreement also contains her agreement to continue to abide by the terms of her&#160;non-competition,&#160;non-solicitation,&#160;non-disclosure&#160;and intellectual property agreement.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In addition, Dr. Ragan&#8217;s employment agreement provides that in the event the severance and other benefits provided for or otherwise payable to Dr. Ragan constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and are subject to the excise tax imposed by Section 4999 of the Code, we will pay either (i) Dr. Ragan&#8217;s severance benefits under the employment agreement in full or (ii) only a part of Dr. Ragan&#8217;s severance benefits under the employment agreement such that Dr. Ragan receives the largest payment possible without the imposition of the excise tax, in each case, depending upon which alternative would result in Dr. Ragan receiving the greater net after-tax payment.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam S. Mostafa</font></div><div style="margin-bottom:0.08pt;margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On March&#160;13, 2019, we entered into an amended and restated executive employment agreement with Mr.&#160;Mostafa, which was amended and restated again in March 2022, pursuant to which Mr.&#160;Mostafa agreed to continue serving as our Chief Financial Officer. Pursuant to the employment agreement, Mr.&#160;Mostafa&#8217;s compensation consists of base salary at an annual rate approved by our Board or an appropriate committee thereof, an annual performance bonus as determined by our Board, employee benefits, vacation, reimbursement of ordinary and reasonable&#160;out-of-pocket&#160;expenses and coverage under our D&#38;O insurance policies, subject to the terms and conditions of such policies. Mr.&#160;Mostafa&#8217;s base salary in 2022 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$460,846</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and in March 2023, Mr. Mostafa&#8217;s 2023 annual base salary was retroactively increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$486,192 (effective January 1, 2023)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. Subsequently, in February 2024, Mr. Mostafa&#8217;s 2024 annual base salary was retroactively increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$510,000 (effective January 1, 2024)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to his employment agreement, if Mr.&#160;Mostafa&#8217;s employment is terminated for any reason, Mr.&#160;Mostafa is entitled to receive his accrued but unpaid salary, accrued but unused vacation days, the amount of any properly incurred expenses prior to termination not yet reimbursed and other benefits. In addition to the foregoing, if Mr.&#160;Mostafa&#8217;s employment is terminated by us without cause or if Mr.&#160;Mostafa resigns for good reason, each term as defined in the agreement, Mr.&#160;Mostafa will be entitled to the following&#58; (a)&#160;his base salary for a period of 12 months following such termination, (b)&#160;a&#160;pro-rated&#160;portion of  Mr.&#160;Mostafa&#8217;s&#160;target&#160;annual bonus for the calendar year in which the termination occurs based on the period worked by Mr.&#160;Mostafa during such calendar year prior to termination, (c)&#160;so long as Mr.&#160;Mostafa is eligible for coverage under our health insurance plan, elects coverage, was covered prior to termination, and elects to exercise his rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly employer contribution we pay for current employees under such plan until the earlier of six months from the date of Mr.&#160;Mostafa&#8217;s termination or the date Mr.&#160;Mostafa is eligible to receive health benefits through another employer, and (d)&#160;Mr.&#160;Mostafa will become vested in the additional number of outstanding equity awards granted to Mr.&#160;Mostafa by us that would have otherwise vested had Mr.&#160;Mostafa remained employed for an additional six months after his termination date. In lieu of the foregoing, if Mr.&#160;Mostafa&#8217;s employment is terminated without cause or if Mr.&#160;Mostafa resigns for good reason, in either case within the&#160;one-year&#160;period following a change of control, as that term is defined in the agreement, Mr.&#160;Mostafa will be entitled to the following, in addition to his accrued but unpaid benefits&#58; (a)&#160;his base salary for a period of 12 months following such termination, (b) 100% of his target annual bonus for the calendar year in which the termination occurs, (c)&#160;so long as Mr.&#160;Mostafa is eligible for coverage under our health insurance plan, elects coverage, was covered prior to termination, and elects to exercise his rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly employer contribution we pay for current employees under such plan until the earlier of six months from the date of Mr.&#160;Mostafa&#8217;s termination or the date Mr.&#160;Mostafa is eligible to receive health benefits through another employer, and (d)&#160;automatic vesting in all outstanding equity awards granted to Mr.&#160;Mostafa by us. As a condition to receiving the foregoing severance benefits, Mr.&#160;Mostafa must execute and not revoke a separation agreement in a form acceptable to us and which will include a complete release of claims and terms related to&#160;non-disparagement,&#160;non-competition,&#160;confidentiality and cooperation.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Mostafa agreed to continue to abide by the terms of his&#160;non-competition,&#160;non-solicitation,&#160;non-disclosure&#160;and intellectual property agreement.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Christophe Arbet-Engels Ph.D. M.D.</font></div><div style="margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On July 26, 2023, we entered into an executive employment agreement with Dr. Arbet-Engels, pursuant to which Dr. Arbet-Engels agreed to serve as our Chief Medical Officer commencing August 16, 2023. Pursuant to the employment agreement, Dr. Arbet-Engels&#8217;s compensation consists of base salary of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$500,000, subsequently adjusted</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> at an annual rate approved by the Company, an annual performance bonus as determined by the Company with a target of up to 40% of Dr. Arbet-Engels&#8217;s annual base salary, employee benefits, vacation, reimbursement of ordinary and reasonable out-of-pocket expenses, subject to the terms and conditions of such policies, and a signing bonus of $100,000. The Company also granted Dr. Arbet-Engels a stock option award exercisable for 1,250,000 shares of common stock at an exercise price of $1.28 per share, which was the fair market value of the Company&#8217;s common stock on the date of grant. In February 2024, Dr. Arbet-Engels&#8217;s 2024 annual base salary was increased to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$510,000</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to his employment agreement, if Dr. Arbet-Engels&#8217;s employment is terminated for any reason, Dr. Arbet-Engels will be entitled to receive his accrued but unpaid salary and the amount of any properly incurred expenses prior to termination not yet reimbursed and other benefits. In addition to the foregoing, if Dr. Arbet-Engels&#8217;s employment is terminated by us without cause or if Dr. Arbet-Engels resigns for good reason, Dr. Arbet-Engels will be entitled to the following&#58; (a) a continuation of base salary for 12 months, (b) a pro-rated portion of his target annual bonus for the calendar year in which the termination occurs, (c) payment of any annual bonus for the prior calendar year to the extent it has not been paid as of the date of such termination (d) so long as Dr. Arbet-Engels is eligible for coverage under our health insurance plan, elects coverage, was </font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">covered prior to termination, and elects to exercise his rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly contribution we pay for current employees under such plan until the earlier of 6 months from the date of Dr. Arbet-Engels&#8217;s termination, or the date Dr. Arbet-Engels is eligible to receive health benefits through another employer, and (e) Dr. Arbet-Engels will become vested in the additional number of outstanding equity awards granted to Dr. Arbet-Engels by us that would have otherwise vested had Dr. Arbet-Engels remained employed for an additional 6 months after his termination date. In lieu of the foregoing, if Dr. Arbet-Engels&#8217;s employment is terminated without cause or if Dr. Arbet-Engels resigns for good reason, in either case within the one-year period following a change of control, as that term is defined in the employment agreement, Dr. Arbet-Engels will be entitled to the following, in addition to his accrued but unpaid benefits&#58; (a) a continuation of base salary for 12 months, (b) 100% of his target annual bonus for the calendar year in which the termination occurs, (c) payment of any annual bonus for the prior calendar year to the extent it has not been paid as of the date of such termination, (d) so long as Dr. Arbet-Engels is eligible for coverage under our health insurance plan, elects coverage, was covered prior to termination, and elects to exercise his rights under COBRA to continue participation in such plan, we will pay an amount equal to the monthly employer contribution we pay for current employees under such plan until the earlier of 6 months from the date of Dr. Arbet-Engels&#8217;s termination, or the date Dr. Arbet-Engels is eligible to receive health benefits through another employer, and (e) automatic vesting in all outstanding equity awards granted to Dr. Arbet-Engels by us. As a condition to receiving the foregoing severance benefits, Dr. Arbet-Engels must execute and not revoke a separation agreement in a form acceptable to us and which will include a complete release of claims and terms related to non-disparagement and no cooperation.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr. Arbet-Engels&#8217;s employment agreement also contains his agreement to continue to abide by the terms of his confidentiality, non-competition, non-solicitation and intellectual property agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">  </font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">401(k) Plan</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We maintain a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a&#160;tax-advantaged&#160;basis. Eligible employees may defer eligible compensation on a&#160;pre-tax&#160;basis, up to the statutorily prescribed annual limits on contributions under the Code. Contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. Employees are immediately and fully vested in their contributions.We provide a discretionary matching contribution equal to 100% of employee contributions up to a maximum of 4% of eligible compensation, as defined under the 401(k) plan. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a&#160;tax-qualified&#160;retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Welfare Benefits</font></div><div style="margin-bottom:0.08pt;margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All of our full-time employees, including our named executive officers, and certain of our part-time employees are eligible to participate in our health and welfare benefit plans, including our medical, dental, life and long-term disability insurance plans. Our health and welfare benefit plans do not discriminate in scope, terms or operation in favor of our executive officers.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_82"></div><div style="margin-bottom:0.08pt;margin-top:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">V</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">S.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ERFORMANCE</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; (CAP) to our principal executive officer (PEO) and our non-PEO named executive officers (NEOs) in the applicable years, and certain financial performance of the Company. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:10.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.700%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:125%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Summary Compensation Table Total for PEO (2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Compensation Actually Paid  to  PEO (3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Average Summary Compensation Table Total for Non-PEO NEOs (4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Average Compensation Actually Paid to Non-PEO NEOs (3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Value of Initial Fixed $100 Investment Based on Total Shareholder Return (5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Net Loss ($000) (6)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(a)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(b)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(c)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(d)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(e)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(f)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(g)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2023</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,044,761&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,285,650&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,394,889&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">838,053&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13.05&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(101,167)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2022</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,872,533&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,300,353&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,862,085&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,611,499&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15.44&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(93,867)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2021</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,141,328&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">667,290&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,189,100&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">572,159&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35.61&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(88,696)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1) &#160;&#160;&#160;&#160;Our PEO in each reporting year is Dr. Ragan. Our non-PEO NEOs in the 2023 reporting year were Mr. Mostafa and Dr. Arbet-Engels. Our non-PEO NEOs in the 2022 reporting year were Mr. Mostafa and Dr. DiBiase. Our non-PEO NEOs in the 2021 reporting year were Mr. Mostafa and Mr. Derek Meisner, who in 2021 was our Chief Legal Officer.</font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)&#160;&#160;&#160;&#160;The dollar amounts reported in column (b) are the amounts of total compensation reported for Dr. Ragan for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table for such applicable year. </font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)&#160;&#160;&#160;&#160;The dollar amounts reported in columns (c) and (e) represent the CAP to our PEO and average CAP paid to our non-PEO NEOs, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to our PEO or the average amounts paid to our non-PEO NEOs during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to our PEO&#8217;s and our non-PEO NEOs&#8217; compensation for each year to determine the CAP and average CAP, respectively&#58;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PEO</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">NEOs</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current Fiscal Year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">SCT Total</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,044,761&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">3,872,533&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,141,328&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,394,889&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,862,085&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,189,100&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Grant Date Fair Value of Awards Granted in Fiscal Year (a)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1,035,784)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2,908,953)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1,258,272)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(854,600)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1,181,700)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(569,376)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year (b)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">446,416&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">2,651,292&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">331,200&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">494,256&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,059,165&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">149,870&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years (b)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(378,191)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(187,499)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(578,588)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(243,327)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(80,725)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(201,431)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year (b)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">426,197&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">92,373&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year (b)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(217,749)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(127,020)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">31,622&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(45,538)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(47,326)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">3,996&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year (b)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Compensation Actually Paid (CAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,285,650&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">3,300,353&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">667,290&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">838,053&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">1,611,499&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">572,159&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and&#47;or &#8220;Option Awards&#8221; columns in the Summary Compensation Table for the applicable year.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The fair value of stock options reported for CAP purposes is estimated using a Black-Scholes option pricing model for purposes of this PVP calculation in accordance with the SEC rules. This model uses both historical data and current market data to estimate the fair value of options and requires several assumptions. The assumptions used in estimating fair value for awards granted and vesting during fiscal years 2023, 2022, and 2021 are as follows&#58;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.898%"><tr><td style="width:1.0%"></td><td style="width:36.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Risk-free interest rate</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.5% - 4.5%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.7% - 4.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">0.5% - 1.5%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Expected term (in years)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.00 - 6.33</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.0 - 4.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.2 - 3.7</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Expected volatility</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">90.8% - 99.4%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94.5 % - 101.4%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94.5% - 97.0%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Expected dividend yield</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;%</font></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The fair value of restricted stock units reported for CAP purposes is based on the closing market price of the Company&#8217;s common stock on the date of each vesting event and at the end of the period.  The fair value of performance-based restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of each vesting event and at the end of the period and assumes that vesting is probable, consistent with the amount calculated in accordance with the provisions of ASC 718 and reported in the Company&#8217;s Annual Report on Form&#160;10-K&#160;for the year ended December&#160;31, 2023 filed with the SEC on March&#160;21, 2024.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4) &#160;&#160;&#160;&#160;The dollar amounts reported represent the average of the amounts reported for our non-PEO NEOs for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table for such applicable year.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(5)&#160;&#160;&#160;&#160;The Company&#8217;s total shareholder return (TSR) reflected in this column for each applicable fiscal year is calculated based on a fixed investment of $100 at the applicable measurement point on the same cumulative basis as is used in Item 201(e) of Regulation S-K.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)&#160;&#160;&#160;&#160;The dollar amounts reported represent the amount of net income (or loss) reflected in the Company&#8217;s audited financial statements for the applicable year.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Pay Versus Performance Comparative Disclosure</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The graphs below reflect the relationship between PEO CAP, average Non-PEO NEO CAP and the Company&#8217;s cumulative indexed TSR, (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2023, 2022 and 2021&#58;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><img alt="pvpfy2023capgraphv3.jpg" src="pvpfy2023capgraphv3.jpg" style="height:421px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The graph below reflects the relationship between the PEO CAP, and average Non-PEO NEO CAP and the Company&#8217;s Net Income (Loss) for the applicable reporting year. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><img alt="pvpfy2023graphversion3.jpg" src="pvpfy2023graphversion3.jpg" style="height:423px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All information provided above under the &#8220;Pay Versus Performance&#8221; heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference.</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_85"></div><div style="margin-bottom:0.08pt;margin-top:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTOR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMPENSATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">FOR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;F</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ISCAL</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Y</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">EAR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2023</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.982%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.222%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Name </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Fees&#160;Earned<br>or Paid in<br>Cash<br>($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Stock</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Awards</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">All Other Compensation<br>($)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Total<br>($)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">William E. Aliski, MPA</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">53,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">165,050&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gary J. Bridger, Ph.D.</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">147,050&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Francoise de Craecker </font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">40,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">152,050&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Alison Lawton</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">154,550&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">David McGirr, M.B.A.</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">54,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">166,050&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Murray W. Stewart, M.D. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13,125&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">76,956&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(5)</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">90,081&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keith Woods</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,228&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">84,600&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">91,828&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Michael S. Wyzga</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">87,288&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112,050&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="4" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">199,338&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dr.&#160;Ragan, one of our directors who also serves as our Chief Executive Officer and President, did not receive any additional compensation for her service director. Dr.&#160;Ragan is a named executive officer and, accordingly, the compensation that we pay to Dr.&#160;Ragan is described under &#8220;2023 Summary Compensation Table&#8221; and &#8220;Narrative Disclosure to Summary Compensation Table.&#8221;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The amounts reported in the &#8220;Stock Awards&#8221; column reflect the aggregate grant date fair value of restricted stock units awarded during 2023 computed in accordance with the provisions of ASC&#160;718, which disregards any estimated forfeitures related to service-based vesting conditions for this purpose. See Note&#160;12 to our consolidated financial statements appearing in our Annual Report on Form&#160;10-K&#160;for the fiscal year ended December&#160;31, 2023 filed with the SEC on March&#160;21, 2024, regarding assumptions underlying the valuation of equity awards. The amounts reported in this column reflect the accounting expense for these restricted stock units and do not correspond to the actual economic value that may be received by our directors upon the vesting and settlement of the restricted stock units or any sale of the underlying shares of common stock.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The aggregate number of shares subject to outstanding stock options held by each director listed in the table above as of December&#160;31, 2023 was as follows&#58; 16,281 shares for Mr.&#160;Aliski&#59; 67,851 shares for Dr.&#160;Bridger&#59; 12,250 for Ms. de Craecker&#59; 12,854 for Ms. Lawton&#59; 18,686 shares for Mr.&#160;McGirr&#59; 26,281 shares for Dr.&#160;Stewart&#59; and 86,605 shares for Mr.&#160;Wyzga. Mr. Woods did not hold any outstanding stock options as of December 31, 2023. In addition, the aggregate number of outstanding shares subject to restricted stock awards held by each director listed in the table above as of December&#160;31, 2023 was as follows&#58; 48,333 restricted stock units for Mr.&#160;Aliski&#59; 48,333 restricted stock units for Dr.&#160;Bridger&#59; 48,333 restricted stock units for Ms. de Craecker&#59; 48,333 restricted stock units for Ms. Lawton&#59; 48,333 restricted stock units for Mr.&#160;McGirr&#59; 3,333 restricted stock units for Dr.&#160;Stewart&#59; 90,000 restricted stock units for Mr. Woods and 48,333 restricted stock units for Mr.&#160;Wyzga.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dr. Stewart continued to serve as an outside director during 2023 following his transition from our interim Chief Medical Officer in July 2023 upon the Company&#8217;s hiring of Dr. Arbet-Engels as Chief Medical Officer. Dr. Stewart was an executive officer for 2023, but not a named executive officer for 2023. As such, his compensation for services as an executive officer have not been included in this table. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">On August 16, 2023, the Company entered into an independent contractor agreement with Dr. Stewart, pursuant to which Dr. Stewart is entitled to receive consulting fees of $64,245 for the period August 16, 2023 through September 30, 2023, and $4,237 per month thereafter until June 30, 2024. For more information see &#8220;Transaction with Related Persons&#8221; below.  </font></td></tr></table></div><div id="if48504d5cdfb4b02afccfa7e833b9374_88"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ARRATIVE</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">O</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;D</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTOR</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMPENSATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ABLE</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Employee&#160;Director Compensation Policy in Effect for Fiscal Year 2023</font></div><div style="margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In March 2023, our Board, upon the recommendation of the Compensation Committee, approved an amendment to our non-employee director compensation policy. Prior to the amendment to our non-employee director compensation policy, the initial equity grant to non-employee directors joining the Board consisted of 13,333 restricted stock units vesting in equal annual installments on the first two anniversaries of the date of grant</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">subject to the&#160;non-employee&#160;director&#8217;s continued service as a director. This vesting accelerates as to 100% of the restricted stock units upon a change in control of the Company. Further, on the date of our annual meeting&#160;of&#160;stockholders,&#160;each&#160;non-employee&#160;director&#160;that&#160;had&#160;served on our Board for at least six months was eligible to receive 6,667 restricted stock units vesting in equal annual installments on the first two anniversaries of the date of grant, subject&#160;to&#160;the&#160;non-employee&#160;director&#8217;s&#160;continued&#160;service&#160;as a director, with 100% acceleration of vesting upon a change in control of the Company.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to the amended policy, for 2023, the initial equity grant to non-employee directors joining the Board consisted of 90,000 restricted stock units vesting in equal annual installments on the first three anniversaries of the date of grant, subject to the non-employee director&#8217;s continued service as a director. This vesting accelerates as to 100% of the restricted stock upon a change in control of the Company. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-top:3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Further, on the date of our annual meeting&#160;of&#160;stockholders,&#160;each&#160;non-employee&#160;director&#160;that&#160;had&#160;served on our Board for at least six months was eligible to receive 45,000 restricted stock units vesting in full on the first anniversary of the date of grant (or the date of the next annual meeting, if such meeting is earlier than the anniversary of the grant), subject&#160;to&#160;the&#160;non-employee&#160;director&#8217;s&#160;continued&#160;service&#160;as a director, with 100% acceleration of vesting upon a change in control of the Company.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For fiscal year 2023, we paid our&#160;non-employee&#160;directors a cash retainer for service on the Board and for service on each committee on which the director was a member. The Chairman of the Board and the Chair of each committee received higher retainers for such service. These fees are payable in arrears in four equal quarterly installments on the last day of each &#160;&#160;&#160;&#160;quarter, provided that the amount of such payment would be prorated for any portion of such quarter that the director was not serving on the Board, on such committee or in such position. The fees paid to&#160;non-employee&#160;directors for service on the Board, for service as a Lead Independent Director and for service on each committee of the Board on which the director was a member were as follows&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"></td><td style="width:63.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.854%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.255%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Annual Retainer Amount for Member (excluding Chair)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Annual Retainer Amount for Chair</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Board of Directors</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35,000</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">75,000</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Audit Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,500</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compensation Committee</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,000</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,000</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nominating and Corporate Governance Committee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also reimburse our&#160;non-employee&#160;directors for reasonable travel and other expenses incurred in connection with attending meetings of the Board and any committee of the Board of Directors on which they served.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">34</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_91"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">E</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">QUITY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">OMPENSATION</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">LAN</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:125%">NFORMATION</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides certain information with respect to all of our equity compensation plans in effect as of December 31, 2023&#58;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Plan Category</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Number of securities to<br>be issued upon exercise<br>of outstanding options,<br>warrants and rights<br>(a)<br></font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Weighted-average</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">exercise price of</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">outstanding</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">options, warrants</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">and rights</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Number of securities<br>remaining available<br>for issuance under<br>equity compensation<br>plans (excluding<br>securities reflected<br>in column (a))<br>(c)<br></font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Equity compensation plans approved by security holders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">506,562&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.65&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,992,569&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Equity compensation plans not approved by security holders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,501,979&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.54&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,523,256&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,008,541&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.97&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,515,825&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.726%"><tr><td style="width:1.0%"></td><td style="width:7.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The weighted average exercise price is calculated based solely on outstanding stock options </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Includes our Amended and Restated 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;) and our Amended and Restated 2017 Employee Stock Purchase Plan (&#8220;ESPP&#8221;). However, the number of securities in columns (a), (b) and (c) do not include purchase rights accruing under the ESPP offering period that commenced November 18, 2023 as the number of shares to be issued for such offering period are not determined until the end of the offering period on May 17, 2024. The maximum number of shares that can be purchased for each offering period is limited to $12,500 divided by the market value of the shares of our common stock on the first day of the applicable offering period. For the offering period that commenced on November 18, 2023 and ends on May 17, 2024, such maximum number of shares is 15,697, or $12,500.  </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Consists of our 2015 Plan and our Inducement Plan.  Descriptions of the 2015 Plan and Inducement Plan are contained in Note 12 of the notes to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 21, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Includes (i) shares of our common stock to be issued upon outstanding stock options under our 2015 Plan, which plan and awards were assumed in connection with our business combination with X4 Therapeutics, Inc. and (ii) shares of our common stock to be issued upon outstanding stock options under our Inducement Plan.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The 2017 Plan has an evergreen provision that allows for an annual increase in the number of shares available for issuance under the 2017 Plan to be added on the first day of each fiscal year, beginning with the fiscal year ended December 31, 2018 and continuing for each fiscal year until, and including, the fiscal year ending December 31, 2027. The evergreen provides for an automatic increase in the number of shares available for issuance equal to the least of (i) 4% of the outstanding number of shares of common stock on such date and (ii) an amount determined by our Board. Any awards granted under our 2010 Special Stock Incentive Plan, as amended (the &#8220;2010 Plan&#8221;), and the Company&#8217;s 2011 Stock Incentive Plan, as amended (the &#8220;2011 Plan&#8221;), that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by the Company are added to shares available for issuance under the 2017 Plan. No further awards may be granted under the 2010 Plan or 2011 Plan. </font></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_94"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION</font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_97"></div><div style="margin-bottom:0.08pt;margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ELATED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ERSON</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">RANSACTIONS</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OLICY</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ND</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ROCEDURES</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has adopted a written related person transaction policy to set forth policies and procedures for the review of any transaction, arrangement or relationship in which our company is a participant, the amount involved exceeds $120,000, and one of our executive officers, directors, director nominees or 5% stockholders, or their immediate family members, each of whom we refer to as a &#8220;related person,&#8221; has a direct or indirect material interest.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a related person proposes to enter into such a transaction, arrangement or relationship, which we refer to as a &#8220;related party transaction,&#8221; the related person must report the proposed related person transaction to our Chief Financial officer. The policy calls for the proposed related person transaction to be reviewed and approved by our Audit Committee. Whenever practicable, the reporting, review and approval will occur prior to entry into the transaction. If advance review and approval is not practicable, Audit Committee will review and, in its discretion, may ratify the related person transaction. The policy also permits the Chair of the Audit Committee to review and, if deemed appropriate, approve proposed related person transactions that arise between Audit Committee meetings, subject to ratification by the Audit Committee at its next meeting. Any related person transactions that are ongoing in nature will be reviewed annually.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A related person transaction reviewed under this policy will be considered approved or ratified if it is authorized by the Audit Committee in accordance with the standards set forth in the policy after full disclosure of the related person&#8217;s interests in the transaction. As appropriate for the circumstances, the policy provides that the Audit Committee will review and consider&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the related person&#8217;s interest in the related person transaction&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the approximate dollar value of the amount involved in the related person transaction&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the approximate dollar value of the amount of the related person&#8217;s interest in the transaction without regard to the amount of any profit or loss&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">whether the transaction was undertaken in the ordinary course of our business&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">whether the terms of the transaction are no less favorable to us than the terms that could have been reached with an unrelated third party&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the purpose of, and the potential benefits to us of, the transaction&#59; and</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">any other information regarding the related person transaction or the related person in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee may approve or ratify the related person transaction only if the Audit Committee determines that, under all of the circumstances, the transaction is in our best interests. The Audit Committee may impose any conditions on the related person transaction as it deems appropriate. The policy also provides that transactions involving compensation of executive officers will be reviewed and approved by our Compensation Committee in the manner specified in its charter.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the policy, we refer to certain related-party transactions below in which (a)&#160;we were a participant, (b)&#160;the amount involved exceeded or will exceed $120,000 or, during such time as we qualify as a &#8220;smaller reporting company,&#8221; the lesser of (1) $120,000 or (2) 1% of the average of our total assets for the last two completed fiscal years, and (c)&#160;one or more related persons had a direct or indirect material interest. Transactions involving compensation for services provided to us by an employee, director, consultant or individual performing in a similar capacity by a related person are not covered by this policy.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_100"></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ERTAIN</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;R</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ELATED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-P</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ERSON</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">RANSACTIONS     </font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January&#160;1, 2022, we have engaged in, or currently propose to engage in, the following related-party transactions. We believe that all of these transactions were on terms comparable to terms that could have been obtained from unrelated third parties.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Agreements with Directors</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Gary J. Bridger, Ph.D.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2020, we entered into an independent contractor agreement, as amended, with Gary J. Bridger, Ph.D., pursuant to which Dr. Bridger was entitled to receive $30,000 per month and a non-qualified stock option to purchase 30,000 shares of our common stock in consideration for his performance of certain consulting services to the Company during the period from September 17, 2020 to January 1, 2023. The consulting agreement terminated in January 2023. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Murray W. Stewart, M.D.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2023, we entered into an independent contract agreement, as amended with Murray W. Stewart, M.D., pursuant to which Dr. Stewart is entitled to receive consultant a fee $64,245 from August 16, 2023 through September 30, 2023 and a fee of $4,237 per month until June 30, 2024.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services Dr. Stewart is to provide are completion of WHIM NDA submission and subsequent related support, chronic neutropenia related clinical strategy, support transition of new CMO and provide general clinical&#47;medical, regulatory and other pertinent support and guidance. The consulting agreement will terminate in June 2024.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment Arrangements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have entered into employment agreements with our executive officers. Each of our executive officers has entered into a written employment agreement with us that provides for payment of base salary, target annual cash incentive compensation, eligibility for employee benefit programs and potential severance benefits. For more information regarding these agreements with our named executive officers, see &#8220;Executive Compensation.&#8221;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Awards Granted to Executive Officers and Directors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have granted options to our executive officers and directors. For more information regarding the equity awards granted to our named executive officers and directors, see &#8220;Executive Compensation&#8221; and &#8220;Director Compensation for Fiscal Year 2023.&#8221;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="if48504d5cdfb4b02afccfa7e833b9374_103"></div><div style="margin-bottom:0.08pt;margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">NDEMNIFICATION</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We provide indemnification for our directors and executive officers so that they will be free from undue concern about personal liability in connection with their service to us. Under our Bylaws, we are required to indemnify our directors and executive officers to the extent not prohibited under Delaware or other applicable law. We have also entered into indemnity agreements with certain officers and directors. These agreements provide, among other things, that we will indemnify the officer or director, under the circumstances and to the extent provided for in the agreement, for expenses, damages, judgments, fines and settlements he or she may be required to pay in actions or proceedings which he or she is or may be made a party by reason of his or her position as a director, officer or other agent of the Company, and otherwise to the fullest extent permitted under Delaware law and our Bylaws.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_106"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSEHOLDING OF PROXY MATERIALS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This year, a number of brokers with account holders who are X4 stockholders will be &#8220;householding&#8221; the Company&#8217;s proxy materials. A single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or X4. Direct your written request to X4 Pharmaceuticals, Inc., Attn&#58; Corporate Secretary, 61 North Beacon Street, 4th Floor, Boston, MA 02134 or contact the Corporate Secretary at (857) 529-8300. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_109"></div><hr style="page-break-after:always"><div style="min-height:27pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By Order of the Board of Directors,</font></div><div style="margin-bottom:0.08pt"><img alt="adamsignature.jpg" src="adamsignature.jpg" style="height:102px;margin-bottom:5pt;vertical-align:text-bottom;width:342px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.202%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Adam Mostafa </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer, Treasurer and Corporate Secretary</font></td></tr></table></div><div style="margin-top:7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2024</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A copy of the Company&#8217;s Annual Report to the Securities and Exchange Commission on Form&#160;10-K&#160;for the fiscal year ended December&#160;31, 2023 is available without charge upon written request to&#58; Corporate Secretary, X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4th Floor, Boston, MA 02134.</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">39</font></div></div></div><div id="if48504d5cdfb4b02afccfa7e833b9374_115"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><img alt="updatedproxycard.jpg" src="updatedproxycard.jpg" style="height:803px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font><br></font></div><div><img alt="importantnotice2024.jpg" src="importantnotice2024.jpg" style="height:444px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>adamsignature.jpg
<TEXT>
begin 644 adamsignature.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UI=&-H($)U
M8VML97D   60 P "    %   $*:0!  "    %   $+J2D0 "     SDV  "2
MD@ "     SDV  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
M   ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D324II* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBJL6H6TVHSV,4H:XMU5I8
MP.5#9V_G@T 6J*** "BBB@ HHJ-IXDG2%I%620$HA898#K@=Z )**** "BBB
M@ HHHH **** "BBB@!110** "BBB@ HHHH #24II* "BBB@ IKR)&I:1@J@9
M)8X HED2&-I)6"(HRS,< #UKD+DS^.7>VA"IX>W;99B?FN\$'Y/]G(QGZXH
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MS[2ZK]V'>Q54 [8 QGOS5_2;&ZU3QW;WVM1DR_8VN_L\F"( SE8D ]0 Q/\
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MG)I5ZUI!(>IC4 J#ZD XS4@=;1110(**** %%% HH **** "BBB@ -)2FDH
M*Q?%"E=+BN\,RV5S%<NJC)**WS<=\ D_A6U2$9&#R* ,6[\4Z?'I\<]E<1WL
MLX MX(6!>5CT&.H'/)[5)H&ERV<$MU?[6U"\827#+T4XX0?[*C@4^S\.:5I^
MJSZC9V:174XP\@S^@Z#\*U* ,+6+"_CU*+6-%CCFNXXC!+!*VT31YR &[$'H
M?<U6@TK4M;U"&\\20Q6\-J0\%C&^\%_[[GH2#TQ]:Z:BF!@ZUH5[>WXO=*U
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0 HHHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>importantnotice2024.jpg
<TEXT>
begin 644 importantnotice2024.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M36ET8V@@0G5C:VQE>0  !9 #  (    4   "II $  (    4   "NI*1  (
M   #.3$  )*2  (    #.3$  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M,S+S\I*@9/5@ .:[BBDM!O4C@E>:'?)!) V2-DA4G@XS\I(YZ]>_.#Q4E%%
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M)XGT&'28=4FUO3H]/G?RXKMKN,0R-S\JOG!/RMP#V/I5/_A/O!__ $-FA_\
M@RA_^*H Z"BLN3Q/H,.DPZI-K>G1Z?._EQ7;7<8AD;GY5?."?E;@'L?2J?\
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M]K6/]F?\_OVE/)^]M_UF=OWN.O7BL_\ X3[P?_T-FA_^#*'_ .*H Z"BL_\
MM_1_[%_MC^UK'^S/^?W[2GD_>V_ZS.W[W'7KQ6?_ ,)]X/\ ^ALT/_P90_\
MQ5 '045G_P!OZ/\ V+_;']K6/]F?\_OVE/)^]M_UF=OWN.O7BL__ (3[P?\
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M_P &4/\ \50!T%%9_P#;^C_V+_;']K6/]F?\_OVE/)^]M_UF=OWN.O7BL_\
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MMO$%W>W<EJ9;5H;(-']GN9&5GS+\JKA59C\O7IQ]10,FK1:F7MX]5FTY9/\
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M] -:=9GB7_D4]6_Z\IO_ $ T <E\#?\ DC&A?]O'_I1)7H%>?_ W_DC&A?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "LSQ+_R*>K?]>4W_H!K3K,\2_\ (IZM_P!>4W_H!H Y+X&_\D8T+_MX
M_P#2B2O0*\_^!O\ R1C0O^WC_P!*)*] H KWW_'L/^NL?_H8HHOO^/8?]=8_
M_0Q10 MC_P @ZV_ZY+_(5/4%C_R#K;_KDO\ (5/0!YS\;O\ D1[+_L+6O_H1
MKT:O.?C=_P B/9?]A:U_]"->C4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6U
M+3;35],N-/U*!+BTN8S'+$XR&4U\.>/_  M'X,\;ZAH<%['>Q6[C9*A!(4C(
M5L=&&<$5]2?&/XGQ_#_P[Y&GO&^N7RE;:,\^4O0RL/0=!GJ?4 U\>223WMVT
MDC23W$\A9F.6:1V/7U))- $0Y-?:7P@\!:=X)\&6[VTMO>7VH1K/<WT)#+)D
M954;N@!X]>3WKX_U[P_JGAC56TW7;.2SNU17,;_W6&001P?\01VKV;]G_P"*
MO]F747@[Q!<*ME,V-/F?_EE(3_JB?[K$G'H>._ !],5Q?Q2\?V_P^\'S7VY6
MU&X!BL83_')C[Q']U>I_ =Q767]_:Z7IUQ?ZA.MO:VT;2RRN>$4#)-?$_P 3
M/'MW\0/%\VHREDL828K& \>7%G@G_:/4_ET H Y6[N[B_O9KN]F>>XG<R2RR
M'+.Q.22?7-?2WP8\!S:Q\$-5TOQ0&33-=E,MO%C#QKA0)03ZLBL.,?*#SFO'
M/A-X ?X@>-(K.8,NF6H$]](O'R9X0'U8\?3)[5];^,X8[?X:Z_# BQQ1Z1<(
MB*,!5$+  #TH ^<)_P!EGQ"NKF*V\0Z.^G[N+B1G60+[QA2,^V['O7T7X!\&
MV'@/P=::%IDIG2'+RW#  S2,<LQ Z>@'8 "OA/ ]*^P_V>O^2,Z;_P!=Y_\
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M/$O_ "*>K?\ 7E-_Z : .2^!O_)&-"_[>/\ THDKT"O/_@;_ ,D8T+_MX_\
M2B2O0* *]]_Q[#_KK'_Z&**+[_CV'_76/_T,44 +8_\ (.MO^N2_R%3U!8_\
M@ZV_ZY+_ "%3T ><_&[_ )$>R_["UK_Z$:]&KSGXW?\ (CV7_86M?_0C7HU
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M26R6UEO%\RWEPOER$1G $20;0-N0Y.3U'IU% 'EGAKQ7XJM[JPA\9VM]:O\
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M"UK_ .A&O1J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+_&CV-Y->VQN;;RKB9BS.OE<?,>6'HW<8.3UKTFBBGV$%%%%(84444 %%%%
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MJWW]G>+/!MU_:MMI'ESW7^FW47FQQ9BQRNY<YZ=1UKTZBFWV_K02T?RM^?\
MF>5:QXDTVT\;>!=7U/6[2>U:TO0VH(OEQ2L509 R<9/&,FGZ6C7>F?$37+6W
MEM]*U*-FLQ+&8_.*0%7E"D @,>^.<5ZE14R5XM>37WNXXNS3]/P.>^'_ /R3
MCP[_ -@V#_T6*Z&BBKE+FDY=R8JR2"BBBI&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9GB7_D4]6_Z\IO\ T UIUF>)?^13U;_KRF_]
M - ')? W_DC&A?\ ;Q_Z425Z!7G_ ,#?^2,:%_V\?^E$E>@4 5[[_CV'_76/
M_P!#%%%]_P >P_ZZQ_\ H8HH 6Q_Y!UM_P!<E_D*GJ"Q_P"0=;?]<E_D*GH
M\Y^-W_(CV7_86M?_ $(UZ-7G/QN_Y$>R_P"PM:_^A&O1J "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HK(O_%GAS2KQK35-?TNRN5 +0W-['&X!Y&58
M@U)IWB/2-7U":STR^BNYH(HYG\G+)L?.Q@_W6!P>A-&X&G14"WUJ]\]DMS"U
MW&@D>W$@\Q4)P&*]0"0>:GH **** "BBB@ HHJ"UOK2^\W[%=0W'DR&*7RI
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ML?\ Z&** %L?^0=;?]<E_D*GJ"Q_Y!UM_P!<E_D*GH \Y^-W_(CV7_86M?\
MT(UZ-7G/QN_Y$>R_["UK_P"A&O1J "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#@?B3:6SZKX0=[>)GDUZ%78H"6&Q^#ZBN?UV34]+\;^-[_ $&_73CI
MVCVUP$6W1Q(45R$.X$!3@@X&>1@BO5[FQM+QH6O+6&=K>02PF6,,8W'1EST/
M)Y'-1RZ3ITTER\UA:R/>1B*Y9X5)G09 5SCYAR>#QS2UMIY_DD.ZOKV7X.YY
MV?$>OWVN:C_9#64=V_ANUN[=9T156:1CG+D9(] 3C.*Z;P%K<FM:+<_:;N\N
M;NTN6M[G[9'"KQN "5!A^1ASP1Z\UM-H>DN'#Z79,)(5MWS;H=T2_=C/'*CL
MO058L[&TTZT2UTZUAM+=.$B@C"(OT X%4VM;?UK<E)V5_P"M$CR71_''B!]-
MTS4YM>AO99]=;3)-,%O&"T9D*YRHW;U7!R,#'4'K4D?B_P 51>'[[5Y]6@,/
M]MOI4>^T3;:QF<*)G88SM&5 Z<@G-=OX4\$:?X9LXUDCMKV^CEF=+XVJI(JR
M2,^T'D@#=CKS6Y%IEA!:RVT-C;1V\S,\L20J$D9CEBPQ@D]R>M):6_KM_D_O
M*>K=OZW_ ,U]QYY=>)-8LE\4:9_PDB2_V38Q7<.KM;Q91VS^YD55VMG:,84'
M#>N#5*U\9>*-0\":OXE^U&UO=-O4:XT<0(3;P1X\R-BR[B74E\]N,8YKTF/P
M]HT.GBQATBPCLPXD%NML@C#@Y#;<8R#SFJ^L^'Q>V=\NE&STZ]OU$=S=M9K*
MTJ8(PW*[C@X&2<>AZ47:U7]?UM_3!6;U_K^MS.\%:Y=^)I=7U?[3YFD/=>3I
ML810-B##OG&3N?=U/\/%<8?$GB1=.UBXL;E([:SU^\CNFMHK=+A;=%!'EB0!
M'()Y+98BO3=!T:U\.Z#9Z1IX(M[.(1(6ZG'<^Y//XTV;PWH=PA2XT;3Y5:8W
M!5[5&!E/63D?>.!SUINU].UORU_ 47IK_6C_ ,SG/%]]'J?P1U2^@F>>.XT=
MI5ED38S@QYR5'0GTKCYO'&M^&M+MA8:C!KJ3>'S>K$D* 6;)L4'*\E/F/WB3
M\IY%>OW%I;7=F]I=6\4UM(FQX9$#(R^A4\$>U06>BZ7I[S-8:;9VK3@"4P0*
MAD &!NP.>/6D]VUU_P"#_F"V5^G_  /\CRV^\3>+(?!?B.>^R\,.GI<6MS=?
M8I7$A?!&R)F4IC!!9>QR34FL>*?%$,OC">QUA;>#0+:TN+>W^R1L'+1!F5B1
MG:>>G//! XKTB+PUH4%I<6L&BZ?';W7_ !\0I:H$F_WE PWXU,^BZ7(MT)--
MLW%XJI<AH%/GJHP _'S #@ T#7G_ %M_E^)YKKOC76VD\3S6VL0Z.-%TZ*>V
MMFAC?[2TD6[>2XS@'Y0%[]<]*[*:_P!9G^&L5]I<MN=8FL(I(Y+DA8S(R@DG
MH!U..V<55\5>!3XFFV?:[.UM6M_L[XTU'N$C/#+%,3\@(XZ'VKI5TRS_ +)3
M3)+:.:S2)8?)E4.I0# !!X/2C=/^NXEHU_7;_@GFEOXWU*YM=+TV+5;FWN+K
M5)+&^O[ZWM]]HRQ;_+79^Z8L>C<^XS5#5=<OM4FTVRO[E+]=+\86UM%?H@07
M V%CD+\NY2<'&!["O5AH>DC2O[,&F68T_&/LGV=/*Q_N8Q^E*-&TM;:VMETV
MS$%K()+>(0+MA<=&48PI&>HJD[23]/P:_P G]X=+>OXW_P _P/+M,\6:U<36
M6E+J$6F)J&M:A"^HK;1 QK"WR1J"NS<WJP).#U-2^);_ %2=_'-E;ZLZ+8Z)
M!/'<P01"20['+98+G#;>W3^'%>DR:!H\UC)93:38R6DLAEDMVMD,;N3DL5Q@
MDGG/6I;?2=.M'=[73[6%I(EA=HX54LBC"H<#E0"<#H*AJ\;>7Z%)VE?^M[GE
M?_"1>(M/L?#.BZ5?75V+C2OM9NXQ:"1V&T"(&4JFU0><9<@CGJ:FF\5>(M2:
M:QU?4K307MM ^VS(%BE2ZD)=6^;)&P;1]QLY/6O16\,:"VG+I[Z)IS62N9%M
MC:(8U8G)8+C&<]ZEN="TB\6W%YI5E.+48@$MNC>5QCY<CY>/2G/WK^=_U_S^
M=B8^[;R_X']>5SE?!E_-I?P,TV_MH#<S6ND>;'"/XV5"0/TK#C\8:W:1:-.N
MNPZN=:T^>XDAC@C7[$R0[PR;>=H;Y2'W<]^U>H6MK;V-K':V4$5O;Q+MCBB0
M(B#T ' %5;?0M(M)+A[72[*![H$7#1VZ*9L]=Q ^;\:)^\Y-=?\ @_U\@C[J
M2[?\ X#PGXF\12:MX075]46_A\0:9)/+']F2,0NBJP92HSR&YSQZ =*F\;-)
M_P +;\*QPZHFEO+97B"Y9%8CA#A0WR[N.X/?BN\BTC38'M6AT^UC:R0QVI2!
M08%(P53CY00!P/2DO]%TO575]3TVSO65&13<0+(0K=5&0>#@9'?%.33::\_Q
MO_F)+2S\OT/*8_B#XGU"UT>SMB[R7,MXC7]FMNC70@D"J4\]A&-PY.,GC@#L
M^*;Q%K/CC0IKNZ32=5.@77G2P+%/C;, "N"R9.%)ZXY'T]2N=$TJ\TY-/N],
MLY[*/ 2VEMT:-<=,*1@4^/2=.AFBFBL+5)88C#&ZPJ&2,\E <<+QTZ4O^#^3
M7ZE?U^*9YBOC_4]2\&Z)/%?7,.KW%A)=SI90VVUE1MN]C.P55R.B\G/&,5!:
MZE>^*/$>@ZC).;*\O?"<\CRP(IV,73) 8$?GGK7I_P#PCVB^3:P_V18>59DF
MV3[,FV GJ4&/E_"I(=%TNV:)K?3;.)H83!$4@53'&3DHN!PI]!Q1+6_S_%-?
MJON!.UOZZI_H<C\)DN+/X1Z7,]Q+>DVQEBB957RQSB-=H&1D=3D\]:QM*\9:
MY/;>&=3?6(;Q]?N_LTVE1P1C[("'RR$?/E-HW;B0?05Z=:6=M86D=K8V\5M;
MQ#;'#"@1$'H .!4$&C:7;:A+?VVFVD-Y-Q)<QP*LC_5@,FJ;O)O^OZ9*5HV_
MK^D</\);.ZMV\4-<:G/=J-<N8RLD<:@N",R?*HY/<=.. *Y?5HKY)/BFEWKE
MS<K#: +;RK& X:#<#PH("YP,8!ZG)YKV:UL;2Q\W[%:PV_G2&67RHPGF.>K-
MCJ3ZGFJ]UH6D7UT]S>Z797$\D1@>66W1F>,]4)(R5/ITJ'JK>5OP7^12?O7\
M[_B>:Q^*O$/A</:O<)JJ+X7&IP0F!4\J1,+M&WDK@YY)/'6MOP'KGB74=4*:
MP'GT^:S%Q'/-):;Q)D<*L#DF,@\%AD8Y)S7:KIMBETEREE;K/'#Y"2B)0RQ]
M=@.,A>.G2H[#1=+TJ2632]-L[)YCF5K>!8S(?5BH&?QJ[W=_ZW?^:^XFUHI?
MUT_R?WGD'C_S3XU\7HD6EO$^@PB5[^7:T:_O.8AM(9_0$KSCFMFU\1WT[-IV
MGZZVAV.EZ';7=N]U!&TMV&0_-)OSA1M (7!R3S7H%YX:T+4=06^U#1=.NKM0
M MQ/:(\@ Z88C/%37VC:9J;0MJ6FVEX8#NB-Q LGEGU7(X_"H6D;?UU_S*NK
MW_KI_D>7ZO\ $75I_#%M?V$UU::E'I*:A<VL,-OY*[L[2[3,&*MCA8\MBM#_
M (2CQ+J/BB46-['!9P:#;ZJUH+99&E<[B8U8\@-C&><<8Q7H%WHNEW\R37^F
MV=S+&A1'F@5V52,$ D< ^E/@TRPM;CS[6QMH9O*6#S(X55O+7[J9 SM'8=!3
M>M[?UO\ \#[A=OZ[?\'[SR+3M5O=8\8?#F_U'7(=1FODN;EH$B1/LQ,'*C;_
M  CI\V3D'FNU\2ZSJ/\ PFVG>'K74QHMO<V<MTU[Y:.TC(R@1KO!4<')X)QT
MQ700>'=$M;P7=MH^GPW*NT@FCM45P[#!;<!G)'!/>K&H:7I^K6X@U6QMKV$'
M<([F%9%!]<,"*;:=K>?]?(#Q_4-1U;Q7!X+OI]4DMI/[>EM$FMH8]DNSS MP
MH96Y(&,<KR>.E==\50@TKP\)RIC_ +?L]Y?&"-QSGM79OIMC*+8265NXM&#V
MX:)3Y+ 8!3CY3@D9%-U'2M/UBU^S:O86M_!N#>5=0K*N1T.&!&:-K>J?Y?Y!
MU;\K?G_F>6ZK<V=EXW\2W7@\VXAA\.32:B;9%: 7(),6X8*E\;L@CIUJ?2_$
MGB>[U2&&TU"-;6U\.6FIR6RVB%IY"#N1< ;0V,<=., 5Z5!H^F6NG/I]MIUI
M#9.I1[:.!5C92,$%0,$8IUOI>GV<XFM+&V@E$*P"2*%581K]U,@?='8=!2Z6
M_K[7^:^X;=]?Z^S_ )/[SR[P_P"-_&$NG'5KBU:^M9=+FNRCR6H"RJ@95B6)
MS(5SD$."PXZ=*K^*[G5K_P"#JZN_BZ6XDN3:3RI;10HD8=U!0$+NV@GN<_+@
MG&17JMKHFE6-Y->66F6=M<S_ .MGAMU1Y/\ >8#)_&F1>']&MX[J.#2+")+S
M_CY5+9 )_P#? 'S?C3O^GYW_ *?D(XB\UW5_[>U'21XG73HM(TV*Z2[E@A9K
M]F#9=LC:$&T A ISW%5]%\4^*/$WBC1[>*]CTJ"YT&+4KB VROE_-P0I/(##
M'4G Z<\UWTGAS1)K>UMYM'L)(;/'V:-[5"L..FP$?+^%6OL%F+[[:+2#[7Y7
MD^?Y8\SR\YV;NNW/..E']?G_ )K[@Z?UY?Y/[SB_ OB#5;S7KW2O$U[))J:0
M_:!!$D+6HC+D*T3Q_-CV?FN\JGI^CZ;I/F?V7IUI9>:VZ3[- L>\^IV@9-7*
M.@=6%%%%( HHHH **** "BBB@ HHHH **** "LSQ+_R*>K?]>4W_ * :TZS/
M$O\ R*>K?]>4W_H!H Y+X&_\D8T+_MX_]*)*] KS_P"!O_)&-"_[>/\ THDK
MT"@"O??\>P_ZZQ_^ABBB^_X]A_UUC_\ 0Q10 MC_ ,@ZV_ZY+_(5/4%C_P @
MZV_ZY+_(5/0!YS\;O^1'LO\ L+6O_H1KT:O.?C=_R(]E_P!A:U_]"->C4 %%
M%9]_K^CZ5<Q6^J:M8V4\PS%%<W*1M)VX#$$_A0!H45076].?71HRW(-^;;[6
M(@C<Q;MN[=C;U[9S5^@ HHHH **** "BBB@ HHI&8(A9C@*,DT +15+2-7L=
M>TF#4])G^T6=P"T4FQEW ''1@".1W%7:-@"BBB@ HHHZ4 %%4='UFPU_3$U#
M29_M%K(S*LFQER58J>& /4$5/>7MKIUJUSJ%S#:VZ8W2SR!$7)P,D\#D@4 3
MT4=>E% !115%]9L(]=BT9Y\7\T#7"0[&YC4@%MV,=2.,YH O45 ]]:Q7L5G)
M<PI=3*SQ0-( \BKU(7J0,C..F:GH **SH_$.BS:H^F1:O8/?QG:]HMRAE4^A
M3.1^5:- !1110 4444 %%%% !15&/6;"779M&2?-_# MQ)#L;Y8V) .[&.H/
M&<U>H **** "BBB@ HHHH ***BN;J"RM9+F\GCMX(E+R2RN%5%'4DG@"@"6B
MJEYJ=GI^D3:I=3JME!"9WF4%P$ R6&W)/'/%36MU#>V<-U:OOAGC62-L$;E(
MR#@\]#0!+1110 4451BUFPGUNXTB*?=?6T232Q;&&U&)"G.,'.#T- %ZBBB@
M HHHH ***@O+VUTZU:YU"YAM;=,;I9Y B+DX&2>!R0* )Z*.O2H%OK5[Y[);
MF%KN-!(]N)!YBH3@,5Z@$@\T 3T44$@ D]!0 451T?6;#7]*AU+29_M%I-GR
MY-C+NP2IX8 ]0>U7J "BBB@ HHJCI^LV&JSWL-A/YLEA.;>Y&QE\N0 ';R!G
M@CD9% %ZBBB@ HIDTR6\$DTS;8XU+,<9P ,FH-+U.TUG2[?4=-E\ZTN8Q)%)
MM*[E/0X(!'XB@"U1110 4451UC6;#0-*EU+5Y_L]I"5#R;&;&Y@HX4$]2.U
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MK&467GL8 ,L-N2F2"0.>HP>.M<Q]DU*3QUX?BL=?D^T?\(Y.QOS!$[XWJ0
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M)/[^W&-WOUJ6/1-*A:%H=,LXS!(TT)6W4>6[?>9>.&.3DCDYJY/FE=_UK?\
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MO7^O7_-?<"T_KT_R?WGET'Q(UK4O#VJ>(-+P\&E:1&)K8Q#!OF/SY.,XC Y
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M]%QN9<=0,CD>HK)/B^Q@TV+4-2BETVTN'B2WENI(0)O,. 5PYP,$$YP0/H:
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M0+(#N9<[E'J1@Y';!H#8GK,\2_\ (IZM_P!>4W_H!K3K,\2_\BGJW_7E-_Z
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MRO.!W,\) _UH(^1L;?QJ67Q5J&B6*M?0?;0&=_WQ:.Y\C=A7:..(J.,\L4'
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MS\;O^1'LO^PM:_\ H1KT:@ K*N/#>F76H_;IH9?/\U)CMN)%0R* %<H&VD@
M#)'85JUQ6N>(;B#Q=#8V6IM!_I,%O):R20@N'ZO&AC+M@,/F+!05Q@X()NT@
M>S9;@\ Z=!X<33!)(\GV=+=IY))'^4,K,$0N1&&*\A<=O05ICPOI0@\ORI]W
MF^;Y_P!KE\[?MVY\W=O^[QC/3CI7'6=P]I:Z-/\ V_/,\%S=1/$[P --ABL+
M80$,W3'7GCM3M,\1:OJMND=OJ\B^=+:K)*?LCRP,[$.H1"VU2!QO&X$')-&[
M^[\0;TNSLE\/:3#&N+8(L8CY,C?\LW,BDG/)WDL2>23SFG+H^EW,D5["A8F0
MW"2Q3N Y<#)X.&4@+P<J<#BN2N];O$MVM]3U\Z?#&MX@NVBB!N7CEVHAW+MS
MMY*J 6[8P:LL3%IG@F=]2DLH%,:O@QA')MFP"64]3\O4=?7!#6JO_6M_\A2T
M=O7\+?YFM%X8TR>QC%O=7,BQHT=O(EV[)",,OR)G8"JDJ#C/XUK/IMI)9PVC
M0CR(&C:.-25"F,@IT]"HX]JX :IJV@:'#+;WLMQ'<1W+^5Y46+<"X1=Z$@?=
M5V)WL1QG@5O:5XCEC\*ZEJEU,;V*UD86S^; \DPVKA&\DE-V\E0!CC;D4KZ7
M^8[;&OJ?AS3-8F,M_#*S-&(W\NXDC$B@D@,$8!@"21G.,FFOX7TE]0-ZUO(9
MM[N!]HDV!G4JS!-VT$@G) [YZUQ%C/JOAJTU&TDANM/N=0M1>I<3^5(#=Y G
M*@.XP=R,%..C5MO<ZO\ VM'I"ZU< #4Q"UUY,/FM']E,NW[FS[W?;TX]Z=NG
M]>8;_P!?<;4'A72+:^@NX8)5DMW,D2_:93&C%"A8(6VYVDC..Y/6K&I:;ID\
M%[+J:1^5/;>1<O)(54Q#<<$YP/O-SP?>N1N?%]U8:+<R7^I1PSG3&:U:144S
M3K)(I*C'S-PA*CCGI5'6/$=Q>2:Q9QZAYMM)97H:TEDB,D)CX!V)&&0'G&YR
M2.U&X]OP_P SKI/!^E>7,UO"?-DBEC07,TLT2>9RW[LN!@GDXQGUJMIW@FU@
M\^34;B:YN99%<30SSQ,FU2HPQE9^C,#\V.>@JKXQAF.MZ->V@9KC3H;B[C1>
ML@7RPZ8[[D+ >Y%<_+K%PM_>>*K1I@-2M8UA<!<PV@G5%D <A1PSR9;@;AG@
M8I+5V_K^O^"+[-_Z['>P>&]*M[-[6&UVPO"D#+YCG*(25&2<\%CSUYJ74]$L
M=7,9ODE+1JRJT,\D3;6QN4E&!(.!D'C@5P5SXPU2.WC']HF*)EF:VNS-8XG9
M2 JRL7\OC)!$9#$<\5>M;F:WU^XCGU S7+ZNC&VF$3&%3:9!7"@@9& WHON<
MFZNQKR.MBT#3(;?R(K;;'OBDV^8WWH@HC/7ML7ZXYS3+7PWI=EJ2WUM!(LZ!
MQ'FXD9(PYRP5"Q502!T KDHM9UFVTFP>[UN1Q?65O<7%W)!$/LH9U#LH"  8
M;JP8#J>,UI:?K=Y)X7UJZM-2.J&UNGCM[HQ(?D"H<XC #;=S'@<XIN^OE?\
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MC,4CB3RBYDF=V;RSE,L22<$>O/?-1)X:TQ&?;'/L=]YA^URF(-O#Y$>[:OS
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MQW]:U;35=;DNFO+F\DC OX+8Z=Y481 \$;,"VW?D,Y.=W;&*/Z_&P.ZW\_\
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MCI\A_2L2VTW6-(@LY7MX+S^RK,VEK%!*=USN9%#OE,1X"#(&[J?2A6Z_UO\
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M7DMP#]P<<=LE?93>X/=V-J37]'B=4EU6Q1FB,ZJUR@)C )WCG[N >>G!I/\
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M6KW%R64)EYL[<*0Y 8$KE?X>>:D;PUJ'E?V>4LYK%;UKSSY)F$LA+%O+*["
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MB-VLSQ+_ ,BGJW_7E-_Z :TZS/$O_(IZM_UY3?\ H!I#.2^!O_)&-"_[>/\
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M$:,OE@0)%E>[ G)4L>#P<"H]&\9 Z);R:O;7B7#6HF5VC3_2CN5/D"MP2SJ
M&"YW#M6DGAU8[E9([N:%8;M[F%8@O&\?O$.X'*EBQXP1G@BH;KP9IEYIL%C<
M-,\5O:FV3<5/&Y'#$%<$@QJ>F.N0:7]?@,TM,U1-3CGQ!-;36\IBF@GV[XVP
M& .TE3E64Y!/6L+5-9\3Z;X<N+Q[&Q-Z)H([>#+%7WNH8$ANOS;1[C/0XK;T
M71K?0[)K:U.Y6<N3Y,4620!TC15[=<9]ZGO["+48$BG9U5)HYAL(!W(X<=>V
M5&:.J^7_  1(YZ]\8XU;0XM-$,EE>)Y]Y-)G,431NT>,?Q$HW7LIJRGC"V<*
MIT^_2XE$9MK=T0/<*^[:R_/@<*Q(8J0!R!Q34\(Z-8^9OEE5;F],^V648+,C
M((ER.$^=L*.YJE;?#[0I=+6."83P%HY()5M[4[=H(!!$6'R&(^?=Z]>: )F\
M9/+/-]GT^X2WCL9KAYI%0F*2-BK*5\P$X92,#J>AQS5N'Q;;/>^1+9WD40F-
MO]L=$$1D$?F$##EON@\XQGC- \(VBVL<$=U<11K:RVLBQ1PQB5),DY"Q@ @G
M(VA??-6?^$<LQ&JEI7"W)NMK,,,QC*8/'3!^M'3^N_\ D']?A_F4XO$\^I1R
M0:9I5U!>2V375FUZ$$4HR I.UR1RP)!P<>AJ5[W5;1M.EU#R5$UV]O-#$. C
M%O*;)R=PVJ#SCYFXX%5?#GA_4K#5/M>IW&4AM!:V\'VGSPB9!^]Y49XV@<[B
M>YK5U73I[^2WD@G6,VH>2)67(,Q4JC'V&YCC'7'I3=E:W]:_Y?B)7=T_ZT_S
M+5_=_8;&6Y\EYA$NXHC(I/XNRJ/Q(K C\=6=Q!#)9:??79D2>1E@,+>6L+!7
M);S-IY88VDYK5O-'_M+1(K&_NI6D3RW:X14#-(A#!MI4KU&<8Q[56L_"UM:$
MNUW=W$K1SH\DS)EO.968_*H&<J,8  ]*6MW_ %Z%*UD4-6\6'RT72+>Z=1>6
MD,EXJ)Y2>;)&2I#'=RCCD*0-PY!Z:6KZY+I>K:?;_8I);>X\PS7"L@$05<YY
M8'CJ< \=.:K2>#K5F01W]]# LL$SV\;ILE>';M9LH6Y\M 0" <=*TM3TB+5'
MMFEFEB,#,?W>W$BLI5D;<#P0>V#Z$4Y;>[_6PETN0Z;K\>H726[V5W9O-"9X
M/M*H/.C! +#:QQC<O#8/S#CKBM<^+]/M"ZS1W&^.XDMWC5 64HN[=C/0@ICN
M2Z\#M9TW0(]/NDN'O;N\>&$P0?:60^3&2"5&U1G.U>6R?E'/7,%SX2TV[UB]
MU&;SC->6X@=0^%3!!WKQD.=J<Y_@7TH=OZ_ %>VI6O/%LT$D4$>BWHNS<0I+
M;RM#N2.0D!\B3:<E6 P3R#G'%7K#Q%;ZAJ"VR6US$L@D,$\BJ(YPC!6VX8D8
M)_B R.1D56F\.6P4M=ZO=M>S2Q;+R1H1(#&2411L"=V.-I)R?;#M'\(:?H>I
M27ED3E]^$:"$;=S9/SB,2'OU8]?I@7]?<@8^_P#$UO8:W%I4\,J2W'RPR^9$
M58[2WW-_F=L9V8JMX0U>\U+3IIM0F,S)';L"$ ^];QNW '=F)_&K$OA6WEUA
MK_[;=H'N!<O;J8_+:0)L!)V;\8[;L>U3Z;I-EX>LVCBN71)/*B#SNO546) .
M ,G:OU)_"DMGW'U,EO%LUT^DW.GZ=?26]W)(ODKY!:4",L#GS,* >H8J<C&*
MM3>,[" Z:TD$X@U(1>3,7B7F1MJJ4+AR<D9PI SUX.)-+\/V<=TFJ1ZA/?RR
M.9?/8Q8DRFS/[M%4\=P,^YXJN/!%FA@$5_?1Q1?9RT:F/$ODL&3<2F[&0,@$
M#VIZ7_KYBZ#D\90RQAXM(U*0MYK(JK%EXXSM>0#S/N@X&#ACG@&KNE>(;?6;
MR>*Q@F:*$#-P2@0D@$ +NWC(;()4 XZ]*HW_ ('TR_AM$D>0/:"18Y&BAE.V
M1MS B1&7J!@XSQUZYOVN@QVVK+?F[GE:.$P0Q,D2I$A*G V(I(^4=2<=J2\P
M9%/XF@@NI(_L5W)!'.+9KM0GEB4D )RP;[Q5<[=N3UZXKZ#K-S)X5N-7U9;E
M2C32E)1%\J*3POEYXP.Y)SGVJU)X;MY+YIC=W0MWN%N7L@R>4TJD$-]W=U .
M V,CIUS=M--@L]-^P*#+!A@1)@[@Q)(/YFEKR^?]?K^ _M:[&=#?:G:6#:IK
M<]HMKY7F&VMK9S(A.,+O+D.><?<&21TJ.7Q;'"X@ETG4%O6E2-;/$1D.\.5;
M(DV;?W;C[W&.:?;Z!!+92V@UB\N[#88%MV>(K$5( PX0/N4KW8GUS4D/AJ%+
MR.\NKV[O+M)$?SYC&&(5755PBJ-H\QSP <GK5:7%TUW*:^-[/['-<S:=J,$4
M=O-.IDC3,HA($BJ Y^8$XYP#V)'-2+XPB%P8KK2M1M DL<4TDRQ;86DQLSM<
MYSD?=SCOBIIO"EC/9_9GEN GE7,60RYQ.VY^W4'I^N:GN= M+MIS*TO^D30S
M. 1C,14J.G0[1G^E(.A1?QG:16;74VGZA'"UN;BW8QH?M2#'* .2#AE.&VG!
MZ<'&GIFK#4EN1]DN+6>VD\N6"XV;E)4,.59E((8=#6<O@^T\@037U]/#'"8+
M>.1TQ;ID'"X4$\*HRVXX'7DYU[>PCMKJ\N(V??>.KODC (0(,<>BCKFAVZ <
MP/%.J6^CRW=Q#%<WBRPQR:=#!Y4MJ7?:=YDEPXYP&  )&1P>-2?Q7:VTCM<V
MEU%:12B&:]8)Y44AP-I^;<>2!D*5R>O6D?PM'<+.;W4[ZZGE1$6XD\I6B"N'
M&T+&%^\ >0>GIQ1-X3M;AG2YO+N:TED6::S8IY4L@Q\YPFX9(#$ A<CIUH_K
M^OZW'H4[WQ6\3:5=/:W=C9W%P5_?K&6N5,,C*$569@2RK@$*W(&.HK;O-42Q
MTM;RYMYU9RBK;@*9"[D!4X.W.2!UQ[XYK.?PA:W%O:V]_>WE[!9R"2W29D_=
M$(R##*@;@-D$DME0<]<W;G3[>^L1I=Q>RR3Q!)1+O43*5;*28 QG<O\ =P<$
M8/(INW3^E_F)7ZF-?>)+NXU+3+*SL]0M))+[R;M<0;XP(FD R6*D$ '*YX!&
M0W%7M;UR[L-4@L;>RED2>TGF-RI3$90#'!8'OSP>HQGG$UOX<@@N8KJ6ZNKF
MYCN#<--,5W2-Y9C (50  IX  Z9YYS/J6CQZE<03-<3P/"KQYAV_.C@;E.Y3
MP<#D8/'6IEM9#C:]V9&G>,$DTN$WMA?)>-! ZPLD8>X,N0I7#8&2K<,5QWP*
MT3X@@_X1V[U;R)D6T24RP2 "16CSN4X)&<CJ"1WSBJU_X.TW4K=8;EI2%AAA
M0D(VWRB2K892I/S'.00?2KUCH=I9:(VE%5FMG5UD5HHT#ALY!6-57H<<"JE9
MWL3'2U_+_@E87NI:99O?:Y<6CP[0%MK2V8.)&8!4#M(0QR=OW5R2#Q4,OBV.
M*2.W;2=1^W23B$68$1D&49PQ/F;-I"-SNZC%2?V%&\<FG7.M7MRGEJT<$K1;
MH=K HZD(')4J,%B>G.:DM_#<$5[%>W%Y=7=W'-YIGF* OB-D"D*H 4!VZ <G
M/-&@RDGC>S-HUQ)IVHQ(8//B#QINF4.J-M <G(9E&&QG/&:?<^,8+.TGFN]-
MO('MG"3PRRVZ-&"NX-EI0I!Z?*Q.>U5[GPY9:MH4<>C:AYGE0M:QS),K* 94
M9CN4'Y@8^/UJ>7P;#-<?:GU74?MIW!KO]SO964+MQY>T#"C!50>O/)J7>V@U
M:^H]/&%I+<JL5E>O;EX4-V%01AIE5HQ@MNYWJ.%X)Y]:MZ7XAM-7ECCM8Y@[
M6PN'#J!Y0+%0C8/#95A@9^Z>:B@\+V5O9_9HY;@IYMO+EF7.80@3MT/EC/U/
M2HO"^CQZ9)JTQ,'VJ\O6FGB@E,BP$@$)D@'OOQ@<N>.:O2[M_7]?H3K97\C.
ME\5ZBU_;HNE7:J-5DM#$GDLTZB%V')? P0"22O;W%7KCQG8VL%C/-;7"PWI5
M5=GA4HQ?9M*F0,2#UVAJN)X>@35/MOVJY;%R;I("4V(YC,;8^7=@ALX)/(&,
M=*HR>";-G!COKZ%2$61$,?[T+(T@!)0D#<QX4C/>IZ+Y#>[_ *Z_Y%W0M9N=
M6L[N:XTZ:V:"XEA2-FC)D",1QAR,\=R!GVYK%@\6ZC,^ESMI-YBX2Z\RTB\D
MLWELH5LE\  9'WAD]NE=)I^FKISW/E3S/'<3--Y4FW;&S$EMN #@DYY)]L55
MLO#L%E-&XNKF40^<(ED*8C64@LHPH) *\9R>3DFEKT'I?R(;;Q;8W<\(MX+I
M[:9HX_M>Q1$LDB!U0Y;=DAEY"D98#.:NWVLV^GR3I,DK&"T>[;8 <HO4#GK_
M )S638> ]*TW4H+RU9]\0CR)(8'WE$"!BYC+@X5?NL!D=.3F]K?AR+6]Q:^O
M+,R6[VTAM60&2-\94[E;'3J,'GK5.U]/ZT_S_ 2WU\O^#^'XD2>*K=]3>U^P
MWJQ).ENUVRIY0D:,.!][=T8#.W&:S3XTW:M9R_9+V#3IK&:>/S(X_P#2CYD*
MQE,,2"=^ &V_>&1Z;0\/6@W_ #S$/=I=D$C[Z(J =.F$'Z\UF2^ =/N(EAN[
MV^N+>*V:V@@E:,I A='&!L^8@QIC=NX'.:-/Z]/\P7F3MXP@69;?^R]0:ZWR
M++;JL9:#8J,2WSX(VR*1M+9SZ\4U?&%N;6"]D@G@M9+>6=598Y&D5-G*F.1@
M/OXQ@DGTQS/IOA6TTLQM:S2+)&LH5TAAC_UFW)VI&JDC8,$CZYJM+X.M_(NW
M,UQ>W4Z2Y,\B0AV=4&28XQM_U:_,%SU/-(:'MXP5)FMY=%U2.[$L40MB(2S&
M178$$2;<81LG/%*_C.R6V$XL[QUCC:6Z"HF;1%<HQ?YN<,K_ '=V=I(S4.C^
M&;Q+Z34-<O))KKSXY(PLRR !$=0"1$@Y\QC@*.W)YHN? 6E75PD[-()5+Y9X
M8)=P:1I,8DC8 !G;&,'!Y)I]1=/Z[_Y!-XGDN=;TNVL+:Z2TFU"6VDNF1/*F
MV12[E')88=.NT9VG!(ZVM3\7Z?I,D\=Y'<!X+B*$JJ EA(NX2#G[@ <D]1L;
M@XY6/PK;Q:I;W:7UZ(K:YDNHK/<GE+(ZL&/W=Q'SL<;L GCCBGZAX6T[5-9&
MI7?FM)]D>T:,,/+96R-Q&/O ,X![!V]:.P^O]=R%O%ULUS<PV=A>WC6K-YQ@
M6/"*I*E_F<9&Y7&!ELHW'3-F+Q)8SQEX!*Z?:H[97"C#,Z*ZL.?NX<>_M5.#
MP;:V=E!;V6H7]N4M_L\TR.ADN4R6_>%D/.6<[EVG+'FI!X2M$OHYK>[O(((Y
MHY_L<;)Y1=$"*3E2WW5 QNQQG&:7E_6^OX?B)^7]?TS&F\87:>#_ #(8+JXO
MTL(YYKN*./RX6?.TL"1GH3A5.!UQ6YK6K76G:QID5M:W%XMP)0\%N$W-M (.
M7*@ <]Q^-5IO!-I)9?9(=0O[:!K=+>9(GC_?*F=N[*'!Y(RN,CKFM+5-&&IW
M%K<)?75E/:E_+DMBG.X8((=6!'X4/R#J44\8V,HB>&VO'A81F:81J%MC(VU5
M<%LYSUVAL=3@<U=U76X]+ECB%I=7DSQO+Y5LJDK&F-S'<P&!N P#DYX!YK,7
MP%I,=];W<1=9(5C4[XH9?-V'():2-F!.3DJ5Z^N#5O7O"MAXAN+>>[+)-;JZ
M(XBBD^5L9&V5'7JH.<9XZ\F@%YD47B^UGO&BM[&]E@$J0K=JL8B=WC$B@9<-
MR&49QC)Y-9DGC:]307OCI<JW"VES<+;$1G=Y3JN[<)< ?-R.IYQC !WH_#MG
M$"$:4 W4=U@;0 R(J   8"X0<55_X1"S,$T,MW=R1R03VZJQ0>7',RLP7"CH
M5X)R>3G-/2_]=O\ ,$5XO$\T6I7L$]G=W$WF+Y%E"L7F1H(4=\G<%X+_ -X\
ML ,U#J/C(3VL+Z)!=21-=V<;WJQIY2B5XR5(8[N4<<A3C<.0>D][X%T_491/
M>7$\UT&W>?+%!(3\BH?E:,IR$4_=ZCC'2I9/!UJS((KZ\MX!-!.]M#Y2QR20
M[=K$;,C[B@A2HXZ"B-KZ^0RSJ^N2Z7JVGV_V*26WN/,,UPK(!$%7.>6!XZG
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M81QABNYBJ?*,J>2!T.,XS5B'Q1I$]X]LERZNC.A>2"1(]R#+J)&4*2 "< ]
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ML[B*:99Y;B0R22KYN6.T*,^9)(Q.% ^]V'%99\1ZC-;0+8PVLMY/+>Q1Q,2
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M]8,*0V=O7GAZW_KO_F#W=R:[\')>Z4+&:]95W799XTVG]^7/'/&W?^..U7=
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MCC\V.-&SO (R &.<CH32>%)-,N]%:^T>XGNX;Z5IWNIXC&\S' W8*KQ@  @
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5F>)?^13U;_KRF_P#0#6G69XE_Y%/5O^O*;_T
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M:0\!2/O,.?O,>*;\OZ_X<2V_K^M_R.UC\2:'+!<S1:SI[Q6KA+B1;I"L+$X
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M?\*U\2_]%+US_OA?\: /1J*\Y_X5KXE_Z*7KG_?"_P"-'_"M?$O_ $4O7/\
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M_P"-'_"M?$O_ $4O7/\ OA?\: /1J*\Y_P"%:^)?^BEZY_WPO^-'_"M?$O\
MT4O7/^^%_P : /1J*\Y_X5KXE_Z*7KG_ 'PO^-'_  K7Q+_T4O7/^^%_QH ]
M&HKSG_A6OB7_ **7KG_?"_XT?\*U\2_]%+US_OA?\: /1J*\Y_X5KXE_Z*7K
MG_?"_P"-'_"M?$O_ $4O7/\ OA?\: /1J*\Y_P"%:^)?^BEZY_WPO^-'_"M?
M$O\ T4O7/^^%_P : /1J*\Y_X5KXE_Z*7KG_ 'PO^-'_  K7Q+_T4O7/^^%_
MQH ]&HKSG_A6OB7_ **7KG_?"_XT?\*U\2_]%+US_OA?\: /1J*\Y_X5KXE_
MZ*7KG_?"_P"-'_"M?$O_ $4O7/\ OA?\: /1J*\Y_P"%:^)?^BEZY_WPO^-'
M_"M?$O\ T4O7/^^%_P : /1J*\Y_X5KXE_Z*7KG_ 'PO^-'_  K7Q+_T4O7/
M^^%_QH ]&HKSG_A6OB7_ **7KG_?"_XT?\*U\2_]%+US_OA?\: /1J*\Y_X5
MKXE_Z*7KG_?"_P"-'_"M?$O_ $4O7/\ OA?\: /1J*\Y_P"%:^)?^BEZY_WP
MO^-'_"M?$O\ T4O7/^^%_P : /1J*\Y_X5KXE_Z*7KG_ 'PO^-'_  K7Q+_T
M4O7/^^%_QH ]&HKSG_A6OB7_ **7KG_?"_XT?\*U\2_]%+US_OA?\: /1JR?
M%<T=OX.UF6=UCC2QF+,QP -AKC_^%:^)?^BEZY_WPO\ C44WPAN=6*0^*/&V
MN:O8*P9[-G$:2X[-CJ/U]"* -#X*6\EM\'-!29=K%)9 /9IG8'\B*[NHK6U@
ML;.&ULX4@MX$$<42#"HH&  .P J6@"O??\>P_P"NL?\ Z&**+[_CV'_76/\
M]#%% "V/_(.MO^N2_P A4]%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
;444 %%%% %>^_P"/8?\ 76/_ -#%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pvpfy2023capgraphv3.jpg
<TEXT>
begin 644 pvpfy2023capgraphv3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2H!VT# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>9^,/^1CN_\ @'_H"UZ97F?C#_D8[O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKS#XT?'+PI\+_#VL07WB.SL?$/V":2SL0^^<R^6?+^102,MC!.!7I-V\L=K,
MT""2=48QHQP&;' )^M?$7[$OA;P?\4[SQEJ_C6RL_$OC9[WS9(=9C2;$+#)D
M$3Y!)<L"<?+A0,9Y /9OV2_C9IOCSX;Z'IFK^+K?5O'&)VN[6XD"W+#S9&7"
MD#?B/;RN<=Z]]KSNU_9]^'NF^+M+\3:9X7L=&UC379X)M,3[,G*,A#1IA&X8
M]1GWK6^*GAOQ%XN\%WFD^&->_P"$9U2Y>-/[3"%GBBWCS-F.0Q7(!R.O4=0
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MVN_ &L^%[=-(TCQ,Z6MY8VPV0Y>412@+T"X>)]O0,N1VK[7H **** "BBB@
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M N\;'_OD4 4_@_\ 'SX@>"OBY:_"OXL0PW5]=@"PU>$*&<D'RR2N%=&VE0V
MP;AL\X^C/B/X8U3QEX-U#1]%\0W'A74KC9Y6K6L?F20X=6.!N7J 5X8?>KY@
M\&^'O%?[2G[1&B?$K5?#5SX4\(^'XT6R34%(FNFC=G3 ."27<L6 V@+MR3R?
M8?C=^T%<_ _7],.H>$=2U;PK=6Y>?5].^8VTH8C8RD!?NX/++^.* /!OBO\
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MDK6J+)< ?(K="?S%8'V_Q1_T#;7_ +Z'_P 77344 <S]O\4?] VU_P"^A_\
M%T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH?_%T?;_%'_0-M?\ OH?_
M !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?^^A_\77344 <S]O\4?\
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MV_Q1_P! VU_[Z'_Q='V_Q1_T#;7_ +Z'_P 77344 <S]O\4?] VU_P"^A_\
M%T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH?_%T?;_%'_0-M?\ OH?_
M !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?^^A_\77344 <S]O\4?\
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MV_Q1_P! VU_[Z'_Q='V_Q1_T#;7_ +Z'_P 77344 <S]O\4?] VU_P"^A_\
M%T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH?_%T?;_%'_0-M?\ OH?_
M !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?^^A_\77344 <S]O\4?\
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MV_Q1_P! VU_[Z'_Q='V_Q1_T#;7_ +Z'_P 77344 <S]O\4?] VU_P"^A_\
M%T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH?_%T?;_%'_0-M?\ OH?_
M !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?^^A_\77344 <S]O\4?\
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MV_Q1_P! VU_[Z'_Q='V_Q1_T#;7_ +Z'_P 77344 <S]O\4?] VU_P"^A_\
M%T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH?_%T?;_%'_0-M?\ OH?_
M !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?^^A_\77344 <S]O\4?\
M0-M?^^A_\71]O\4?] VU_P"^A_\ %UTU% ',_;_%'_0-M?\ OH?_ !='V_Q1
M_P! VU_[Z'_Q==-10!S/V_Q1_P! VU_[Z'_Q='V_Q1_T#;7_ +Z'_P 77344
M <S]O\4?] VU_P"^A_\ %T?;_%'_ $#;7_OH?_%UTU% ',_;_%'_ $#;7_OH
M?_%T?;_%'_0-M?\ OH?_ !==-10!S/V_Q1_T#;7_ +Z'_P 71]O\4?\ 0-M?
M^^A_\77344 <S]O\4?\ 0-M?^^A_\71]O\4?] VU_P"^A_\ %UTU% ',_;_%
M'_0-M?\ OH?_ !='V_Q1_P! VU_[Z'_Q==-10!BZ5=:W-=A;^SAAM\'+1D$Y
M[?Q&MJBB@ HHHH **** "OG7XM?L9Z'XU\1S>*?"NL7?@CQ3)(9VN;+)ADE.
M27V@JR,3U96 ZG:3G/O'B2[O[#P[JMSI5JM]JD-K+):6K' FF"$HA.1P6 '7
MO7S/:_M[:;X>C6T\<^ O$OA[65^5[>&!'4L."1YK1L.>V#]30!@>&OC5\3_V
M>_B5HO@KXJS1^(="U618;/6T^:0 L%#B3 +@,PWJXW $$'& ?LFOBGQ$OB7]
ML[XH>$9[7PIJ'AOP#X?G::34M6BV27 9D9P!G!+"-%"J6QDL3@@5]6_$SXC:
M3\*/!M[XFUM;EM.M&C606D?F29=P@P"0.K#J: /FW]M3_DKWP-_["K?^E%K7
MUW7YV?M%_M+^$?BIX^^&FLZ+'J2VGAV^:XO!=6ZHY4RP/\@#G)Q&W7':OKWX
M.?M*>$OCEJFH6'AR/4DGL85GE^W6ZQKM+;1@ACSF@#TS4]3M-%TZYO[^YBL[
M*VC:6:XF8*D:*,EB3T %?(6CPW7[9?QPM/$,EM+!\+?",I6T$RE?M\^0QX/]
MXA"P[(J@X+5Q7[6WQ^_X2CXI2?#[5VU+2? FDW2+JBZ;&CW=\P ;@.RKMR0%
M!./XR&P%'H/A;]N[X1>"O#]CHFB^&/$UAI=E&(H+>.TML*/4G[1DDG))/)))
M- '=_MTB3_AG/6M@.T75IOQ_=\Y?ZXKO?V>'CD^!/@$Q8V_V+:@X_O")0?US
M5#Q59V'[2O[/U['IJ36MMXBT[SK,7R!'CD#!XBX!.,.BDX)XZ9KYV^!O[4UO
M\!?"H^'OQ-T35]+U+17D2VECMP^Z(LS!6!8="2%9<J5QR,9(!N_MMI]L^+'P
M1M(#MNWU.0 Y_O3VH7]0:^OJ^./ JZM^U7^T3I/Q#DTBZTGP#X70?V<UXFUK
MF56+(1U!;>0QVY "*,Y.3]CT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7F?C#_D8[O_@'_H"UZ97F?C#_ )&.[_X!_P"@+0!TWP__ .0--_U\-_Z"
MM=-7,_#_ /Y TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !11
M10 5Y1XE^$.I:_\ M$>$O'_VVU72-#TV:U^QMN\YII!,I8<;=N)%[YXKU>B@
M I*6B@"O:V%M9;OL]M#!N^]Y2!<_7%)J<]Q:Z;=S6=M]LNXXG>&VWA/-<*2J
M;CP,G R>F:LT4 >)?LV_!74/A_#KGBGQ;Y4_CWQ)<R7&H21L'6W0N6$*$=L_
M,<<?='\(->U30QW$;1RHLD;<%7&0?PI]% $5O;0VD?EP1)#'G.V-0H_(5+11
M0!#<VD%Y&$N(8YT!R%D0,,^O-/AACMXUCB18XUX"H, ?A3Z* "J[:?:-<_:&
MM83<9!\TQC?QTYQFK%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7E'QB^$.I?$KQU\-=8MKZUMM.\,:FVHW<$^[?,0
MT3)LP",CRVZXZBO5Z* "BBB@ HHHH **** "H+JQMKW;]HMXI]OW?-0-C/7&
M:GHH 15"*%4!5 P !@"EHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "O,_&'_ ",=W_P#_P! 6O3*\S\8?\C'=_\  /\ T!: .F^'_P#R!IO^OAO_
M $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBDH 6BDR*-U "T4FZC=0 M%)NHW4 +12;J-U "T4FZC=0 M%)NHR*
M%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "O,_&'_(QW?\ P#_T!:],KS/QA_R,=W_P#_T!: .F^'__ "!I
MO^OAO_05KIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S\8?\C'
M=_\  /\ T!:],KS/QA_R,=W_ , _] 6@#IOA_P#\@:;_ *^&_P#05KIJYGX?
M_P#(&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK4ZF2=#0!D
M:M,8XV^E?/'[1.I&3P'JL.>&,7_HU#7O^NM^Y?Z5\R_M 2G_ (1>_7_:C_\
M1BUW8'_>Z/\ BC^:.?$?P9^C_(^:****_8CX@**** "BBB@ HHHH **** "N
MS^#MQ]E^)&C2]-IE_6)Q7&5U'PS;9XXTL_[3_P#HMJX<=_NE;_#+\F=&'_C0
M]5^9]V^%KXS1H<YKMK=MRBO-/ \A:&/GM7I%I]P5^.GVY:I:2EH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S\8?\
M(QW?_ /_ $!:],KS/QA_R,=W_P  _P#0%H Z;X?_ /(&F_Z^&_\ 05KIJYGX
M?_\ (&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDG0T^F2=#
M0!SVO?ZE_I7S%\?_ /D6[[_>C_\ 1BU].Z]_J7^E?,7[0'_(M7W^]'_Z,6N[
M ?[W1_Q1_-'/B/X,_1_D?-M%-W4;J_93X<=13=U&Z@!U%-W4;J '44W=1NH
M=13=U&Z@!U=+\-_^1VTS_>?_ - :N8W5TWPV;_BMM,_WG_\ 0&K@Q_\ NE;_
M  R_)G1A_P"-#U7YGVQX%_U,?TKTNS^X*\T\"_ZF/Z5Z79_<%?C9]P6Z6DI:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "O,_&'_ ",=W_P#_P! 6O3*\S\8?\C'=_\  /\ T!: .F^'_P#R!IO^OAO_
M $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M9)T-/IDG0T <]KW^I?Z5\Q?M ?\ (LWW^]'_ .C%KZ=U[_4O]*^8?V@O^19O
MO]Z/_P!&+7=@/][H_P"*/YHY\1_!GZ/\CYKHIN:,U^RGPUQU%-S1F@+CJ*;F
MC- 7'44W-&: N.HIN:,T!<=73?#7_D=M+_WG_P#0&KE\UT_PU_Y'C2_]Y_\
MT6U<&/\ ]TK?X9?DSHP[_?0]5^9]M>!?]3']*]+L_N"O-/ O^IC^E>EV?W!7
MXV?<ENEI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KS/QA_R,=W_P#_T!:],KS/QA_P C'=_\ _\ 0%H Z;X?_P#(
M&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K*\5>*-+\%>'K[7-:NA9:78Q^;<7!1GV+G&=J@L>2. ":
MLZSJ]IX?T>^U2_F%O8V,$ES<3$$A(T4LS<>@!-?'>O\ Q ^+/[77A#7=.\&^
M%M-T?P+=2?9?MVISXN)MC*Q .<=0,X0@9(W$B@#Z_P##VOV'BK0M/UG2Y_M6
MFW\"7-M-L9-\; %6VL 1D$<$ UHUX!^SYJWQ6\-:CI_@3QSX/M;31=/TQ8K#
M7--??%MA"(D<A#,-Q'KM/R]#R:ZSXY>./'OAD:'I7P]\*+XAUC5FF#7EUD6M
MBD>SYI#E1EM_&6'W#PW2@#U.BOC[QSXT_:5^#.B'Q5KUQX<\0Z);LIN[6TA!
M,*LVWYL(C8R0,J6QD$\9KZ3^$_Q%L_BQ\/=%\56,36\.H1%F@8Y,4BL4D3/?
M#JP!XR,'O0!UU%%>$_M'?M#:A\,=0T3PGX1TN/7/'.N$"UMI<F.%"VT.R@@D
MD@@#( VL2<#! /=J*^0O%/BK]IOX4>'V\7:Y)X>U_2+0>;>Z;;Q*7ACSRS;4
M0X'JK-@<G@&OHOX2?$_3?B]\/],\5:<IMX;I&$MO(P+6\JDJZ$^Q'!XR"#@9
MH [*BODR7X]?%+X[>-M7TGX/6NF:;X=TF412Z]J:AA,V2,@D, IP2%56; R2
M,X#_  [^T%\2/A+\4M(\&?&&UT^YLM:94LM=TY0B!F8*"2 %*!B P*JRY#'(
MQD ^L**X#XX?%_3O@CX N_$E_$;N0,L%I9J^PW$[ [4SV& 23@X"G@]*\(TC
M6/VI?&V@IXHT]_#NCVES&MS:Z+-$JRR1D94#>K$9&/ONIY[4 ?6U%>(?LR?M
M#2_&O3=6T[6]/71_%VB2"._M$!5'!)7>JL=RD,I5E.<''/.![?0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM<T'4M-G020WEM);NC=&5T*D?D:^(/V4_%-QH_[*'Q?*2LAL8[J:!L_<DDM
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M (UF?\(7I/\ SP;_ +^-_C1_PA>D_P#/!O\ OXW^- &G_:EG_P _<'_?Q?\
M&C^U+/\ Y^X/^_B_XUF?\(7I/_/!O^_C?XT?\(7I/_/!O^_C?XT :?\ :EG_
M ,_<'_?Q?\:/[4L_^?N#_OXO^-9G_"%Z3_SP;_OXW^-'_"%Z3_SP;_OXW^-
M&G_:EG_S]P?]_%_QH_M2S_Y^X/\ OXO^-9G_  A>D_\ /!O^_C?XTG_"%Z3_
M ,\&_P"_C?XT :G]J6?_ #]P?]_%_P :/[4L_P#G[@_[^+_C67_PA>D_\\6_
M[^-_C2_\(7I/_/!O^_C?XT :?]J6?_/W!_W\7_&C^U+/_G[@_P"_B_XUF?\
M"%Z3_P \&_[^-_C1_P (7I/_ #P;_OXW^- &G_:EG_S]P?\ ?Q?\:/[4L_\
MG[@_[^+_ (UF?\(7I/\ SP;_ +^-_C1_PA>D_P#/!O\ OXW^- &G_:EG_P _
M<'_?Q?\ &C^U+/\ Y^X/^_B_XUF?\(7I/_/!O^_C?XT?\(7I/_/!O^_C?XT
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MP?\ ?Q?\:/[4L_\ G[@_[^+_ (UF?\(7I/\ SP;_ +^-_C1_PA>D_P#/!O\
MOXW^- &G_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XUF?\(7I/_/!O^_C?XT?
M\(7I/_/!O^_C?XT :?\ :EG_ ,_<'_?Q?\:/[4L_^?N#_OXO^-9G_"%Z3_SP
M;_OXW^-'_"%Z3_SP;_OXW^- &G_:EG_S]P?]_%_QH_M2S_Y^X/\ OXO^-9G_
M  A>D_\ /!O^_C?XT?\ "%Z3_P \&_[^-_C0!I_VI9_\_<'_ '\7_&C^U+/_
M )^X/^_B_P"-9G_"%Z3_ ,\&_P"_C?XT?\(7I/\ SP;_ +^-_C0!I_VI9_\
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M_&LS_A"])_YX-_W\;_&C_A"])_YX-_W\;_&@#3_M2S_Y^X/^_B_XT?VI9_\
M/W!_W\7_ !K,_P"$+TG_ )X-_P!_&_QH_P"$+TG_ )X-_P!_&_QH T_[4L_^
M?N#_ +^+_C1_:EG_ ,_<'_?Q?\:S/^$+TG_G@W_?QO\ &C_A"])_YX-_W\;_
M !H T_[4L_\ G[@_[^+_ (T?VI9_\_<'_?Q?\:S/^$+TG_G@W_?QO\:/^$+T
MG_G@W_?QO\: -/\ M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QK,_X0O2?^>#?]
M_&_QH_X0O2?^>#?]_&_QH T_[4L_^?N#_OXO^-']J6?_ #]P?]_%_P :S/\
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M_P!_&_QH T_[4L_^?N#_ +^+_C1_:EG_ ,_<'_?Q?\:S/^$+TG_G@W_?QO\
M&C_A"])_YX-_W\;_ !H T_[4L_\ G[@_[^+_ (T?VI9_\_<'_?Q?\:S/^$+T
MG_G@W_?QO\:/^$+TG_G@W_?QO\: -/\ M2S_ .?N#_OXO^-']J6?_/W!_P!_
M%_QK,_X0O2?^>#?]_&_QH_X0O2?^>#?]_&_QH T_[4L_^?N#_OXO^-']J6?_
M #]P?]_%_P :S/\ A"])_P">#?\ ?QO\:/\ A"])_P">#?\ ?QO\: -/^U+/
M_G[@_P"_B_XT?VI9_P#/W!_W\7_&LS_A"])_YX-_W\;_ !H_X0O2?^>#?]_&
M_P : -/^U+/_ )^X/^_B_P"-']J6?_/W!_W\7_&LS_A"])_YX-_W\;_&C_A"
M])_YX-_W\;_&@#3_ +4L_P#G[@_[^+_C1_:EG_S]P?\ ?Q?\:S/^$+TG_G@W
M_?QO\:/^$+TG_G@W_?QO\: -/^U+/_G[@_[^+_C1_:EG_P _<'_?Q?\ &LS_
M (0O2?\ G@W_ '\;_&C_ (0O2?\ G@W_ '\;_&@#3_M2S_Y^X/\ OXO^-']J
M6?\ S]P?]_%_QK,_X0O2?^>#?]_&_P :/^$+TG_G@W_?QO\ &@#6BOK>=]D=
MQ%(W]U7!-3UEZ?X;L-+N!/;Q,L@!&2Y/6M2@ HHHH **** "BBLWQ)K4?AOP
M[JNKS)YD6GVLMVZYQE8T+$9[<"@#2HKA_@K\2F^+_P -=(\6MI9T;^T/-Q9F
M?SM@25X\[]JYSLST'6NXH **** "BBB@ HHHH **** "BBB@ KYW_;I\4:GX
M?^"L-CID[6S:YJD.ESRJ=N(621V7/;)C /JI85]$5Y[\=_A':_&SX;W_ (:G
MG^QW#,MQ:717<(9TSM)'H02I[X8T <M\/_V0/AEX'TFUAF\.6OB#4$5?/OM6
M3[097'4^6V449[!>G7/6NON?@'\-+J$QO\/_  RJGO'I,$;?FJ U\[Z;\4OV
MA_@K9V^B^(? #>/+.W7RX=3TY9)Y9% X+R1!N .[HK'N33U_;'^*5YNBL_@A
MJSW!&5Q%=2?CM$()_.@"C\5OAKI7[+_Q@^'WC#P,\VE6.KZFNFZCI(E9XWC9
MEW;0Q)P5+<'(#!",5]GU\@^%/A=\5OC[\3_#OC#XIV</AWPYH<HN[+1(\*7<
M$,H\O<S#+*NXR')"X  /'U]0 4444 %%%% !1110 5YGXP_Y&.[_ . ?^@+7
MIE>9^,/^1CN_^ ?^@+0!TWP__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@
MK734 %%%% !1110 4444 %%%% !1110 4444 %%%% ',?$SP#8_%'P+JWA?4
M9[BUM-1C5&FM2!(A5U=2,@C[RCCN,U\?:K\/_B?X$^,GAKX7:-\8=7F@UFTE
MNTNKA7/V2%%D(&TR-G/EL!M*CIT[?=%9$_A'1;KQ-;^(IM*M)-=MX#;0ZBT0
M,\<1+$HK]0/F;C_:/K0!Y7\&?V7='^%GB&X\4:GK%[XP\8W"LKZQJ75=PP2B
MDL0Q'!8LQQD# )!F^.'P)UGXC:[IGB3PKXTOO!WB/3[<VRR0%C#/&6+;7"L"
M.2?[P/I7LM% 'RMJ/[.GQK\?:>=&\9_%V%M"DPEQ!IEH \T?=6*I'D'/\1(]
M0<5] ?#7X;Z+\)_!]CX;T&%HK&U!)DD(,LSGEI'( RQ/MV &  *ZFJVIZ?%J
MVFW=C.9!#<Q/"YB<HX5E(.UAR#@]1R* /DGX#6%U\3?VMO'WQ'TZ28^%[(R:
M?%<LQVW,FQ(PJ^JX0O[93UKUC]H7]FVR^.']EZG:ZK+X>\4Z3_QYZG"I8;=V
MX*P!!X;D,#E23UZ5Z/X%\!Z'\-?#-KH'AVQ73]+MMQ2(,6)9CEF9B26))ZD^
MW0"N@H ^4=2_9B^+OQ$M8=$\>_%=+OPPKJ9;?3[?$LZJ<@,=B GW<O@X.#@5
M]+^$?"NF>!_#6G:#H]N+73-/A$$$6<D*.Y/<DY)/<DFM>B@#Y;U?]DGQ3X+\
M;ZEXD^$?CA?"@U)]\^FWD.^%3NW8!PP902<*R<9(R<UN?#+]ES5+'XA0>/?B
M3XLD\:>)K50+.-4*V]L1G##.,XR2 %4 DG!)X^B** .-^+GPKT?XR>![SPUK
M7F1P3%98KB''F02K]V1<\<9(P>H)'>OG_3?V:_C?X<T9?#&D?%^&#PNB^3&3
M;LMQ''R,(=I9.#T608_ 5]944 >;_ OX&Z-\"?";Z3IDTE_>7,@FOM1G4*]S
M)C . 3M4<X7)QD\DDFO2*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *0FEJ*1MHH 1Y M0M>*.]9FI:@(%/.*^(/B!\
M2-9\:Z_=7$]]<)9K*PM[59"J1(#@< XW8ZGO7K9?E\\PG)1=DMV>7C\?# Q3
MDKMGWFETK=ZG60-TKY)^ _QFO;/4H] UJ]DN;:<[;2>=RS1OV0L?X3V]#@=Z
M^H-/U(3*.:PQF#J8*K[*?R?<WP>+AC*7M(?-=C9I:CC?=S4E<!VA1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,DZ&GTR3H: .>U[_4
MO]*^8/VA/^17O_\ >C_]&+7T_KW^I?Z5\P?M"?\ (KW_ /O1_P#HQ:[\!_OE
M'_%'\T<^)_@3]'^1\RY-&3245^SGP@N31DTE% "Y-&3244 +DT9-)10 N31D
MTE% "Y-=1\,C_P 5SI?^\_\ Z+:N6KJ/AC_R/6E_[S_^BVK@Q_\ N=;_  R_
M)G3AOX\/5?F?;_@7_4Q_2O2[/[@KS3P+_J8_I7I=G]P5^,'W1;I:2EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% =.N-08L\+L6$8!).UO,785!VG>&P"<5]C5\?\ [;B_8OBU\$[^%0UT-2<
M#[QV3VK*/S8_K7V!0 4444 %9/BSQ5I7@?P[?:[K=XEAI=E'YD]PX)"C( X
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M.:_+I1<6XO='Z7&2DDULRU12"EI#"BBB@ HHHH **** "BBB@ HHHH ****
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M^+'W9;I:2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTC$EG=O=F+,?K724 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@,9'&45-;]?4Z84M112;E%2UYAZ(4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4R3H:?3).AH Y[7O]2_TKY>_:&_Y%74/]Z/_ -&+7U#KW^I?Z5\O
M?M#?\BKJ'^]'_P"C%KOR_P#WRC_BC^:.;$_P)^C_ "/F&BBBOVP^""BBB@ H
MHHH **** "BBB@ KJ?A?_P CWI7^\_\ Z+:N6KJ?A?\ \CWI7^\__HMJ\_,/
M]SK?X9?DSIPW\>'JOS/N/P+_ *F/Z5Z79_<%>:>!?]3']*]+L_N"OQ0^]+=+
M24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-Z%K^I%6U0A[:\90 'EC8J7P.A8!6('&6.*]1H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "HY%R*DI* ,+5K 31MQFO)?&
MWAL2*YV_I7N$\>]37*>(=)$\;?+0!\;^,_#[02,ZK\R_J*XROHOQUX8_UA"5
MX3K^EMI]TQ"X1C^1K[3(<?9_5*C_ ,/^7^1\?G>!O_M5->O^9V?P7^(#>$]<
M%C=2;=.O' R3Q')T#?0]#^![5]>Z'J8FC7FOSZKZ5^ _Q).L:>-,O)<W]HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#Q#I6A&XSY/]I7L5OYF,9V[V&<9'3U% &Y17#_\ "\_AO_T4'PK_ .#JV_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBN9_X3"X_P"@/=?K_P#$T?\ "87'_0'NOU_^)H Z:BN9_P"$PN/^@/=?K_\
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MBN9_X3"X_P"@/=?K_P#$T?\ "87'_0'NOU_^)H Z:BN9_P"$PN/^@/=?K_\
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MC_H#W7Z__$T?\)A<?] >Z_7_ .)H Z:BN9_X3"X_Z ]U^O\ \31_PF%Q_P!
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MC_H#W7Z__$T?\)A<?] >Z_7_ .)H Z:BN9_X3"X_Z ]U^O\ \31_PF%Q_P!
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M;^W"8/#'PVU?6KSD>7]HZ>AQ'&Y/TX^M?7DL*3QM'*BR1L,%6&0?PIP&!@#
MH ^2[>^_:4^-S>5]FM/A5H$OWK@H5N]OH Q,@;Z"/ZU]1^&=)FT'PYI6F7-_
M/JMQ96D5M)?W))EN61 IE<DGYF(W'D\FM*B@ HHHH Y?XG>-S\-_ FK^)1IE
MQK TZ-96L[7_ %CJ756(X/"@EC[*:\GT7]NCX1ZGIZW%UK5YI$Q7)M+O3IFD
M!],Q*Z_^/=Z^@*\!\9? B7Q)^TUX2\3CP]I<GA'3].F^W,\<7[ZY83*H>,C+
MXW1D,0>GM0!Y+HU]/^U)^U;X>\:>'-)O+/P?X9CC635;J,Q?:&B=Y !VRSR
M!<YV@DXZ5ZI^UU^T=-\$_#UMI6C1Y\3:Q$_V>Y=<QVD8PIE(_B;)^4=,@D],
M'WZUM8+&WCM[:&.W@C&$BB4*JCT ' K.USPAH/B:2*36-$T[57B!6-KZTCF*
M ]0"P.* /D;]G?XI? [X-://?ZCXY_MCQIJO[W5-6ETR]=BQ.XQHQASMW<DG
MECR>P'T]\-_B_P"$?B[9WMUX2U?^UH+.18IV^SRP[&89 Q(BD\ ]*L?\*I\$
M_P#0G:!_X*X/_B:O6^C:1X'TB_GT?0K>TC2-IWM=)M$1YRJD@!4 W,<8'UH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[WKTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 1A5*\MQ(IXJ]3'7- 'F_BK0Q/&_RUX%XZ\+X\SY.
M#7U=JEB)HVXKRKQKX<$J.=M--Q=UN)I25F?(]Y:O9W#1..G0^HJ72=4N=$U*
MWOK1_+N('#HW]#['I^-=AXV\.-&[LJX9>1_A7"=.#7ZAEN,CF&'M/XEHU_7<
M_-<PP<L#7]SX7JG_ %V/M'X9>.K?Q3HMM>PMMW#:\><E''53_GIBO3[.X$B
MYKX7^$_CQO!?B!5FD(TVZ(289X0]G_#O[?2OL;P_JRW$*$,"",@@U\)F6!>!
MKN*^%[?Y?(^VR[&K&4>9_$M_\_F=<II:@ADW**FKR3U1:*** "BBB@ HHHH
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MQN] #ZXHJAH.N67B;1+#5]-G6YT^^@2YMYEX#QNH93[<$5?H **** "BBB@
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MUZ97F?C#_D8[O_@'_H"T =-\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2=#3Z
M9)T- '/:]_J7^E?+7[1W_(GZC_O1_P#HU:^I=>_U+_2OEK]H[_D3]1_WH_\
MT:M>AEW^^T?\4?S1RXK^!4]'^1\JT445^X'Y[<**** N%%%% 7"BBB@+A111
M0%PKK?A/_P E TC_ 'I/_1;5R5=;\)_^2@:1_O2?^BVKS\Q_W*M_AE^3.G"O
M]_3]5^9]W^!?]3']*]+L_N"O-/ O^IC^E>EV?W!7X>?H9;I:2EH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)T-/IDG0T <]KW^I?Z5\M?M'_P#(GZC_ +T?_HU:^I=>_P!2_P!*^6OVD/\
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M%% !1110!F>)]$'B;PUJVD-<26BZA:36AN(?OQ>8A7<ON,Y'TKXR\:6/QT^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=W.3S]F444 %%%% !1110 4444 %>9^,/^1CN_\ @'_H"UZ97F?C#_D8[O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M77=;LM'TW4C-KD,:R0+<6Y>+Y60-B0;5D^4^OO7JG_#>WPH_Y^]5_P# !O\
M&@#(\,_!/]H#3O$FE7>I_%>VO--@NXI;JW#R$RQ*X+I@Q '*@CD]Z^HJ\"T+
M]MWX8>(M;T_2K2\U+[5?7$=K#YEBP7>[!5R<\#)%>^T %%%% !1110 4444
M%>9^,/\ D8[O_@'_ * M>F5YGXP_Y&.[_P" ?^@+0!TWP_\ ^0--_P!?#?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_5?F?>O@7_4Q_2O2[/[@KS3P+_J8_I7I=G]P5^%'Z*6Z6DI: "BBB@ HHHH
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MU&UEF:%1A=[K#<;L?5G_ .^J^R* "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M":^4;[Q+^T7X&^)&@_#8^+]#UG5-8MY)K*\G@5@D4:NQ:1C$&SB-NH;)'4T
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M^W7_ 'T/\*Z:B@#F?^$%M_\ G]NO^^A_A1_P@MO_ ,_MU_WT/\*Z:B@#F?\
MA!;?_G]NO^^A_A1_P@MO_P _MU_WT/\ "NFHH YG_A!;?_G]NO\ OH?X4?\
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M )_;K_OH?X4?\(+;_P#/[=?]]#_"NFHH YG_ (06W_Y_;K_OH?X4?\(+;_\
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MU%0 4444 %%%% !1110 5YGXP_Y&.[_X!_Z M>F5YGXP_P"1CN_^ ?\ H"T
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M"O@#[LDHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?[76MV7B+QY\*/!>GW"7'B!O$5O=R0P_.]M$&"[G Z Y+<]D)Z5]24 %%%%
M!1110 4444 %>9^,/^1CN_\ @'_H"UZ97F?C#_D8[O\ X!_Z M '3?#_ /Y
MTW_7PW_H*UTU<S\/_P#D#3?]?#?^@K734 %%%% !1110 4444 %97BP:LWA;
M61H)B77393?8&GQY8N-A\K=GMOVY]JU:JZIJEIHFF7>HW\Z6MC9PO<3SR'"Q
MQHI9F)]  3^% 'RK_9_[6W_03T#_ +YMO_B*Y3XD>.OVG_A7H::UKM_IJZ3Y
MJQ37=K:03K;[C@-(%3<%SQD \X'4C/T9_P -2?"C_H>=*_[[;_"N-^+W[5?P
MI_X5UK]G'X@M?$$]]8S6T6G6L;R&9G0J QQA5YY)(]LGB@#T_P"#-YXCU'X:
MZ+>>*M2T_5]9N8VG>^TO'V>:-G9HF7"J/]64Z"NVKQ']C+3M4TW]G?PPFJB5
M7D\^:WCF!#) TK&/KV(^8>S"O;J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!#5:YA#J>*M4UEH X3Q-HPGC?Y<UX1XZ\,8\P[/TKZ@U"T$
ML9&*\V\8>'Q-&_RT ?'>K:>VGW3(1\AZ?X55AE>"5)(V*2(P964X((Y!%>F>
M./#)'F?+@]0:\RDC:*1D8893@U^EY1C_ *Y1Y)OWX[^:[_YGYSFN!^J5>>'P
MRV\GV_R/K+X-?$9?%6BQF5P+ZWQ'<)[]F'L?\1VKVBQNA(@YKX#\#^+KCP9X
M@@OXBS19V3Q _?0]1]1U'TK[/\'^)(-6L;>XMY1+#*@='4]0:^1S; ?4ZW-!
M>Y+;R\CZO*L=]<I<LW[\=_/S.]4TZJUO,'458%>$>V+1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %,DZ&GTR3H: .>U[_4O]*^5OVEO^1*U
M/_>B_P#1J5]4Z]_J7^E?*W[2W_(E:G_O1?\ HU*]'+?]^H?XX_FCEQ?^[U/\
M+_(^2:*,T9K]Z/S8**,T9H **,T9H **,T9H **,T9H *['X/_\ )1M&_P!Z
M3_T4]<=FNQ^#_P#R4;1O]Z3_ -%/7FYE_N-?_!+\F=>$_P!XI_XE^9]]^!?]
M3']*]+L_N"O-/ O^IC^E>EV?W!7X,?I!;I:2EH **** "BBB@ HHHH ****
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M@+0!TWP__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@K734 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME?*W[3'_ ").I_[T7_HU*^J=>_U+_2OE7]IC_D2=4_WHO_1J5Z66_P"_4/\
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M8QTH ^;O#/\ P4 \'>*/$FE:-!X<UV*?4;N*TC=UA*JTCA 3A\XR>U?45%%
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MKQO]D;P3J/@/X"^';#5H)+74)O-O)+>7AHA)(S(I'8[-I(/()(->R4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UEIU% &9J%J)$
M/%>;^,/#XFC?Y?TKU>1-PK!UC3Q-&W% 'R+XY\,X\SY<=P<5YA)&T,C(PPRG
M!KZI\<>&A(LA"5\_>,-!:UF:55Y7K[BOI\DQ_P!7J>PJ/W9?@_\ @GS><X'Z
MQ3]M37O1_%?\ H^#/%5QX.UZWU&#+*IVRQ@_ZQ#U']1[@5]G^#?$T&L:?;75
MO*)8)D#HP[@U\)UZU\"?B$=#U)=%NY<6MP^;=F/"2'^'Z-_/ZU[>>8#V]/ZQ
M37O1W\U_P#QLEQWL:GL*C]V6WD_^"?95O,)%%617.Z-J(FC7G-;T;[A7YZ?>
MDM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0Q7.<D1?%3]H;5/VG_#(\!?##PIK3_VJ\:ZAJ6H0K''!$&#%=R,P4$@99B.
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M?W!7F?@4CR8_I7I=FWR"OP,_2RY2TW=2[J %HI-U&Z@!:*3=1NH 6BDW4;J
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M9\SZ8^RJ "BBB@ HHHH **** "O,_&'_ ",=W_P#_P! 6O3*\S\8?\C'=_\
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M'!%3URGPO^&^E_"7P58^%]&ENIM.LVE:-[QU>7]Y(TA!*JHX+$#CH!UZUU=
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MR?Q-^'7AGXG>%;C2/%=G'=:6I\_S'<QM R@_O%<'Y2 3STP2#D$UY#\"=!^
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MSJB@XYQEATK5^(GBH^!O 7B+Q$L/VE]+T^>\6$YP[)&6"G'0$@9/:OD7X*_
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M**** "BBB@ HHHH **** "NN^$__ "4#2O\ MK_Z*>N1KKOA1_R/^E_]M?\
MT4]>=F7^XU_\$OR9U83_ 'BG_B7YGT5D49%-HK\#/TL=D49%-HH =D49%-HH
M =D49%-HH =D49%-HH =D5J>&;C[+KMI*#C:3^JD5DU9TUME]"?]J@#Z1\+7
MQFC0YS7;6[;E%>:>!Y"T,?/:O2+3[@H M4M)2T %%%% !1110 4444 %%%%
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M522QR=H &#FOJ^N6\#_%'PE\2+7[1X9\06.L*!N:.WE'FH/]N,X9?^! 5U-
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M\#_&M_R(_P#GFO\ WR*/(C_YYK_WR* ,#_A/--_NS_\ ? _QH_X3S3?[L_\
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MP/\ &C_A/--_NS_]\#_&M_R(_P#GFO\ WR*/(C_YYK_WR* ,#_A/--_NS_\
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M )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&C_A/--_NS_\ ? _QK?\
M(C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH_P"$\TW^[/\ ]\#_ !K?
M\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&C_A/--_NS_\ ? _Q
MK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH_P"$\TW^[/\ ]\#_
M !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&C_A/--_NS_\
M? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH_P"$\TW^[/\
M]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&C_A/--_N
MS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH_P"$\TW^
M[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&C_A/
M--_NS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH_P"$
M\TW^[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]\#_&
MC_A/--_NS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#? _QH
M_P"$\TW^[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_NS_]
M\#_&C_A/--_NS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS_P#?
M _QH_P"$\TW^[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A/--_
MNS_]\#_&C_A/--_NS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/--_NS
M_P#? _QH_P"$\TW^[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR* ,#_A
M/--_NS_]\#_&C_A/--_NS_\ ? _QK?\ (C_YYK_WR*/(C_YYK_WR* ,#_A/-
M-_NS_P#? _QH_P"$\TW^[/\ ]\#_ !K?\B/_ )YK_P!\BCR(_P#GFO\ WR*
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M@DV@>P&/:O::* *.BZ'I_AO2K;3-*LH-.T^V3RX;:VC"1HOH *O444 %%%%
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M^!?]3']*]+L_N"O-/ O^IC^E>EV?W!0!;I:2EH **** "BBB@ HHHH ****
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M/$FE66H?!NYL;"YNXH;BZ,<ZB&-G 9\D8& 2>>.*^HJ "BBB@ HHHH ****
M"O,_&'_(QW?_  #_ - 6O3*\S\8?\C'=_P# /_0%H Z;X?\ _(&F_P"OAO\
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M77UYU\ ?BK+\9OAAIOBBXL$TVYN))HI;>-RZ!DD9<J3S@@ _4D5Z+0 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBCU-6S3ZIVMP)%%6U-?-GT0M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4R3H:?3).AH Y[7O\ 4O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M//UK$KVGQUX7QYGR<<UX]>VC6=PT;=NA]17Z#D>/]O3^KU'[T=O-?\ ^#SK
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*&O:U:^&]#U'5[YF2RL+:2ZG95+$1HI9B!W. >*XGPO^T1\-?%VGI>6'C31T
M5EW&&\NTMID'?='(588]<8]Z]"FACN(7BE198I%*NCC*L",$$=Q7R-\?/V8O
M#5S\2_AI#X:\"21Z;J6JM_;TVE0S+;QVRM$2LFP[80P:3!&T\'!XH Y7]IKQ
M!H/QM^.?PVTCX?7,.MZ_:SD7FI:;B2-8_,C=/W@X81A97)!P W7)./9_V@/V
M:M;^,'CS0/$^C^,CX:N-(MA% HMFD:.02,_FHP<;6Y4=/X!S7J'@'X1^#OA?
M#*GA?P]9Z091B2:)2TKCT:1B6(]B<5U] 'Q3\7_V?_BCX;^&/B75-7^,FHZY
MIEK9/+<:=*DH6X0#E#F0CGZ5O?L/_#OQ9;^$?#?BR3QO<R>%)H;N./PN8V,2
M-Y\B;@2V!\ZL^0N?FQW-?4?BKPQIWC3PYJ.A:M"UQINH0M!<1JY0LAZ@,""/
MPJKX%\#Z/\-_"MCX<T"V:TTFRW^3"\K2$;W:1OF8DG+.Q_&@#Y+^'/B&Q_9_
M_;"\?:+XCN5TW2O%#M=6E[<'9%NDD,T8+'@+\\L>3_$H%>E?M??&KP[X?^#>
MM:-9ZO:7^MZY#]BMK.TF65]CD;W8*>%V;L$]20*]3^)GP9\'?%^S@@\5:-%J
M+6^?(N%=HIHL]0KJ0<>W3VKDO ?[)'PP^'NKP:KI^@&[U&W8/#<:A.\_EL.C
M*A.W(['&1@8H V/V;_ <_P -_@GX4T.[5DOH[7[1<HXPR2RLTK(1ZJ7V_P#
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M]QK_ ."7Y,ZL)_O%/_$OS/HBBDW4;J_ S]+%HI-U&Z@!:*3=1NH 6BDW4;J
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M .@W)^1_QH Z:BN9_P"$;U?_ *#<GY'_ !H_X1O5_P#H-R?D?\: .FHKF?\
MA&]7_P"@W)^1_P :/^$;U?\ Z#<GY'_&@#IJ*YG_ (1O5_\ H-R?D?\ &C_A
M&]7_ .@W)^1_QH Z:BN9_P"$;U?_ *#<GY'_ !H_X1O5_P#H-R?D?\: .FHK
MF?\ A&]7_P"@W)^1_P :/^$;U?\ Z#<GY'_&@#IJ*YG_ (1O5_\ H-R?D?\
M&C_A&]7_ .@W)^1_QH Z:BN9_P"$;U?_ *#<GY'_ !H_X1O5_P#H-R?D?\:
M.FHKF?\ A&]7_P"@W)^1_P :/^$;U?\ Z#<GY'_&@#IJ*YG_ (1O5_\ H-R?
MD?\ &C_A&]7_ .@W)^1_QH Z:BN9_P"$;U?_ *#<GY'_ !H_X1O5_P#H-R?D
M?\: .FHKF?\ A&]7_P"@W)^1_P :/^$;U?\ Z#<GY'_&@#IJ*YG_ (1O5_\
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MG5PMOIVJ2#_D.R?K_C5V/0]5;_F.2?D?\:\D]0ZVBN7'A[5O^@Y)^1_QI?\
MA'-6_P"@Y)^1_P : .GHKF?^$;U?_H-R?D?\:/\ A&]7_P"@W)^1_P : .FH
MKF?^$;U?_H-R?D?\:/\ A&]7_P"@W)^1_P : .FHKF?^$;U?_H-R?D?\:/\
MA&]7_P"@W)^1_P : .FHKF?^$;U?_H-R?D?\:/\ A&]7_P"@W)^1_P : .FH
MKF?^$;U?_H-R?D?\:/\ A&]7_P"@W)^1_P : .FHKF?^$;U?_H-R?D?\:/\
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M*?\ D?M+_P"VO_HIZ\[,O]QK_P""7Y,ZL)_O%/\ Q+\SZ&HHHK\#/TL****
M"BBB@ HHHH **** "K6E?\A"#_>JK3[>&2XGCCBE,,C,,2#MS0!]'>!?]3']
M*]+L_N"O$O!.@:HT,>-8D''H?\:](M/#FK;!_P 3N3\C_C0!V%+7,?\ "-ZO
M_P!!N3\C_C2_\(WJ_P#T&Y/R/^- '345S/\ PC>K_P#0;D_(_P"-'_"-ZO\
M]!N3\C_C0!TU%<S_ ,(WJ_\ T&Y/R/\ C1_PC>K_ /0;D_(_XT =-17,_P#"
M-ZO_ -!N3\C_ (T?\(WJ_P#T&Y/R/^- '345S/\ PC>K_P#0;D_(_P"-'_"-
MZO\ ]!N3\C_C0!TU%<S_ ,(WJ_\ T&Y/R/\ C1_PC>K_ /0;D_(_XT =-3).
MAKG/^$;U?_H-R?D?\:9)X;U?!_XG<GY'_&@"77O]2_TKY=_:)_Y%/4/]Z/\
M]&+7OVN^'=5$+YUJ0\>A_P :^:OCUI=[:^&[V2?4'N(U:/*$'GYU]Z]#+_\
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M.B@ HHHH **** "BBB@ KS/QA_R,=W_P#_T!:],KS/QA_P C'=_\ _\ 0%H
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %121[JEI*
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MJV.^" <>U=56;XDUJQ\.^'=3U75&":;8VTES<LPR/+12S<=^ >* /C[]G?\
M9'\&_%#X<Z=XV\7WNHZ]JVLO)<2JMV41")&4@D?,S'&6);J<8XR?5O\ AAGX
M0?\ 0!NO_!E/_P#%U\Z?!GQ9\7_[0\0WWP9\'21^!M0O'EMM-U61'MK=OXO*
MDD>,9XY"D@< Y(!KU3_A,/VMO^A&T#_O_;?_ "50!])^ ? >C?#/PK9^'?#]
MN]KI5J7,43RM(07=G;YF))^9C70UR'PGOO&&H> ].G\>:?;Z7XI8R_:K6T96
MC4"1A'@J[CE-IX8]>W2NOH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ I*6B@!C)FH9+=6[59I* ,>ZTM),_+7/ZEX9C
MF!^3]*[<K44D ;M0!XQK7@5)-V(_TKS[7/A^1NQ'^E?35SIJ29^6L'4?#:3
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M?_(^:7_VU_\ 13UR==9\*_\ D?-+_P"VO_HIZ\[,O]QK_P""7Y,Z\'_O-/\
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M$VY10!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 4M9T6P\1:7<Z;JEE!J&GW*>7-:W,8>.1?0J>#7S
MYK7[ GPLU:^:X@76=)1GWFWLKU3'U^[^\1R!^/:OI"B@#SCX4?L^^"/@RLDG
MAO2=E_*NR34;IS+<LO'R[S]U>!PH .!FO1Z** "BBB@ HHHH **** "O,_&'
M_(QW?_ /_0%KTRO,_&'_ ",=W_P#_P! 6@#IOA__ ,@:;_KX;_T%:Z:N9^'_
M /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH *P/'_B@>"? OB'Q"467^R]/G
MO!&QP':.-F"_B0!^-;]8GC;PS'XS\&Z[H$KB./5+&:S,A7.SS(RN['MG/X4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 >%_M1?$SQ/X7@\*^$/!)2#Q5XNO&M+>]<C_1HTV;W
M((!^<?-C@!B.<8\?T?X5^)_@O^T9\*EU?Q[J?BN[UY[XW7GO($79#ROS2-O!
M+]\?='%>I_M6>#?$7G^#?B+X4L6U;5_!UX\\FFQJ6>YMWV;PH7DD;.@&<,Q[
M8/B'CC]K7P=XR^+WPJ\4FVU/3;?PZU]_:=O<0!I(FDB55";3\PW CL>.0* /
M<?VEO&&N?#OQQ\*]=T[5KJVTFXUI=,U/3TD_<W$<A7DIT+!1)@GOCTKW^OC*
M\\?WG[8WQ;\&6?AK1+VS\#>&=074[_4K^+ E="K!#@E02!M5<DG>20 *^S:
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MH]U&ZBP$F:,U'NHW46 DS75?"\_\5UIG_;7_ -%/7([JZKX7M_Q76F?]M?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:1J
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M?1AQ7V\*\9'F)J6P;J-U5TF![U*&S70G<+#]U&ZDHIB%W4;J2B@!=U&ZDHH
M7=75?"UO^*ZTS_MK_P"BGKE*ZKX7_P#(]:9_VU_]%/7G9E_N-?\ P2_)G7@_
M]YI_XE^9] 9HS3<T9K\#/TT=FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F
M@!V:OZ%_R%K;_>_H:SLU?T'_ )#%M_O?T- 'TKX%_P!3']*]+L_N"O-/ O\
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MP<,A>++*!D9*YW'&"5'2@#Z9\'^,M&\?>'[;7- ODU+2KDL(KF-64-M8JW#
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MP_Y&.[_X!_Z M '3?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0
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MU:6:+']OLY,;U9!P=IP-V."Z^BX^GZ "BBB@ HHHH **** "O,_&'_(QW?\
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M  H_X2O2?^?Q?^^6_P * -:FM67_ ,)7I/\ S^+_ -\M_A36\5Z3_P _B_\
M?+?X4 1ZQ_J6^E?//QM_Y%G6/^O67_T U[CK'BG2C"V+Q>G]UO\ "OG[XT:]
M87'AS5DCN59FMI0!@\G:?:NC#_QH>J_,SJ_PY>C/DO=[T;O>HM]&^OW6Q^=<
MQ+N]Z-WO46^C?18.8EW>]&[WJ+?1OHL',2[O>C=[U%OHWT6#F)=WO1N]ZBWT
M;Z+!S$N[WKI/AVW_ !6.G\_\]/\ T6U<MOKI/ARW_%9:?_VT_P#1;5Y^8+_8
MZW^&7Y,Z<*_W]/U7YGM^:,TW)HR:_$C] '9HS3<FC)H =FC--R:,F@!V:,TW
M)HR: '9HS3<FC)H =FMSP3=&T\46,N<;2WZHPK!R:L:?>)87L,\K[$5N6^O'
M]: /J'P_J'VB->:ZJ%MRBO)/!OB[33"FZ[7I_=/^%>A6OBS2MH_TQ?\ OEO\
M* -^EK(_X2O2?^?Q?^^6_P *7_A*])_Y_%_[Y;_"@#6HK)_X2O2?^?Q?^^6_
MPH_X2O2?^?Q?^^6_PH UJ*R?^$KTG_G\7_OEO\*/^$KTG_G\7_OEO\* -:BL
MG_A*])_Y_%_[Y;_"C_A*])_Y_%_[Y;_"@#6HK)_X2O2?^?Q?^^6_PH_X2O2?
M^?Q?^^6_PH UJ3;65_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A0!HM$&[53NK)
M9%/%1?\ "5Z3_P _B_\ ?+?X5')XJTG!_P!,7_OEO\* .2\4Z*DD+_+VKX]_
M:B\/K'X(U5PO1HO_ $:E?9OB#Q+I30O_ *6O3^ZW^%?*/[3VI6-YX%U6.&=9
M)&:+  /_ #U3VKT,N5\;17]Z/YHY<5IAZC\G^1\'7>C@YP*QKK22N>*]"DM0
MW:J%QIP;M7[-5PJ>Q\!"LT<WX;\9Z_X+D']FWSK!G)M9?GB/_ 3T^HP:]?\
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MTG_G\7_OEO\ "C_A*])_Y_%_[Y;_  H UJ*H6>O6&H3"&WN%EDQG: ?\*OT
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MK[X;_$VZM;"#5)-%UBX=8H]/U:/RG=R<!5<$HQ)X W9/I7M= !1110 4444
M%%%% !7F?C#_ )&.[_X!_P"@+7IE>9^,/^1CN_\ @'_H"T =-\/_ /D#3?\
M7PW_ *"M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &#XR\=:#\/=*CU/Q%J46E:?).EL+B8-L$C9V@D X
M'!Y/ [FK%OXNT*\L5O8-:T^>S9/,6XCNHVC*_P!X,#C'O4'C3P/H7Q$\/SZ)
MXBTV+5-+F(+P2DCD'(8,I!4CU!!KXTTW]DWP=J?[4>L>$1IVIQ>$M/T9;\_O
MWP\[-& HE(SC#GC.?D//!H L_"V+2=>_;PU74_ 0B?PS;V\SWT]BO^C.S6^Q
MRI'&&G(/'!()''-?9D?B;2)M=GT6/4[-]8@199+ 3KYZ(PR&*9S@XZXK(^'O
MPO\ "_PKT<Z;X7T>WTJW8@RM&"TLQ'0R2,2S'D]3QGC%<3\7/V6/ _QEUI-:
MU=-0L-:5%C-_IESY<C*OW00RLN1Z[<^_% $W[4GC30O"?P1\61:Q=6Z3:EIT
M]E9VLC#?/-(A5-J]3M9@Q(Z 9K@_V6_A[J%Y^R/<:'?![:3Q#;7_ )"SKC9%
M.K1H<?W2/G'J&K3\+_L-_#3P_J\6HWJ:MXGFC.Y8]<NUECXZ;E1$# >C9'J#
M7T#'&D,:1QHL<: *JJ,  = !0!\H_L ^-+5/!.M>!;Z5;7Q#I&HS2FRD.',3
M;0Q [E9%<''3*^M5OVZ->A\;7'@KX6Z-/'=>(-2U:.XEAC.XP#:T<?F8Z9\U
MF^B$],5Z5\3_ -C_ .'_ ,4O$3Z]=1ZAHFKROYD]UHLZPF9O[S*R.N[_ &@
M3W)K1^$?[+7@3X,ZHVJZ1;7>HZR0RKJ6JS"::,-G=LVJJJ2#@D+G'&>30!Y'
M^WAX3N-&\"^ /$6GIYL7A>]$!&/NJZQ[&/H-T"CZL*^FO"OCK1/&/@^T\3Z;
MJ$,FCW$'VC[0S@+&N,L')^Z5Y!!Z$'-:'B#P_IOBK1;S2-7LHM0TV\C,4]M.
MN4=3Z_H0>H(!%?.UQ_P3[^&LMY+)%J'B2TM9'#FQAOH_)XZ+\T18CZL3SUH
MYK]GV9/BW^UM\1?B+8-YN@V,(L+6XQ\LK%4B1E]BD+M_P-?6OKZN<\ _#W0/
MACX;@T+PWIT>G:=$2Y126:1R "[L>68X')] .@ KHZ "BBB@ HHHH 9-"EQ&
MT<J!XV&"K#(-4O\ A']-_P"?&#_O@5H44 9__"/Z;_SXP?\ ? H_X1_3?^?&
M#_O@5H44 9__  C^F_\ /C!_WP*/^$?TW_GQ@_[X%:%% &?_ ,(_IO\ SXP?
M]\"C_A']-_Y\8/\ O@5H44 9_P#PC^F_\^,'_? H_P"$?TW_ )\8/^^!6A10
M!G_\(_IO_/C!_P!\"C_A']-_Y\8/^^!6A10!G_\ "/Z;_P ^,'_? H_X1_3?
M^?&#_O@5H44 9_\ PC^F_P#/C!_WP*/^$?TW_GQ@_P"^!6A10!G_ /"/Z;_S
MXP?]\"C_ (1_3?\ GQ@_[X%:%% &?_PC^F_\^,'_ 'P*/^$?TW_GQ@_[X%:%
M% &?_P (_IO_ #XP?]\"C_A']-_Y\8/^^!6A10!G_P#"/Z;_ ,^,'_? H_X1
M_3?^?&#_ +X%:%% &?\ \(_IO_/C!_WP*/\ A']-_P"?&#_O@5H44 9__"/Z
M;_SXP?\ ? H_X1_3?^?&#_O@5H44 9__  C^F_\ /C!_WP*/^$?TW_GQ@_[X
M%:%% &?_ ,(_IO\ SXP?]\"C_A']-_Y\8/\ O@5H44 9_P#PC^F_\^,'_? H
M_P"$?TW_ )\8/^^!6A10!G_\(_IO_/C!_P!\"C_A']-_Y\8/^^!6A10!G_\
M"/Z;_P ^,'_? H_X1_3?^?&#_O@5H44 9_\ PC^F_P#/C!_WP*/^$?TW_GQ@
M_P"^!6A10!G_ /"/Z;_SXP?]\"C_ (1_3?\ GQ@_[X%:%% &?_PC^F_\^,'_
M 'P*/^$?TW_GQ@_[X%:%% &?_P (_IO_ #XP?]\"C_A']-_Y\8/^^!6A10!G
M_P#"/Z;_ ,^,'_? H_X1_3?^?&#_ +X%:%% &?\ \(_IO_/C!_WP*:WA_3?^
M?&#_ +X%:5-:@#EM8T#31$W^A0=/[@KY[^-FDV4/AG6'2UB1EM92"JC(^0U]
M)ZQ_J6^E?._QR_Y%76O^O2;_ - -=&'_ (T/5?F95?X<O1GQENHW5%NHW5^\
MV/S<EW4;JBW4;J+ 2[J-U1;J-U%@)=U&ZHMU&ZBP$NZC=46ZC=18"7=72_#E
MO^*ST[_MI_Z+:N5W5TOPW;_BM-._[:?^BVKS\Q7^Q5O\,OR9U87^/3]5^9[G
MN]Z-WO3-U&ZOPX_0Q^[WHW>],W4;J '[O>C=[TS=1NH ?N]Z-WO3-U&Z@!^[
MWHW>],W4;J '[O>IK2-+BZBCD4.C,,JPR#5;=5G36_TZ'_>H ]S\#Z)I[0QY
MLX3Q_<%>E6?A_3=@_P!!@_[X%<'X%_U,?TKTNS^X* (O^$?TW_GQ@_[X%+_P
MC^F_\^,'_? J_2T 9_\ PC^F_P#/C!_WP*/^$?TW_GQ@_P"^!6A10!G_ /"/
MZ;_SXP?]\"C_ (1_3?\ GQ@_[X%:%% &?_PC^F_\^,'_ 'P*/^$?TW_GQ@_[
MX%:%% &?_P (_IO_ #XP?]\"C_A']-_Y\8/^^!6A10!G_P#"/Z;_ ,^,'_?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ0A45TVCT=?BA?KC?I\+>NUB/\:E7XK2C[^D@_2?'_LM/E\*CGY?TJ!O"O\
MLU^<+.,=':I^"_R/IWE."?\ R[_%_P"9;7XK0_QZ;*H_V9 ?Z5,GQ4T_C?9W
M2^NT*?ZBLAO"O7Y?TJ)O"Y_N_I6JSS'+[2^Y&3R7!/[/XLZ-/B?I#8S'=)_O
M1C^C5.OQ(T-LYGD3ZQ-_2N0;PN?[OZ5$WAEO[M;+/\8M[/Y?\$R>181]_O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%>9^,/\ D8[O_@'_ * M>F5YGXP_Y&.[_P" ?^@+0!TWP_\ ^0--_P!?#?\
MH*UTU<S\/_\ D#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.2O2RW_?J'^./YHY,9_NU3_"_P CXKHHHK][/S(**** "BBB@ HHHH ****
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MU_WC_(T ?37@7_4Q_2O2[/[@KS3P+_J8_I7I=G]P4 6Z6DI: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O,_&'_ ",=W_P#_P! 6O3*\S\8?\C'=_\
M /\ T!: .F^'_P#R!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *:U.IK4 8NL?ZEOI7SG\>O^1-U_\
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M** "BBB@ HHHH **** "BBB@ IK4ZFM0!BZQ_J6^E?.7Q\_Y$SQ!_P!>,_\
MZ+:OHW6/]2WTKYR^/G_(E^(?^O"?_P!%M73AOX]/U7YF5;^'+T9\%Y-&33=U
M&ZOZ$/RT=DT9--W4;J '9-&33=U&Z@!V31DTW=1NH =DT9--W4;J '9-=/\
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MX%_U,?TKTNS^X*\T\"_ZF/Z5Z79_<% %NEI*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KS/QA_P C'=_\ _\ 0%KTRO,_&'_(QW?_  #_ - 6@#IO
MA_\ \@:;_KX;_P!!6NFKF?A__P @:;_KX;_T%:Z:@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"_ZF/Z5Z79_<%>:>!?\ 4Q_2O2[/[@H MTM)2T %%%% !1110 4444 %%%%
M!1110 4R3H:?3).AH Y[7O\ 4O\ 2ODO]JS_ ))UK'^]#_Z.2OK37O\ 4O\
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MZ6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_N-?_!+\F=>#_P!YI_XE^9[?12;J-U?@9^FBT4FZC=0 M%)NHW4 +12;J-U
M"T4FZC=0 M;'@_\ Y&2Q_P!X_P#H)K&W5L^#?F\36(_VF_\ 030!]8^!?]3'
M]*]+L_N"O-? R_N8_I7I5G]P4 6Z6DI: "BBB@ HHHH **** "BBB@ HHHH
M*9)T-/IDG0T <]KW^I?Z5\E_M5_\D[UC_>A_]')7UKKP_<O]*^3/VK%_XMSK
M)[;H?_1R5Z66_P"_4/\ ''\T<F,_W:I_A?Y'Q-NHW4W-&:_>S\R';J-U-S1F
M@!VZC=3<T9H =NHW4W-&: ';J-U-S1F@!VZNE^'+?\5GIW_;3_T6U<QFNE^'
M)_XK+3_^VG_HMJ\[,O\ <:_^"7Y,Z\'_ +S3_P 2_,]PW4;JCR:,FOP,_323
M=1NJ/)HR: )-U&ZH\FC)H DW4;JCR:,F@"3=1NJ/)HR: )-U:_A%O^*BLO\
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M_9M^#/BZU^(GB3XJ?$*.*Q\1:U&8H-+B(;[/&Q0DM@G!"QHJKDD#.[DU]*T
M<1\(_%_B?QKX7FO_ !7X4D\'ZDMT\*6,D_FEXPJD29P,9)88_P!G/>NWHHH
M**** "BBB@ HHHH IZQ'<3:;<):EA<,N$VMM.?KVKB_[)\4?\]+K_P "Q_\
M%5Z!10!Y_P#V3XH_YZ77_@6/_BJ/[)\4?\]+K_P+'_Q5>@44 >?_ -D^*/\
MGI=?^!8_^*H_LGQ1_P ]+K_P+'_Q5>@44 >?_P!D^*/^>EU_X%C_ .*H_LGQ
M1_STNO\ P+'_ ,57H%% 'G_]D^*/[]U_X%#_ .*H_LCQ/_?N?_ H?_%5Z!10
M!Y]_8_B?^]<_^!0_^*H_L?Q/_>N?_ H?_%5Z#10!Y]_8_B?^]<_^!0_^*H_L
M?Q/_ 'KG_P "A_\ %5Z#10!Y]_8_B?\ O7/_ (%#_P"*H_L?Q/\ WKG_ ,"A
M_P#%5Z#10!Y]_8_B?^]<_P#@4/\ XJC^Q_$_]ZY_\"A_\57H-% 'GW]C^)_[
MUS_X%#_XJC^Q_$_]ZY_\"A_\57H-% 'GW]C^)O[US_X%#_XJC^Q_$W]ZY_\
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M_P"&=] _Z$/0/_ "U_PKW:BNCZS7_G?WLS]C3_E7W'A/_#.^@?\ 0AZ!_P"
M%K_A1_PSOH'_ $(>@?\ @!:_X5[M11]9K_SO[V'L:?\ *ON/"?\ AG?0/^A#
MT#_P M?\*/\ AG?0/^A#T#_P M?\*]VHH^LU_P"=_>P]C3_E7W'A/_#.^@?]
M"'H'_@!:_P"%'_#.^@?]"'H'_@!:_P"%>[44?6:_\[^]A[&G_*ON/"?^&=]
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MO$R]&N!]+H?_ !5>@T4 >?\ ]D^*/[]U_P"!8_\ BJ/[)\4?\]+K_P "Q_\
M%5Z!10!Y_P#V3XH_YZ77_@6/_BJ/[)\4?\]+K_P+'_Q5>@44 >?_ -D^*/\
MGI=?^!8_^*H_LGQ1_P ]+K_P+'_Q5>@44 >?_P!D^*/^>EU_X%C_ .*H_LGQ
M1_STNO\ P+'_ ,57H%% 'G_]D^*/^>EU_P"!8_\ BJ/[)\4?\]+K_P "Q_\
M%5Z!10!Y_P#V3XH_YZ77_@6/_BJ/[)\4?\]+K_P+'_Q5>@44 >?_ -D^*/\
MGI=?^!8_^*H_LCQ/_?N?_ H?_%5Z!10!YW)H'B*48<3./]JY4_\ LU9.K?#*
M;7K5[;4]$M=1MY,;X;M8I4;!R,AB0>0#^%>M44TW%W6XFKJS/"?^&=] _P"A
M#T#_ , +7_"C_AG?0/\ H0] _P# "U_PKW:BNCZS7_G?WLS]C3_E7W'A/_#.
M^@?]"'H'_@!:_P"%'_#.^@?]"'H'_@!:_P"%>[44?6:_\[^]A[&G_*ON/"?^
M&=] _P"A#T#_ , +7_"C_AG?0/\ H0] _P# "U_PKW:BCZS7_G?WL/8T_P"5
M?<>$_P##.^@?]"'H'_@!:_X4?\,[Z!_T(>@?^ %K_A7NU%'UFO\ SO[V'L:?
M\J^X\)_X9WT#_H0] _\  "U_PH_X9WT#_H0] _\  "U_PKW:BCZS7_G?WL/8
MT_Y5]QX3_P ,[Z!_T(>@?^ %K_A4MM\ =&LYEFM_!&AP3+]V2.RME89&."!Z
M5[C12>(K25G-V]6"I4T[J*^X\;_X4]!_T+&F_P#?F"C_ (4]!_T+&F_]^8*]
MDHKG-3QO_A3T'_0L:;_WY@H_X4]!_P!"QIO_ 'Y@KV2B@#QO_A3T'_0L:;_W
MY@H_X4]!_P!"QIO_ 'Y@KV2B@#QO_A3T'_0L:;_WY@H_X4]!_P!"QIO_ 'Y@
MKV2B@#QO_A3T'_0L:;_WY@H_X4]!_P!"QIO_ 'Y@KV2B@#QO_A3T'_0L:;_W
MY@J2'X2I:RK+#X<L(I%Z.D4*D?B*]@HH \UA\)ZU:C$-LT0_V)D7^35971O$
MR]&N!]+H?_%5Z#10!Y__ &3XH_OW7_@6/_BJ/[)\4?\ /2Z_\"Q_\57H%% '
MG_\ 9/BC_GI=?^!8_P#BJ/[)\4?\]+K_ ,"Q_P#%5Z!10!Y__9/BC_GI=?\
M@6/_ (JC^R?%'_/2Z_\  L?_ !5>@44 <GX<T_6[?4E>_:8V^T@^9.'&>W&X
MUUE%% !1110 4444 %>(?&#]D/P-\7=0GU>2.XT'Q!+\SZCII"^:W9I(R-K'
MW&&/K7KOB0ZF/#NJG11$=8^RR_8A/_J_/V'R]WMNQGVKY9G_ &Q/B!\/6LM+
M\>_"2^CU>XD%O!/8S,D5Y+D#;$-CAF)(X5VZCCI0!SEKXS^)/[(_Q.\.^&_%
MFOMXP\#:Q)Y-O=7)+21IN5692Q+(R;T)0EE*G YY'T1\9?B1XZ\"WNF1>$?A
M]-XS@N(W:XFCNO*\A@0 N-IZ@DYKP^Y\$_$3]JOXF^&=:\7>%I/ G@CP_-YT
M5G>D_:IR2K,"K ,2VQ 254*,XR<Y^PZ /'?A'\5/B+XT\3RV'BKX93>$=-6V
M:5=0DN_,!D#* FW:.H)/_ :]BHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O,_&'_(QW?_ /_0%KTRO,_&'_ ",=W_P#_P!
M6@#IOA__ ,@:;_KX;_T%:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS7P;\&1X4^,'
MC3Q[)J_VZ;Q%'#$MG]F\O[*L:JN-^\[\[5[+C'>O2J* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0_C+X8L;'3-2(2+5M/XV<@,Y*NZ.%R-RC:P!SSP#]=4 %%%% !1110 4444
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M8_E/K6LD@S-S@J"P R.0N&.,$[<XK7^&O[2GB_3?BO!\./BOH%GHFLWH_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5YGXP_P"1CN_^ ?\ H"UZ97F?C#_D8[O_ (!_Z M '3?#_P#Y
M TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*"..-!A54#  '8 5Q/QD^,6@_!3P?-KFMR[G.8[2QC(\VZEQPBCT]6Z ?@"
M>)?M_P#B*WE^'^@>#K:/[;X@UK5(I+6TC&Z3:@9=P'J6=5'KEO0UWGQBAN/A
MK^R3J^G&X_TC3O#L.EM,I/S$HEN2#[[C^=<=^S_\)=>\>>,F^,OQ*BQKETH;
M1=)8$)8P8.Q]IZ':3M!Y&2Q^8\>D_M3:6^L?L]^.;>-#(RZ>;C:!GB)ED)_
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MOK;P1K5QXD\%Z!J]W#]FNK_3[>ZFA QY;O&K,OX$D4 ;=%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F?C#_ )&.[_X!_P"@
M+7IE>9^,/^1CN_\ @'_H"T =-\/_ /D#3?\ 7PW_ *"M=-7,_#__ ) TW_7P
MW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'AG[6'P)USX\^%=$TS0KW3[*>QOC<2-J#R*I0H5XV(QSD]P/K7N=
M%% !7A/[57P%USXZZ;X8M]$OM/LGTN\>>8Z@\BAD8*/EV(V2-O0XZ]:]VHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X9^TI\"=<^,VL^
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M@*!P !V%/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O,_&'_ ",=W_P#_P! 6O3*\S\8?\C'=_\  /\ T!: .F^'_P#R
M!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O,_&'_(QW?_  #_ - 6O3*\S\8?\C'=_P# /_0%H Z;X?\ _(&F_P"OAO\
MT%:Z:N9^'_\ R!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,_&'_(Q
MW?\ P#_T!:],KS/QA_R,=W_P#_T!: .F^'__ "!IO^OAO_05KIJYGX?_ /(&
MF_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW=2K!;01M+++(<*B*,EB>P !->2_\-=?"'=M_P"$VM,YQ_J)\?GY==?\9/\
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M_P"A@U3_ ,#9/_BJ /L*BOCW_A8'B+_H8-4_\#9/_BJ/^%@>(O\ H8-4_P#
MV3_XJ@#["HKX]_X6!XB_Z&#5/_ V3_XJC_A8'B+_ *&#5/\ P-D_^*H ^PJ*
M^/?^%@>(O^A@U3_P-D_^*K8\&^.->N_&&AP3:YJ,L,M_ CQR7<C*RF10003R
M"* /JJFR2)#&TDC*B*"S,QP !U)-.KY$_;&\9:YXV\>>%O@QX:N&MGUHQS:E
M(AQE&8A4;!^ZJH\C#N M 'L&M?M9?"30-1-E=^-K)YPVPFTBFN8P?]^)&7\<
MUW_A'QQH'C[2QJ/AW6+/6;+.TRVDH?8W]UAU4^QP:\_\'_LI_##PCH4.G?\
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M!!5AU1E/*L.X-8'Q8^.7@_X+Z?#<>)M2\F>?_46-NOF7$P[E4'8?WC@=LYH
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M:>/_  [\.])_M+Q+K%KHUF6VK)<O@NV,[57JQQV )KY:_9*:[^%OQ_\ B/\
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M_DC<_P#QNCZCBO\ GU+_ ,!?^0?7<+_S]C]Z/3**\S_X:1^'/_0Q?^2-S_\
M&Z/^&D?AS_T,7_DC<_\ QNCZCBO^?4O_  %_Y!]=PO\ S]C]Z/3**\S_ .&D
M?AS_ -#%_P"2-S_\;J6W_:)^'EU*L:>(T#-T,EK.@_-D %'U'%?\^I?^ O\
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MXQGEB@''7I7,:FK^W)\1/^$)^"-YIT$OEW_B"4:>FT\B+[TQ^FT;#_UTJO\
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MA6??M)Z+)&2P7<<,K'D')7TS4?\ @H#\-+?2WGLH-9O[[9F*Q%H$9G/12Q;
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METD$ ')+!;TC'X$5WOBK]O;P;/X1F_X12VU34?%5W$8K/3Y+0CRYF&%+G)#
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M=>M_"/QN^#NOWR2G3]-NEO)C$N6*17,+N%!P"<#IGN* .U_X9>^*'_1PFO\
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MAF\Z!2O_ 'TI/_ :A\0ZEKG[+?[1GBWQSK'AJ\U_P=XD'.K62AWM S*VPD\
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MHNJO'[#S%5P3[9MP,^_O7TWJ6O32>"[K6]$MO[5N&T]KRQME./M+>67C3/\
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M@'C*_L0?"S7?!GAOQ)XG\163:9J'B:Y2:.RD0QR1Q(9""R'[NYI&P.N #WH
M\7\+^%_'_BK]J+XL0_#_ ,3VWA>_BO+A[F>Y3<)(_/P%'R-WP>E(_A_5[?\
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M@+0!TWP__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@K734 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %74-+L]6A\F^M(+R'.?+N(ED7/K@BGV=C;:;;K!:6\5K O2.% BC\!4]%
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MBAC6*)!A410% ] !4E%% '"?'+X<)\6/A7X@\,_*MS=0;[5VZ+.A#QG/8;E
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MUZ97F?C#_D8[O_@'_H"T =-\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\
MH*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7F?C#_D8[O_@'_H"UZ97F?C#_ )&.
M[_X!_P"@+0!TWP__ .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7F?C#_ )&.[_X!_P"@+7IE>9^,/^1CN_\ @'_H"T 7
M_#/B:VT*QEM[B*8R&4M\BCC@#')'/%:__"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
M !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?
M*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_
M /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'
M_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\
MQ5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC
M=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-
M/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%%
M !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\
M?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YX
MW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_P
ML#3_ /GC=?\ ?*__ !5'_"P-/_YXW7_?*_\ Q5%% !_PL#3_ /GC=?\ ?*__
= !5<EK=T-:U:XNK>*0QOMX*\C"@<XSZ444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>pvpfy2023graphversion3.jpg
<TEXT>
begin 644 pvpfy2023graphversion3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2I!V8# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#S3Q%IR^'=12&TFF :(.69N>I&. ..!15OX@?\ (9A_Z]U_]":B@#:^
M'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#"%YXTD_ JQ!]B: /*/VI/VL/ .L?#CQ3X.T'4Y=8U>\C6V6>SB)MA^\4O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBJ>L2746D7SV2"2\6"0P*>\@4[1^>* /*OBG^U
M;\//A+J,VEZGJDE]K$0_>6&FQ>=)&<<!SD*I]B<^U?.O[%/[0G@CX?\ AB_\
M.^)=2FT[6-4U>2[%S-"QMR'CC107&=IRK<D <]:7_@G_ *;X6\4:MXNO=>AM
M=5\9><D\;:BJRR^4VXR2(&R=Q<_,PYY7GGGZY\7?!WP3X[@6+7?"^FW^T@K*
M8 DJX_NR+AA^!H [&OG?XY?&GQ-8?&CP-\-O US#!JFH2K/JD\ENLWE6Y/3!
MZ81)'/? 7D9KZ(KXS_9CF/Q1_:N^)OCFX/G1Z?OM;5NH56D\J(_7RH&'XF@#
MZY\2>)-+\'Z'>:QK5[%IVF6B>9/<S'"H,X_$DD  <DD 5\YZA_P4$\!PW4RZ
M=H7B35K2%B'O(;6-8\#^(;I <8S]X+5;_@H@NIM\']'-KO\ [.75T-YLS_SS
MD$>['\.X]^^WVKVGX$7?AF_^$GAI_"8MAH_V*- EN!\L@0"17 _CW9W9YS0!
M5^#O[07@_P".5I</X<NYDO;90UQIU]&([B)2<!B 2K#W5B!D9QFNE\?_ !%\
M._"_P])K?B;4X],T]6$:NX+-(Y!(1% )9B > .Q/05\@_"FQL=6_;VU^^\$1
M1KX9LTG-[)9J!!DVX1]I'&#<'(QUP2..GUO\0/A?X:^*5KIMKXGTU=4M;"Z%
MY#!([*AD"LHW $;EPQ^4\' S0!X!<?\ !17X?PWS11Z'XBGM5.!<+# "P]0I
ME'ZD5[W\,?BMX:^+WAT:SX9OQ>6RMY<T;J4E@?&=CH>A_0]B:TY? OAN;0WT
M5] TPZ0Z>6;$6D8AV^FS&,5\<_L7V(\+_M+?%#P[I,CMX>M4NHD^8LI\F\5(
M23W.QI.?K0!['^U-\6?%OP5O/!GB/2Y(Y?";WWV76;0VZL[@X9=KD94E%E Q
MC! ZYKW?3[ZWU2QMKVTE6XM;B-9H94.5=& *L/8@@UY?^U3X33QE\ ?&-JR;
MI;6S;4(B!DAH")>/<A&7Z,:P_P!BOQD_C#]G[0EF?S+C27DTMVSVC(,8_"-X
MQ^% 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_$#_
M )#,/_7NO_H344?$#_D,P_\ 7NO_ *$U% &U\/\ _D#3?]?#?^@K735S/P__
M .0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %5=4TN
MTUK3;K3[^WCN[*ZB:&>"5<I(C##*1Z$&K5</\7/B]HGP6\.VFN>(([M]/N+V
M.R+6<8D:-G5V#$$CY0$.<9/H#0!\Y^)?V)/$?@76Y]?^#_C.XT6=B2-.NIGC
M.W.=@E7(=?19%],L>M+\*?VKO&OA+XD6GP\^,&E+;:A<2);Q:HL:QN'?B,N$
M_=NC' WI@#OGG'N6G?M/_"K5+%+N+QUI$<;#(6XF,,@X[HX##\J^4_CCXHL?
MVI/VA/!FC?#]7U!-- 2XU98F1 HE#N_(!V1@<$XRS$#.1D ^_:^2/&WP*_:-
M\06M[#'\4[&>UD,@%O'+)9LT9S\NZ.'KC P3CD\U]$?%#XIZ#\(?#T&M^(Y)
MX=-DNH[0RV\)E*,X8AF YVC:<XR?:JNE_'3X=ZQIRWUKXXT VQ7<6EU&*)D'
M^TKL&7Z$"@#Y?_9:\::=\$?B')\-/%W@N+PKXJU%HXEUA9FE^V.?]6K,S, K
MGA?+.TL<$ U]LU\'_$WQ'8?M'?M<>![7P43J=EHC6YN]4MP0ICBG,LKJQ_A4
M' ;NQXSD9^R/B7\1-*^%/@G4O%&M"X;3K$)YB6J!Y7+NJ*J@D DLPZD4 =17
MRK??L&64_B36]8L_'VLZ7)J5S+<;+.()LWN6VL0WS $^U>Y>"_C#X?\ '/PP
M/CVQ-U!H:V\]Q*+F(":-8=WF JI(R-AZ$YJOX:_: ^''BW3TO-.\::,8V )C
MN;M+>5?]Z.0JP_$4 ?)GQ(T7XK?L<WVE>(=/\<7GBSPI<7"VTEOJ#NR!MN[R
MWB=F"[@K8="#\O.. ?H[XS>*HO&G[*OB+Q#IH9+?5/#_ -K1'^\J2(&*G'<
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M>L44 %>/_$#]D[X9_$C5YM5U/0?LVIS-OFN=/G:W,I[EE4[23W;&3W->P44
M><?##]GOP'\()GN?#>AQP:@Z[&O[AVFGVGJ S$[0>X7 ->CT44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVTE9/];*F7FD]GD<EV'H"<#M4?Q)^#WA#XO6MC;^+='&K163M);C[1+"49@
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MJ*/B!_R&8?\ KW7_ -":B@#:^'__ "!IO^OAO_05KIJYGX?_ /(&F_Z^&_\
M05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BDR*-PH 6BDW4;J %HI-U
M&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW"C- "T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_$#
M_D,P_P#7NO\ Z$U%'Q _Y#,/_7NO_H344 ;7P_\ ^0--_P!?#?\ H*UTU<S\
M/_\ D#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E,9\=:5CC-9M]>
M"%2<T 69+I5[U VI)_>KY$_:<\>:]I?CZRATK7-2TZV.G1LT-G=R1(6\V4%B
M%(&< #/L*\@_X65XN/7Q5K1_[B,W_P 57U&&R&IB:,:RFE<\FKF$:4W!QV/T
M8_M-/[WZT?VFGK^M?G-_PLCQ=_T-.M?^#";_ .*H_P"%D>+?^AIUK_P83?\
MQ5=/^K5;_GXON9E_:D/Y6?HS_::>OZT?VFGK^M?G-_PLCQ;_ -#3K7_@PF_^
M*H_X61XM_P"AIUK_ ,&$W_Q5'^K5;_GXON8?VI#^5GZ,_P!IIZ_K1_::>OZU
M^<W_  LCQ;_T-.M?^#";_P"*H_X61XM_Z&G6O_!A-_\ %4?ZM5O^?B^YA_:D
M/Y6?HS_::>OZT?VFGK^M?G-_PLCQ;_T-.M?^#";_ .*H_P"%D>+?^AIUK_P8
M3?\ Q5'^K5;_ )^+[F']J0_E9^C/]IIZ_K1_::>OZU^<W_"R/%O_ $-.M?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >?_$#_D,P_P#7NO\ Z$U%'Q _Y#,/
M_7NO_H344 ;7P_\ ^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?^@K734 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD\V\FM1%=L>IGC)CD)^K*6^A% 'H5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >?\ Q _Y#,/_ %[K_P"A-11\0/\ D,P_]>Z_^A-10!M?
M#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA%. #M0,WJ,5[]\1/A)X>^*4^A2Z]%/,=&NQ>VJPS&-?,!!^8#J/E''UKM*
M(K6VALK:*WMXD@@A01QQ1J%5% P% '0 =J^,?@#%_P *C_;,\=^#)_W=KK2S
M36?8-R+B(#UQ&T@^JU]IUX;\;/V?]3\=?$KP7X[\+ZA9Z5KVAS+]H:\WA;F%
M7#*OR@\\R*<]0_M0!K?M&?L]:=^T!X9M+66\.EZSISM)8W^PNJ;L;T=<C*MM
M7W!4'U!\IT?PE^U1X6L8M(MO$'AW5;:)?*BO;IED=%' )9HPS<?W@QKZRHH
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M$5A+#%J=K"OV7SP&!D:14'RGK][.*TO@WXFU#QE\+/"VN:M)#+J6H:?%=3M
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MZ[)$#C/O@T :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %:X^X?I7 >,_P#4O]*[^X^X?I7 >,_]2_TH ^+?C9_R.2_]
M>R_^AO7 UWOQN_Y')?\ KV7_ -#>O/Z_7LI7^PTO0^)QG^\3]1]%,HKUK'$/
MHIE%%@'T4RBBP#Z*9118!]%,HHL ^BF446 ?7K/[/O\ R%-2_P"V7_L]>1UZ
MW^SW_P A34_^V/\ [/7A9XO^$^I\O_2D>CE_^\P^?Y,^QO"?_'NOTKM(?NUQ
M?A/_ (]U^E=I#]VOR@^R)J*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN#&2P'3?'D,,#(Y/WB:^Y;BYALX))[B5((8QN>21@JJ/4D]* //?VCKUM/\
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MP/\ &C_A/--_NS_]\#_&M_R(_P#GFO\ WR*/(C_YYK_WR* ,#_A/--_NS_\
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M--_NS_\ ? _QH_X3S3?[L_\ WP/\:W_(C_YYK_WR*/(C_P">:_\ ?(H P/\
MA/--_NS_ /? _P :/^$\TW^[/_WP/\:W_(C_ .>:_P#?(H\B/_GFO_?(H P/
M^$\TW^[/_P!\#_&C_A/--_NS_P#? _QK?\B/_GFO_?(H\B/_ )YK_P!\B@#
M_P"$\TW^[/\ ]\#_ !H_X3S3?[L__? _QK?\B/\ YYK_ -\BCR(_^>:_]\B@
M# _X3S3?[L__ 'P/\:/^$\TW^[/_ -\#_&M_R(_^>:_]\BCR(_\ GFO_ 'R*
M ,#_ (3S3?[L_P#WP/\ &C_A/--_NS_]\#_&M_R(_P#GFO\ WR*/(C_YYK_W
MR* ,#_A/--_NS_\ ? _QH_X3S3?[L_\ WP/\:W_(C_YYK_WR*/(C_P">:_\
M?(H P/\ A/--_NS_ /? _P :/^$\TW^[/_WP/\:W_(C_ .>:_P#?(H\B/_GF
MO_?(H P/^$\TW^[/_P!\#_&C_A/--_NS_P#? _QK?\B/_GFO_?(H\B/_ )YK
M_P!\B@# _P"$\TW^[/\ ]\#_ !H_X3S3?[L__? _QK?\B/\ YYK_ -\BCR(_
M^>:_]\B@# _X3S3?[L__ 'P/\:/^$\TW^[/_ -\#_&M_R(_^>:_]\BCR(_\
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MO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S3?[L_P#WP/\ &M_R(_\
MGFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/^$\TW^[/_P!\#_&M_P B
M/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S3?[L_P#WP/\ &M_R
M(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/^$\TW^[/_P!\#_&M
M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S3?[L_P#WP/\
M&M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/^$\TW^[/_P!\
M#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S3?[L_P#W
MP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/^$\TW^[/
M_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S3?[L
M_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/^$\T
MW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_ (3S
M3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP/\:/
M^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#_&C_
M (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[/_WP
M/\:/^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_ -\#
M_&C_ (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\TW^[
M/_WP/\:/^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW^[/_
M -\#_&C_ (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P/^$\
MTW^[/_WP/\:/^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^$\TW
M^[/_ -\#_&C_ (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?(H P
M/^$\TW^[/_WP/\:/^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H P/^
M$\TW^[/_ -\#_&C_ (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:_P#?
M(H P/^$\TW^[/_WP/\:/^$\TW^[/_P!\#_&M_P B/_GFO_?(H\B/_GFO_?(H
M P/^$\TW^[/_ -\#_&C_ (3S3?[L_P#WP/\ &M_R(_\ GFO_ 'R*/(C_ .>:
M_P#?(H P/^$\TW^[/_WP/\:Z".02QHZ]& 89]Z3R(_\ GFO_ 'R*?0 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >?_$#_D,P_P#7NO\ Z$U%'Q _Y#,/
M_7NO_H344 ;7P_\ ^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?^@K734 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "J>L6<FH:3>VL4I@EG@>))1_ S*0&_#-7** /@?]BWXK:'\%=>\5>"?
M&[+X;U*XNTVW5X-B++'E&BD?HN,Y4GY>6YY&?O&SO;?4;6*YM)XKJVE&Z.:%
MPZ./4$<$5YW\5OV=? GQDS+X@T=1J6W:NJ6;>3<J.@RPX?'8.& ]*^1_B5\+
M_'7[%=[:>*O!GBF>_P#"T]TL,EK<< ,02$GBSM<$*1Y@ (/]TD9 /T#KXP_8
MFD/CWXT?%;QW-^]>:7RX96YPD\SOM'L%A0?3%?4/AOQBOCWX5V/B6QB\DZGI
M0NTAW;O+=H\E,XYVMD9]J^8?^";.S_A&_'&/]9]KM<_39)C^M '<_MX_#_5_
M&WPAMKS2(I+MM%O1>W%K$"S-#L96< =2N0?H6/:M?X*_M4> /$GPRL[C4-<L
MO#]_I-E''?V-[((V0HH4M&#_ *Q20,;<GD C/%:G[3G[0:? GPO9_8;1=2\2
MZL[0Z?:ODH-H&Z1P.2 64;1@DL/<UXGI/[!=[X\T74/$'C7Q%_9?C+5C]I%O
MIEI$MK:.W)61% #GUV;0#GENI '_  %TZ]^.'[5FN_%ZRL9].\*6>^*UFF3;
M]J?[.+95]SLR[8SM.T=ZZG_@H5XRN-#^%&E:%;2&/^V[\"?'\<,0WE?^^S$?
MPK#^!?Q>\7_!GXH6/P7^(JPW,#;+?2-2@4#:&!\H @#?&Y&T$C<K<'H<4/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[DB+&BHBA$48"J, #TIU 'QS\*_V[/#OAGP+8Z)XXTS6;7Q'H\"V<WDVZO\
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M(K9/4M'& /J2!7T7HO[%WPAT>V2,^%O[0D  :>]O9W=\=R X4?@!5S5/V/\
MX0ZK&ZR>#+> L,!K6XGA*\=1M<"@#K/A3X?\ :+X?$GP^MM&32YL!KC2&23S
M2.F^0$EB,_Q$D5V]?#7B/P#<?L9_&WP?J_AC5+N?P=XCNA8WMC=/N*C<H96(
M #8#[T;&05(/&<_<M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLY;.SPCV-O ;=K?TS$54@>A P<'!XKO* "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"M<?</TK@/&?\ J7^E=_<?</TK
M@/&?^I?Z4 ?$GQV_Y'9/^O5?_0WKSK->B?';_D=D_P"O5?\ T-Z\[K]FRC_<
M*7H?"X[_ 'F?J&:,T45ZYPAFC-%% !FC-%% !FC-%% !FC-%% !FC-%% !FO
M8?V<_P#D*:K_ -L?_9Z\>KV']G/_ )"FJ_\ ;'_V>O S[_D75?E_Z4CTLN_W
MJ'S_ "9]F^$_^/=?I7:0_=KB_"?_ ![K]*[2'[M?D)]L34444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 45R'CGXN^#?AKM'B7Q'8:3,R&1+::8>
M<Z^JQCYB/?%?/O[%?QSLM:\*:E8^,/' NO%%YJ\CVMKJ]\S2^28XPJ1F0]"V
M_"J?PH ^L:**\2^-GQ^U#X?_ !#\%>"?#>F6NL:_K\Z^;'=.RK;PLX0/\OKB
M0Y[",G% 'MM%17-U#96\EQ<2QP01J7>61@JJHZDD\ 5XYK'[8WP@T6_-I-XP
MBGD5BKO:6D\\:XSSO2,JPX_A)H ]HHKF_ OQ(\,_$O2VU#PQK5KK-JAVN;=O
MGC/8.APR$_[0&:W[FZALK>2XN)8X((U+O+(P554=22> * ):*\7UC]L;X0:+
M?FTF\813R*Q5WM+2>>-<9YWI&58<?PDUZ)X%^)'AGXEZ6VH>&-:M=9M4.US;
MM\\9[!T.&0G_ &@,T =)17BW[0/QXU+X&ZWX.GETFWN_"NJW9M=0OF9A+:G*
MG*@<'Y2S 'KL8<=:]GCD2:-)(V62-P&5E.00>A!H =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'G_ ,0/^0S#_P!>Z_\ H344?$#_ )#,
M/_7NO_H344 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !1110 4
M444 %%%% %/6-4AT32;W4;C=]GLX'N)-@RVU%+' [G K@/AU^T=\//BA%&-&
M\26J7C==/OF%O<@^@1\;OJN1[UZ2RK(K*RAE88*D9!'I7A7Q*_8O^&WQ%FDN
MXM.D\-:D_+7&BE8D8^K1$%/K@ GUH ]WHKXOD_8W^+/@Q@G@CXM3):K]V&XN
M;FR4#&,;8S(IX]AT[57_ .%%_M0S+%"WQ&CC13@/_;$P(R>I(BR?UH ^T9I+
M>S66ZF:*!0O[R9R% 4>K'L,G\Z\SU+]IKX=6/C#2?#%MX@AU?6=2NX[**'2Q
M]H1'=@H+R+\@ )&1DD>E>!6?["OC+QA-'+\0OB?=:BH(+PP2379/TDF88[\[
M#]*][^%?[,OP_P#A"T=SHVCBZU5.FJ:D1/<@^JG 5#_N*M 'JM%%% !117._
M$+QQIWPV\%ZOXFU5F%CIL!E=5^\[9"H@]V8JH]R* #XA^.+'X:^"M7\3:E'-
M-9:;#YTD=N 9&Y  7) R21U-2^!O&%IX_P#"&D^(["&XM[+4[=;F&.[55E56
MZ;@I(!^A-?'E]K7QV_:Z\%ZB-*TW1_#G@747\N-+AP&G5) <"0AG;#(,L%4$
M@CU%>A? R?XW_#?Q1X:\#^+O#]EJ'@T0&SAUC3P&^R+%"Q3<R$8!V*O[Q026
M&#GB@#Z>HKD/BUXPU/P'\/=8US1M%F\0ZK:I&+;38%9FF=Y%C'"@D@;]Q YP
MIZ=:^;/^$;_:P\9VXU=O$&E>&-P\R+2<Q1LH[+@12>O1WSQSS0!]A45\I_LW
M_M*^,-6^)5U\,?B;:)'XFC\P07:Q+$[2(I=HY%3Y#E 65U ! [Y!KZLH ***
M^$_#'Q6^/_Q@^)7C+1?!WBW3["'2+N;$%U9VRHD0F9$56,#L<8'4Y]Z /NRB
MOE72O"/[5L>J6;7OC?0'LUF0S+Y%ORFX;AQ; ],]"#[BOJEF"J23@#DDT +1
M7QWJGQX^)O[0GQ$U3PS\'9[31- TL_O]>ND!\W!P&+%'VJQ!VJJEB 23C(&3
MXL^(7QZ_9=U'3-4\9:K9>-_"=S.(9&C4$ \G;O\ +1T<@$C.Y>.] 'VU17/:
M=X\T74O D/C".[5-!DL/[2^TR<;(=F\EAV(&<CL017RCHOQ4^-7[46NZK-\.
MKVT\%>#[";R5N[M!OE] S[')DVD,50 +D9)X) /L^BOBF;XW?%[]F7QUI.F_
M%6ZM_$_A?4CA=0M44E5! =HW"(Q9,@E''(/!YS7VE!/'=0QS0NLL4BATD0Y5
ME(R"#W&* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** *UQ]P_2N \9_ZE_I7?W'W#]*X#QG_ *E_I0!\1_';_D=D_P"O
M5?\ T-Z\[KT3X['_ (K9/^O5?_0WKSG=7[-E'^X4O0^"QW^\S]1U%-W4;J]<
MX1U%-W4;J '44W=1NH =13=U&Z@!U%-W4;J '44W=1NH =7L/[.?_(4U7_MC
M_P"SUXYNKV+]G$YU35?^V/\ [/7@9]_R+JOR_P#2D>GEO^]0^?Y,^SO"?_'N
MOTKM(?NUQ?A/_CW7Z5VD/W:_(3[@FHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "J>L7DFG:1?7<41GE@@>5(EZN54D*/KBKE)0!\&_L=_#7PY\?=8\:
M>+O'J?\ "3:XMTF;>YD8(OF!B9"H(SG!51T4+P.F/HCQ7^QS\*_%$4?E>'O[
M!NHW#I=:-*8'&#G&TY0@X[J3Z8KR/QU^R#XR^'OC2Z\8_!;71ITLK,YT=Y!$
M5#-DQH6'EO'G&$DP!@<FD\(_MI>*O /B6#PW\9/"DFD2-A?[3MX&B8#.-[1D
ME9%]6C/;@&@#[(KXV^!<_P#PMO\ ;.\>^,)_WEIH$<MI9=PN#]G1AZ9196^K
MFOKNXU:!=#DU2WECN+46YN8Y8VW(Z;=P8$=01W%?'_\ P3?A\[2_'^H2'?<3
MW5JKR'[QPLK?S<T =7_P4*\0:GI'P>TRRLGDAL]2U1(;QXS@.BQNZQM[%E#?
M\ KT'X1_ WX9P_#'0!9^%]$UBWO+"&:2^N[**XDN2R!B[.P)ZDG'0= !73?'
M&S\&7WPQUF'Q]-%;>&FCS-,[;71P<HT> 3YF<;0 23Q@Y(KX+\!:A\9- \)^
M)&^%#>)+[X>[W6"YGM$$H4GYGA3+$-U!,6?4@'H >E?"/1K;P#^WEK7A[P9N
M3PUY4R7EO"Y:.)?LPD9#[)<%5&>G2O0_^"A7B#4](^#VF65D\D-GJ6J)#>/&
M<!T6-W6-O8LH;_@%4/V%]8^&W]D7EIHSW,?C^9-^JG5B#<S8.6\DCK&&Y(^]
MGENQKW;XXV?@R^^&.LP^/IHK;PTT>9IG;:Z.#E&CP"?,SC: "2>,')% ',_"
M/X&_#.'X8Z +/POHFL6]Y80S27UW917$ER60,79V!/4DXZ#H *^>_A'HUMX!
M_;RUKP]X,W)X:\J9+RWA<M'$OV82,A]DN"JC/3I7FO@+4/C)H'A/Q(WPH;Q)
M??#W>ZP7,]H@E"D_,\*98ANH)BSZD ]/?OV%]8^&W]D7EIHSW,?C^9-^JG5B
M#<S8.6\DCK&&Y(^]GENQH ],_:_\&IXR_9^\41[0;C38AJD+$?=,)W.?^_?F
M#\:?^R/XX?QW\ _#-S.Y>[L8VTV8DY),)VJ<^I38?J:]&\>6::AX'\16LBAH
MY].N(F5NA#1,"/UKYE_X)QZ@\OPU\4618F.'5A*H[ O"@/\ Z * /K>BBB@
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M^% '4T5RO_"%6W_/[=?]]#_"E'@FW_Y_;G_OH?X4 =317,?\(/;_ //[=?\
M?0_PI?\ A!;?_G]NO^^A_A0!TU%<S_P@MO\ \_MU_P!]#_"C_A!;?_G]NO\
MOH?X4 =-17,_\(+;_P#/[=?]]#_"C_A!;?\ Y_;K_OH?X4 =-17,_P#""V__
M #^W7_?0_P */^$%M_\ G]NO^^A_A0!TU%<S_P (+;_\_MU_WT/\*/\ A!;?
M_G]NO^^A_A0!TU%<S_P@MO\ \_MU_P!]#_"C_A!;?_G]NO\ OH?X4 =-17,_
M\(+;_P#/[=?]]#_"C_A!;?\ Y_;K_OH?X4 =-17,_P#""V__ #^W7_?0_P *
M/^$%M_\ G]NO^^A_A0!TU%<S_P (+;_\_MU_WT/\*/\ A!;?_G]NO^^A_A0!
MTU%<S_P@MO\ \_MU_P!]#_"C_A!;?_G]NO\ OH?X4 =-17,_\(+;_P#/[=?]
M]#_"C_A!;?\ Y_;K_OH?X4 =-17,_P#""V__ #^W7_?0_P */^$%M_\ G]NO
M^^A_A0!TU%<S_P (+;_\_MU_WT/\*/\ A!;?_G]NO^^A_A0!TU%<S_P@MO\
M\_MU_P!]#_"C_A!;?_G]NO\ OH?X4 =-17,_\(+;_P#/[=?]]#_"C_A!;?\
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MH_X06W_Y_;K_ +Z'^% '345S/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^%
M'345S/\ P@MO_P _MU_WT/\ "C_A!;?_ )_;K_OH?X4 =-17,_\ ""V__/[=
M?]]#_"C_ (06W_Y_;K_OH?X4 =-17,_\(+;_ //[=?\ ?0_PH_X06W_Y_;K_
M +Z'^% '345S/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^% '345S/\ P@MO
M_P _MU_WT/\ "C_A!;?_ )_;K_OH?X4 =-17,_\ ""V__/[=?]]#_"C_ (06
MW_Y_;K_OH?X4 =-17,_\(+;_ //[=?\ ?0_PH_X06W_Y_;K_ +Z'^% '345S
M/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^% '345S/\ P@MO_P _MU_WT/\
M"C_A!;?_ )_;K_OH?X4 =-17,_\ ""V__/[=?]]#_"C_ (06W_Y_;K_OH?X4
M =-17,_\(+;_ //[=?\ ?0_PH_X06W_Y_;K_ +Z'^% '345S/_""V_\ S^W7
M_?0_PH_X06W_ .?VZ_[Z'^% '345S/\ P@MO_P _MU_WT/\ "C_A!;?_ )_;
MK_OH?X4 =-17,_\ ""V__/[=?]]#_"C_ (06W_Y_;K_OH?X4 =-17,_\(+;_
M //[=?\ ?0_PH_X06W_Y_;K_ +Z'^% '345S/_""V_\ S^W7_?0_PH_X06W_
M .?VZ_[Z'^% '345S/\ P@MO_P _MU_WT/\ "C_A!;?_ )_;K_OH?X4 =-17
M,_\ ""V__/[=?]]#_"C_ (06W_Y_;K_OH?X4 =-17,_\(+;_ //[=?\ ?0_P
MH_X06W_Y_;K_ +Z'^% '345S/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^%
M'345S/\ P@MO_P _MU_WT/\ "C_A!;?_ )_;K_OH?X4 =-17,_\ ""V__/[=
M?]]#_"C_ (06W_Y_;K_OH?X4 =-17,_\(+;_ //[=?\ ?0_PH_X06W_Y_;K_
M +Z'^% '345S/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^% '345S/\ P@MO
M_P _MU_WT/\ "C_A!;?_ )_;K_OH?X4 =-17,_\ ""V__/[=?]]#_"C_ (06
MW_Y_;K_OH?X4 =-17,_\(+;_ //[=?\ ?0_PH_X06W_Y_;K_ +Z'^% '345S
M/_""V_\ S^W7_?0_PH_X06W_ .?VZ_[Z'^% '345S/\ P@MO_P _MU_WT/\
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MPW_H*UTU<S\/_P#D#3?]?#?^@K734 %%%% !1110 4444 %>=-^SK\,'8L?
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M;SJ-V72+:Y9?D<Y#$85N>#4WAOX)_$?]H3XK:7XW^*VGP>'M"THK]ET1#AY
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M/_CW7Z5VD/W:_'S[@FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8?\ KW7_ -":BCX@?\AF'_KW7_T)J* -KX?_ /(&F_Z^&_\ 05KIJYGX?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 445Y?\ L^_&]/CUX5U/7(M&;1H+349+!%:Y\[S0J(^_.Q<9$@XY^IH
M]0HHKG?&'Q$\-^ 18GQ#K%MI/VZ0PVPN&(,KC&0H'U'YB@#HJ*** "BBB@ H
MHHH **YW7OB)X;\,:_I6B:KK-K8:KJC!+*UF;:T[%@H"]LY('U-=%0 4444
M%%%% !1110 5XYI_QKU;Q!^TI?\ PZTK3K-M&T>P%UJFH3,WFAV12JQX.WK+
M&#D'H_I7L=?'OQ6US7?V9?VC-;^(J>')]?\ "7B:QCBN&MR5^SRHJ @O@@-F
M+=\V 0YP<J< 'IO[4O[0EW\&=)TK3/#UDFI^+]<D,5E R&01J"%WE!RS%F"J
MO<YZXP?,O"7[1'Q=^&?CKP]I7QCT*&WT7Q!*(+>^C2)6@=F !)B8J0"PW*P#
M '/;!K? W2_$?[1OQ_;XM>)M%DTCP]H\(BTBUG!*EP"$"E@-^TL\A<#&\C'H
M-S]N2^7Q)?\ PW\!Z:/.\0:CK"7<<<?WXHQF(,?0%G8Y_P"F;>E 'U?1110
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M\^?P?J'V:*3).$=Y59!GLKQ.1Z!\=A0!]14444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM;*GYHR01A>1CG[#^&?Q^\"?%H+'X<U^WGOBNXZ=<9AN5P,G]VV"P'<KD>]
M'H=?'6L3#X[?MR66E2'[3X?\#0M,8QRAFCVEB??SWC4^HBK[#DD6&-G<X506
M)] *^,?^"?K-XF\5?$_Q9<?\?5[<0GGDYEDFE?/X[: /7OVLOCY<? _P3:+H
MZI)XGUB5H+ 2)O6)5 \R7;T8KN0 'J7'4 BO,=)_9A^,WBK28=>USXR:OHWB
M.9/.73X9)C' 6'W"R2H$., A4P.1S6;_ ,%!;:ZTCQ-\-O$SP27&EV<\D<@
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M_ X/X5X9_P $\]??4O@QJ.G2')TW5I4C_P!QXT?'_?1?\Z /J.BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFO&-2^*7[2?CNQETG1OAO!X6GFS#)JEP^UH0>"R&1P!CU ;VYQ0!P?@OX?\
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M#]*X#QG_ *E_I7?W'W#]*X#QG_J7^E 'PS^T!_R/4?\ UZ+_ .AO7FM>E?M
M?\CU'_UZ+_Z&]>:9K]LR;_D7T?0_/\<_]IGZBT4F:,U[)PW%HI,T9H"XM%)F
MC- 7%HI,T9H"XM%)FC- 7%HI,T9H"XM>T_LS_P#(4U?_ +8?^U*\5S7M7[,_
M_(4U?_MA_P"U*^>X@_Y%M7Y?^E(]/+/][A\_R9]J^$_^/=?I7:0_=KB_"?\
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MF!16'J #Z@M-'T_3[$65K8VUM9 8%O#"JQXX&-H&.P_*OCW]K3P7IGP;\?>
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MFBL=;CEF(:61=/C#2$# +'S.<  <U-_P\&^%_P#S[Z__ . 4?_QR@#I/AO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY^+7\A_\31Y'BC_GXM?R'_Q- '345S/D>*/^?BU_(?\ Q-'D>*/^?BU_(?\
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MY^+7\A_\31Y'BC_GXM?R'_Q- '345S/D>*/^?BU_(?\ Q-'D>*/^?BU_(?\
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M$F6.0=48J3AAZ'F@#2HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX1DA+?)Q]*Y6\T>2!C@$>QK[+"9]1JVC77*^_3_@?UJ?(XK(ZM+WJ#YE^/\
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MS>'1_P Q&6Z=5*\$-D0%!QGC<>HYKWOX)_'7PY\=O#LNI:&TL%S:LL=YI]R
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MQT#_ ,&<'_Q5/A^*'@VXFCBB\6Z%++(P5(TU*$LS$X  #<FO#O\ AWS\+_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!I6HI( W:IZ* ,FZTQ) ?EKG]2\,QS
M_)^E=H5J*2$-0!XWKG@=) V(_P!*\ZU[P#C<1'^E?3=SIJ2 _+6!J7AN.8'Y
M: /D/6/!\D);Y./I7*7FBR0,< CV-?66M^!TD#?N_P!*\ZU[X?D;B$_2NW#8
MROA'>C*WET^XX\1@Z&*5JL;^?7[SP%XVC.&&*;7H&L>#I(2W[OCZ5R=YHLD#
M' (]C7V6$S^E4M'$+E??I_P#Y#%9%5I^]0?,NW7_ ()9\,>-]:\'S^9I=])
MA.6A8[HW^JGC\>M>H6/QUAUJW\G5(/L5QC'F1DM$W]5_7ZUXH\;1G##%-KU<
M1@,)F$>=K5]5_6IYF'QV*P,N1/;H_P"M#&^.FI1W?C2&2-U=&LTPRG(/SO7
M++GO7I>I:-9ZO'MNH5D(& _1E^AKCM4\"7=IF2PD^U1_\\W.'']#^E>Y@>7"
MT(4+WY=!5<2L14=1Z-F0&IV:I-))!(8ID:*1>"C@@C\*F28&O733(L6**C#9
M[TN:L0^BF9HS0 ^BF9HS0 ^BF9HS0 ^BF9HS0 ^O;?V8O^0IK/\ VP_]J5X?
MFO;_ -F'_D*:S_VP_P#:E?.\0_\ (LJ_]N_^E(]7*_\ >X?/\F?;7A/_ (]U
M^E=I#]VN+\)_\>Z_2NTA^[7XN??$U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445A^.?$DG@_P9KFNPV$FJ2Z;937:V4;;6F*(6V X.,XZX/T- 'CG
MQH_8S\&_%K4KC6K66;PSXBG)>6\LE#Q3/_?DB)&6]U*D]R:\'UCQ'\:_V-=3
MTXZQJO\ PF'@F:;R8S<2-+$W&?+#-\\+[02%R5X/WL&O:_"G[>?PLURPCEU6
M\OO#=UCY[>[LY)@&[[6A5\CW('T%>1_M,_M!:9^T3IFF?#OX;Z=?>(KNZODG
MDNOLK(N%!"A%8;@,MEG8*% ]S@ ^Q]-\66WB?P#!XDTHN]K?:<+ZVW##;6CW
MJ#SP><'T-?*G_!-F-1X<\<./OM=VH/T"28_F:^G?A7X'?P#\,/#OA>YF6ZFT
M^PCMIY%SM9]OS[?]G)./;%?+7[ ;-X3\=_$_P9<G_2;66,A6X;]Q++%(?S9*
M /:OVI/V>Q\?/!]I#8W$-CXATR1I;&XN ?+96 #Q.0"0&PIR <%1QR:\UT6\
M_:OT'3K?0_[%\/ZDD4:QKK-Y/$TF!P-V)EW'&.3&2<=SG/O_ ,2OC%X4^$:Z
M6_BK46TR#4I6A@F\AY5W* 3NV D#D<XKB/%G[8WPK\,Z)<7T'B6'6KE5)AL=
M/1WEF;'"YQA?JQ _E0!\P:7X;\9)^VSX/L_&>LPZ_P")@\5W<RV:XB@58GE$
M2_*O"J,]!U[]3^A=?(W[)O@O7OB)\3/$7QM\56;61U/?%I-O)G(1L+O7(!V+
M&HC5OXLL:]5_:>^/R? 7P1%=VUL+S7=2=[?3XI!^[5@ 6D?U5<C@<DD#@9(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*YQGI0!];4444 %%%% !1110 4444 >?_$#_ )#,/_7NO_H344?$#_D,P_\
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M)GDX##H!E2,YXKT&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J.XN([6WEGF<1Q1J7=VZ*H&2?RJ2F31)<1/%(BR1NI5D89# \$$4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4450FU[3+;5H-+FU&TBU.X4O#9/.
MHFD49R50G<1P>0.QH OT5F^(?$>E^$]'N=5UF_M],TVW7=+<W4@1%';D]R>
M.I)P*YSP-\:/ _Q*NY;3PSXEL=6NXE+O;Q.5EV@X+!& )&<<@8Y% ':T444
M%%%% !1110 4444 >?\ Q _Y#,/_ %[K_P"A-11\0/\ D,P_]>Z_^A-10!M?
M#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734 %%%% !1110 4444 %%%?
M!/[77QN\=Z?\:+_P7!XGN/"/A5%MPES;QO&71X49Y&>-3(P#,R[5./EQCJ:
M/L+Q]\9O!/POB+>)O$=CIDH&X6I?S+AAZB),N?KBOF7Q]_P41MFF-AX"\,3:
MC<R-Y<5WJN55F/ "PQDLV3C&64^U1? O]E'X0^,D74[GQO\ \+$OF_>36L$_
MV503R=\6?.Z]V9<^E:'[7G@7P[X$L?A=9^'M$L=&MO\ A(4W)9P+'OQMY8@9
M8^YR: ,_PEX"_:-^+WBO1M;\7:S-X5T&VO8;MK%IOLVY$=6*B"+DGC_EJ0?>
MOM.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI6[U85\]* )**2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO)\--%N'7PSX7BEU'7+J$\&9%.4STRN1&/\ :=\C"U:_X)N_\B3XQ_[",/\
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M%% !1110 4444 %%%% !1110 4444 5KC[A^E<!XS_U+_2N_N/N'Z5P'C/\
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M2O5PNC_E_P O\CTLOSIQM3Q6J[_Y_P"9ZTGBS66_YB]]_P"!+_XU(/%6L_\
M07OO_ E_\:XO3=82=00V:V(KA7'6OB)1E!N,E9H^SC)32E%W3-W_ (2C6?\
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M(ZGH01P17R5_P4/\/>&?^%?Z3K,\5O!XJ^W+!:S( )IX=C&16[LB_(<G.TX
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MX3S3?[L__? _QH VKC[A^E<!XS_U+_2MVX\=Z;M/RS]/[@_QK@_&'C;3WA?
MFZ?W!_C0!\5_M'?\C_%_UY)_Z,DKRRO2?C[J,6I^.(Y8=VT6BK\PP?ON?ZUY
MM7[GDO\ R+J/H?G68?[U4]0HHHKVCSPHHHH **** "BBB@ HHHH *0KFEHH
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M )YK_P!\BI** (_(C_YYK_WR*/(C_P">:_\ ?(J2B@"/R(_^>:_]\BCR(_\
MGFO_ 'R*DHH C\B/_GFO_?(H\B/_ )YK_P!\BI** (_(C_YYK_WR*/(C_P">
M:_\ ?(J2B@"/R(_^>:_]\BCR(_\ GFO_ 'R*DHH C\B/_GFO_?(H\B/_ )YK
M_P!\BI** (_(C_YYK_WR*/(C_P">:_\ ?(J2B@"/R(_^>:_]\BCR(_\ GFO_
M 'R*DHH C\B/_GFO_?(H\B/_ )YK_P!\BI** (_(C_YYK_WR*/(C_P">:_\
M?(J2B@"/R(_^>:_]\BCR(_\ GFO_ 'R*DHH C\B/_GFO_?(H\B/_ )YK_P!\
MBI** (_(C_YYK_WR*/(C_P">:_\ ?(J2B@"/R(_^>:_]\BCR(_\ GFO_ 'R*
MDHH C\B/_GFO_?(H\B/_ )YK_P!\BI** (_(C_YYK_WR*/(C_P">:_\ ?(J2
MB@"/R(_^>:_]\BCR(_\ GFO_ 'R*DHH C\B/_GFO_?(H\B/_ )YK_P!\BI**
M (_(C_YYK_WR*/(C_P">:_\ ?(J2B@"/R(_^>:_]\BCR(_\ GFO_ 'R*DHH
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M_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI**
M(_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\B
MI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_
M -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\
MYYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\
MB/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\
M?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">
M:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C
M_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI**
M(_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\B
MI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_
M -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\
MYYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\
MB/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\
M?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">
M:_\ ?(H\B/\ YYK_ -\BI** (_(C_P">:_\ ?(I]+10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X'^TA^S1/\
M%?4--\5>%=5'ASQOI:XAO 607 !R@9U^9&4YPX!X)!'3'OE% 'Q2E[^V!HZI
MIXLX=0( 5+MO[/<D#U;</S89.*Z'X0_LM^-==^(UE\0/C%K*ZKJ5BPDM-+\P
M3;74DH7*X1%5OF")D$X)QR#]:U\H_MP:YJ.C^)OA&MA?W5DLVJ3"06\S1A\/
M;8W8/.,GKZF@#ZNHHHH **** "BBB@ HHHH \_\ B!_R&8?^O=?_ $)J*/B!
M_P AF'_KW7_T)J* -KX?_P#(&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ
M "BBB@ HHHH **** "BBB@#XL^*'AS4?VIOVIK[P'<ZG-8>#_"EL)9_LWWF8
MK'O(SE?,+R!02,!4)QU!]9@_8=^#\-B(&\.7$TH 'VJ34K@2'WP'"_\ CO>O
M*?B!XAO/V5_VJ-0\:ZC8SWW@WQ?!Y<DEORT3@1E\ D NKIN /5)#CD''M]M^
MUY\(KFQ%V/&EK&F 3')!,L@SVV;,_D* /G_5?!ES^Q;\</"5]X>U*YO?!7BF
MX^PW=E=MN:+YT#9P &*AU9&QGY64\9)^X:^%_B#\1X_VOOCEX'\,>#K:X?PY
MH=T;Z[U"="F] Z&23:?NJ%0*N[!+28('%?=% !1110 4444 8#> _#S>,%\5
MG2;<^(E@^S+J)7]Z(^FT'TP3^=;]%% !1110 5Q>O?"+PWXF^(6C>,]3MYKS
M6-'B\JQ628F"$Y8[Q'TWY;J?13U ([2B@ HHHH **** "BBB@ HHHH ****
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MLU6M_N#Z59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3C'.!0!^@M%%% !1110 4444 %%%% 'G_P 0/^0S#_U[K_Z$U%'Q _Y#,/\
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MRH#G.UY68KD$C@CCCI7H= !1110 4444 %%%% !1110 4444 %%%% !1110
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M  80_P#Q5'_"XO"'_0TZ-_X,(?\ XJOSRR:,FC_5JE_S\?W(/[4G_*C]#?\
MA<7A#_H:=&_\&$/_ ,51_P +B\(?]#3HW_@PA_\ BJ_/+)HR:/\ 5JE_S\?W
M(/[4G_*C]#O^%Q>$/^AIT7_P80__ !5/7XQ>#S_S-6BC_N(0_P#Q5?G=DT9-
M'^K5+_GX_N0?VI/^5'Z7>'_&NB^)O._LG5['4_)V^;]CN4FV9SC=M)QG!QGT
M-;\<@:OCK]D+4/L=QXG7.-_V7]/._P :^L].NO.0<U\AC\,L'B94(NZ5OQ29
M[6'JNM251JUS6I:8II]>>=(4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,/-TZJLT?>4:U.O!5*;NC5HJ)) U29K V%HHHH **** "BBB@ HHHH ****
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MHHH **** "BBB@ KY(^-R^)/V>?CW)\7M)TB37O#&LV:V>M6]NI!M]BHNYB
M0N?+C8,1C(93C()^I-0\3:/I-QY%]JUC9SXW>7<7*1M@]#@G-56\;^&9%96U
M_265A@J;R(@CT^]0!\.2?M7^#;O]I^P^(AMM6AT./0SI[PO;H9Q+ES]T.01\
MPYW5K:OXWU+]M_XK^&M'T31[K2O N@W/VR]N[I07;D$[RI*JS*-BH"?O,Q)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU#RT9PV%9L-)\B1J&52Q&2QP.V<8_"/]JF8^8WC^T1G^8K]OQ@GM@0X'X<4
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M+K86]Q=1.'DTZ8^6Q\Q1\P7*!NG*OD9*$5]+K\6/!#*&'C'0"",@_P!J0?\
MQ5>9_$+]C/P!\2O&.I>)=6EUA-1U!U>9;:Z1(\JBH, H<<*.]<]_P[Y^%_\
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M@BNK6=&BE@F0.DB$8*LIX((X(->"_MO6\5K^S5K4,$:0PQS6:)'&H5543H
M!T H [;]FW7M1\4? WPAJFK7DNH:C<6A::YG;<\A#L,L>YP!S7I=>2_LG_\
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M_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\
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M1110 4444 %%%% !7K7P%_YCO_;#_P!J5Y+7K/P%_P"8Y_VP_P#:E?.<1?\
M(KJ_]N_^E(]7*_\ ?(?/\F>M9-&3117XJ?H 9-&3110 9-&3110 9-&3110
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M=/\ KU7_ -#>OJ.'/]_7HSR,U_W9^J//-U&ZH\BC(K]7L?%DFZC=4>11D46
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M10!A?\(7I/\ SP;_ +^-_C1_PA>D_P#/!O\ OXW^-;M% &%_PA>D_P#/!O\
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MCMX4BB18HHU"HB#"J ,  =A3Z** "BBB@ HHHH **** "BBB@ HHHH ****
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M(R"#7YWUZ1\-?C1J?@>2.TNR]_I&<>43\\0_V">W^R>/3%>7F.1J5ZN$T?\
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M\QVNI!4X+X."!UH ]9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX4^E=Q <J* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Y_P#$#_D,P_\ 7NO_ *$U%'Q _P"0S#_U[K_Z$U% &U\/
M_P#D#3?]?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444
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M^TS_ ,E$A_Z\4_\ 1DE>35^YY+_R+J/H?G&8?[U4]0HHHKVCS@HHHH ****
M"BBB@ HHHH **** "O5O@3_S'/\ MA_[4KRFO5?@7_S&_P#MA_[4KYSB+_D5
MU?\ MW_TI'K95_OD/G^3/6,T9IE%?BI^A#\T9IE% #\T9IE% #\T9IE% #\T
M9IE% #\T9IE% #\T9IE% &WX3_Y#,?T_J*^D_!G^I3Z5\U^$?^0U']/ZBOI3
MP9_J4^E '?V_W!]*LU6M_N#Z59H **** "BBB@ HHHH **** "BBB@ HHHH
M**** &E<U#- ''2K%)0!S^HZ0DRGY:\\\4>$4FC?Y,\>E>OO&&K'U33UEC/'
M:@#XQ^)'@TQ+(0GKVKY=\0^/-1^'OBY;<I]KTQXE9[9C@J=S LA['CIT/ZU^
MA?Q'\.I)!+A>U?G]^T%H(A\9JNW_ )=E/_C[U[^1J3Q:4>S/*S*,98=J:NKG
MH/AWQ-IWBK3Q=Z=<":/HZ'AXSZ,.QK4(R,$9%?*FGWVH^%=16]TV=K>=>#C[
MK#T8=Q7N'@/XK6'BS9:7>VPU;IY+'Y)3ZH3_ .@GGZU^C1J:VEN? 5L*Z?O0
MU1;\0>!UD+7.F 12=6M^BM_N^A]NGTKCUF:&5HI5:.53AE88(->P5D:]X9M=
M>CS(/*N%&$G4<CV/J*[J=9QT9C"MTD>?K,&Z4\-4.IZ9>:#<>5=)\I^Y*OW7
M^A_I3(YPW>O3C)2U1T^:+611D5&'S2[JT)'Y%&13-U&ZBP#\BC(IFZC=18!^
M11D4S=1NHL!ZM\#O^8U_VP_]J5ZG7E7P-;_D-_\ ;#_VI7J>ZOQCB'_D9U?^
MW?\ TE'WV5_[G#Y_FQU%-W4;J^</5'44W=1NH =13=U&Z@!U%-W4;J '44W=
M1NH =13=U&Z@!U:&@_\ (3BK-W5HZ"?^)I%0!]"^#3^X3Z5WUO\ <'TK@/!G
M^I3Z5W]O]P?2@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(
MS!5+,0 !DD]J\@_9C^-&J?'3P3JFOZEI]KIXM]3DLH%M=^'C6.-]QW$\_O,<
M>E 'L%%%</\ $CXR>&/A3<:);:_<S1W6LW'V>RM[:!II)&!4$[5YP"ZC_@0Q
MF@#N**** "BBB@ HHHH **** "BBN(OOC)X8TWXH6?P_N[J:W\1WEO\ :;>.
M2!EBE7#'"OT)PC?]\D=>* .WHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** //_B!_R&8?^O=?_0FHH^('_(9A_P"O=?\ T)J* -KX?_\ (&F_Z^&_
M]!6NFKF?A_\ \@:;_KX;_P!!6NFH **** "BBB@ HHHH **** ///C%\>/"?
MP/TJ*Z\1W<GVFX#&UT^U3?/<;<9VC@ #(^9B![YXKYZ;_@I)H?VK:O@G4#;?
M\]#>QA^G]W;C]:32?".F_&[]MSQG_P )1$NI:7X:M$6TTRY.Z-BHB0 H>J;G
MD<CH689X.*^OH-)L;6Q%E#96\5F  +>.)5C '0;0,=A^5 'G/P8_:.\&_'*&
M2/0KJ6WU6&/S9]+O4"3HF0-XP2K+DCE2<9&<9KU&OC']ICP?IGP1^,GPU\=>
M#[:/1+N_U(V]]:60$44X#1[B$4<;T=U;'7*GKR?LZ@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "D-+3';&30 UY M59KY4[U5U&\\E2<XKXM_:PO/MGQ'L7S]
MW2XU_P#(LW^->EE^#^O5_8\UM.U_\CEQ-?ZO3Y[7/M)M60?Q4W^V(_[PK\Q]
MWO1N]Z^G_P!6/^GW_DO_ -L>3_:W]S\?^ ?IO_;$?]X4?VQ'_>%?F1N]Z-WO
M1_JQ_P!/O_)?_M@_M;^Y^/\ P#]-_P"V(_[PH_MB/^\*_,C=[T;O>C_5C_I]
M_P"2_P#VP?VM_<_'_@'Z;_VQ'_>%']L1_P!X5^9&[WHW>]'^K'_3[_R7_P"V
M#^UO[GX_\ _3?^V(_P"\*/[8C_O"OS(W>]&[WH_U8_Z??^2__;!_:W]S\?\
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M%%% !1110 4444 >?_$#_D,P_P#7NO\ Z$U%'Q _Y#,/_7NO_H344 ;7P_\
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MO_<X?/\ -CJ*;FC-?.'JCJ*;FC- #J*;FC- #J*;FC- #J*;FC- #J*;FC-
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M:S_T%[[_ ,"7_P :R<T9H UO^$JUG_H+WW_@2_\ C1_PE6L_]!>^_P# E_\
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M>QY,DFZI*L>(/#%[X;D+MFXLR?EG4=/9AV/Z5G1S;N]>K"HIJZ.C=71Z_P#
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MQ;]/0?X5\;_&C[7'XP47K*\OV9<%.F-[_P#UZ^ZO&?\ J7^E?#GQ];'CB/\
MZ]%_]#>OJ.&_]_7HSQ\U_P!V?JCSS?1OJ'=1NK]8L?%W)M]&^H=U&ZBP7)M]
M&^H=U&ZBP7)M]&^H=U&ZBP7)M]&^H=U&ZBP7)M]&^H=U&ZBP7)M]&^H=U&ZB
MP7/3_@VV?[7_ .V/_L]>DY%>9?!IO^0Q_P!L?_9Z]*W5^/Y__P C*K\O_24?
M<Y;_ +I#Y_FQ^11D4S=1NKY\],?D49%,W4;J 'Y%&13-U&Z@!^11D4S=1NH
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M$?T_PH ]M\'P^)/)3;<6_3T'^%=Y;P>*-H_TBVZ>@_\ B:Q?!G^I3Z5W]O\
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MTH [^W^X/I5FJUO]P?2K- !1110 4444 %%%% !1110 4444 %%%% !1110
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M\HJ3=40:EW5\Z>J2;J-U1[J-U $FZC=4>ZC=0!)NHW5'NHW4 2;J-U1[J-U
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M[J-U $F[WHW>]1[J-U $F[WHW>]1[J-U $F[WHW>]1[J-U 'J?P3;_D,\_\
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M]J#_ )*-!_UX)_Z,DKR&OW/)?^1=1]#\XS#_ 'JIZA1117M'G!1110 4444
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M.&'0CWH 9>V-MJ5L]M=V\5U;OC=#,@=&P<C(/!Y%97_""^&_^A>TK_P"B_\
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M7"A_Z\4_]&25]^>,_P#4O]*^ ?VF#_Q<.'_KQ3_T9)7UG#'_ ",5Z,\3./\
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MS_4I]* ._M_N#Z59JM;_ '!]*LT %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y
M_P#$#_D,P_\ 7NO_ *$U%'Q _P"0S#_U[K_Z$U% &U\/_P#D#3?]?#?^@K73
M5S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444
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M /2_@VW_ "%_^V/_ +/7I6[WKS+X.'']K_\ ;'_V>O2=U?BO$7_(TJ_]N_\
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M/_\ A8&H_P#/&U_[Y;_XJC_A8&H_\\;7_OEO_BJ] HH \_\ ^%@:C_SQM?\
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MP3_T%-?_ / B#_XS1_PQ?X)_Z"FO_P#@1!_\9KZZ_P"%6>"_^A0T'_P60?\
MQ-'_  JSP7_T*&@_^"R#_P")H_MK,?\ G\P_L_"_\^T?(O\ PQ?X)_Z"FO\
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ML?\ \17T)_PJSP7_ -"AH/\ X+(/_B:/^%6^"_\ H4-!_P#!9#_\30!\]_\
M"BM!_P"?O4O^_L?_ ,16CH7PETCP_??:K>XO7DV[<2NA'4'L@]*]WC^&OA"/
ME/"NB(?]G3H1_P"RU>M_".A6O^HT73X?^N=K&O\ (4 >>:;JLNEJ%B5& _O@
MG^M:R>.K^,8$-M_WRW_Q5=Y'8VT/$=O%&/\ 90"I@H'08H X#_A8&H_\\;7_
M +Y;_P"*H_X6!J/_ #QM?^^6_P#BJ] HH \__P"%@:C_ ,\;7_OEO_BJ/^%@
M:C_SQM?^^6_^*KT"B@#S_P#X6!J/_/&U_P"^6_\ BJ/^%@:C_P \;7_OEO\
MXJO0** //_\ A8&H_P#/&U_[Y;_XJC_A8&H_\\;7_OEO_BJ] HH \_\ ^%@:
MC_SQM?\ OEO_ (JC_A8&H_\ /&U_[Y;_ .*KT"B@#S__ (6!J/\ SQM?^^6_
M^*H_X6!J/_/&U_[Y;_XJO0** //_ /A8&H_\\;7_ +Y;_P"*H_X6!J/_ #QM
M?^^6_P#BJ] HH \__P"%@:C_ ,\;7_OEO_BJ/^%@:C_SQM?^^6_^*KT"B@#S
M_P#X6!J/_/&U_P"^6_\ BJ/^%@:C_P \;7_OEO\ XJO0** //'\=7\@P8;;_
M +Y;_P"*K)U+59=44K*J*#_<!']:]8*@]1FH9+&VFXDMXI!_M(#0!\D_$#]F
MSPS\1M<35-2OM6@N$A$ 6TFB5-H9FSAHV.<L>]<S_P ,6^"?^@IK_P#X$0?_
M !FOLVX\(Z%=?Z_1=/F_ZZ6L;?S%49/AKX0DY?PKHCG_ &M.A/\ [+7K4LUQ
MU&"ITZK26R.*>"P]23G.";9\@?\ #%O@G_H*:_\ ^!$'_P 9H_X8M\$_]!37
M_P#P(@_^,U]=_P#"K?!?_0H:#_X+(?\ XFC_ (59X+_Z%#0?_!9!_P#$UK_;
M68_\_F1_9^%_Y]H^1/\ ABWP3_T%-?\ _ B#_P",T?\ #%O@G_H*:_\ ^!$'
M_P 9KZ[_ .%6>"_^A0T'_P %D'_Q-'_"K/!?_0H:#_X+(/\ XFC^VLQ_Y_,/
M[/PO_/M'R)_PQ;X)_P"@IK__ ($0?_&:/^&+?!/_ $%-?_\  B#_ .,U]=_\
M*L\%_P#0H:#_ ."R#_XFC_A5G@O_ *%#0?\ P60?_$T?VUF/_/YA_9^%_P"?
M:/D3_ABWP3_T%-?_ / B#_XS1_PQ;X)_Z"FO_P#@1!_\9KZ[_P"%6>"_^A0T
M'_P60?\ Q-'_  JSP7_T*&@_^"R#_P")H_MK,?\ G\P_L_"_\^T?(G_#%O@G
M_H*:_P#^!$'_ ,9H_P"&+?!/_04U_P#\"(/_ (S7UW_PJSP7_P!"AH/_ (+(
M/_B:/^%6>"_^A0T'_P %D'_Q-']M9C_S^8?V?A?^?:/D3_ABWP3_ -!37_\
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MZ_X41H'_ #^:E_W]C_\ B*/^%$:!_P _FI?]_8__ (BOH7_A5G@O_H4-!_\
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M8_V4 H X-/'5_&,"&V_[Y;_XJG_\+ U'_GC:_P#?+?\ Q5=^% Z#%+0!Y_\
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M<K[F52E"M'DJ*Z/C/_AB_P $_P#05\0?^!$'_P 9H_X8O\$_]!7Q!_X$0?\
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M_P 9H_X8O\$_]!7Q!_X$0?\ QFOKK_A5G@O_ *%#0?\ P60?_$T?\*L\%_\
M0H:#_P""R#_XFC^VLQ_Y_,/[/PO_ #[1\B_\,7^"?^@KX@_\"(/_ (S1_P ,
M7^"?^@KX@_\  B#_ .,U]=?\*L\%_P#0H:#_ ."R#_XFC_A5G@O_ *%#0?\
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M ,**T'_G[U+_ +^Q_P#Q%'_"BM!_Y^]2_P"_L?\ \17T)_PJSP7_ -"AH/\
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M;7_OEO\ XJO0** //_\ A8&H_P#/&U_[Y;_XJC_A8&H_\\;7_OEO_BJ] HH
M\_\ ^%@:C_SQM?\ OEO_ (JC_A8&H_\ /&U_[Y;_ .*KT"B@#S__ (6!J/\
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M9;FZ@7/8><SX_P#'Z]_KP;]B'29-+_9S\/O(NUKR:YN0.^#,Z@_B%!_&O>:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S_ .('_(9A_P"O=?\ T)J*
M/B!_R&8?^O=?_0FHH VOA_\ \@:;_KX;_P!!6NFKF?A__P @:;_KX;_T%:Z:
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#R+XT_LO^"_CE>PZCK2WMCJ\,(@2_T^8(Y0$E5965E8 D]L\]:^3_V;
MOV7= ^-7_"42ZSK6LC1]%U1K&SBM947S5&3EBRL!QM^Z!U-?H;69H/A?1O"M
MO-!HNDV.CP32F:6*PMD@5Y" "[!  6.!R>>* ,KX>?#/PW\*]!71_#&EQ:99
M[M\FTEGE?&-[N<ECQW/L,"NHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMBPPA:4^<N/I*DD8^M?9]>:?%KX#Z)\7-8\,ZO>WM]I6K>'[G[1:7FGLBO\
M>5MK;E.0&12/3GUH V_BS\.X_BMX%O\ PU+JEWH\=VT9-U9'$B['5\>X.W!^
MM?.MS_P3NT6\55N/'6MSA3D"2)&Q^9KZZHH ^<OAC^QG8_#/QQI/B.#QIK5^
MVGNSBTFVK')E"NUL'IST]J]P\;>"=&^(GAF]T#7[)+_3+M=LD3$@@@Y#*1RK
M X((Z5NT4 ?)#?L 1Z?+<0:%\2]<TG29R0]GY6XLO8,R2(K<^JU[9\$_V?\
MPM\"=*GM]"BEN+ZZQ]JU*\(:>;'1>  J@DX4#ZY/->ET4 %<]\0O!L'Q"\$Z
MUX;N;B2T@U2V>V>>( L@8=0#Q70T4 <'\%?A+9_!7P+#X9L;^?4H(YY)_M%P
MJJQ+G.,#L*\-_P""@7BB9O!GAGP1IP,^J:_J2L+>/EW2/A5Q_M221X]=IKZN
MKS37?@-HGB7XR:1\1=2O;ZZU#2H%AM-/9D^S1D;L/C;NR"Y;KUP>V* .J^'O
MA*+P'X%T#P[ 0R:9916I<?QLJ@,WXG)_&NAHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** //\ X@?\AF'_ *]U_P#0FHH^('_(9A_Z]U_]":B@#:^'
M_P#R!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** //\ X@?\AF'_ *]U_P#0FHH^('_(9A_Z]U_]":B@#:^'_P#R!IO^OAO_
M $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M &"*V6-R\TJK'&8X4&?+5U+ #)VMSWKPU;<_M4?M@S/(HN/!?@LA#WCE,;G
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MK;&<=59C(_RGD #/7%?3= !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G_P 0/^0S#_U[
MK_Z$U%'Q _Y#,/\ U[K_ .A-10!M?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\
M7PW_ *"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/Y5\=_#WX;^._P!HKXW:?\2?B%H<GAKPYI!1M.TFY5D=]A+1*%8!BNX[V=@
MW0#'W?2/VS->\?V/@&QTCP%I&J7\NK2R0W]SI-K)/-!"%'RC8"5WY(W>BD=Z
M .#_ &@?BUJWQT\5'X-_#)A=K,VW6]8C8^2D:GYTW#I&O&YA]XX09R0?H[X2
M_##2O@_X%T[PSI +PVX+37# ![B9N7D;W)[=@ .U?&OP/^('COX$^%SIFC_
M'Q!<WMP0][J<UK="6Y89QG%O\JC)PHX&3U))/MWPS_:-^(_C+QUI.BZU\'-9
M\/:9=NRS:I<17"QVX",P9B\*KC( Y(Z^M 'T;7Q1^VU_R7KX3?\ 72+_ -*D
MKZ5^-7Q*UWX8>'K+4- \$ZCXZNI[H0/9::7#Q)L9O,.R.0XRH'3'S=?7XO\
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M>_?!GX3Z7\%_ 5CX;TP^<8\RW5VRX:YG;&^0CMT  [  <XS7QO\  KQMXZ^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M //_ (@?\AF'_KW7_P!":BCX@?\ (9A_Z]U_]":B@#:^'_\ R!IO^OAO_05K
MIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S_P"('_(9
MA_Z]U_\ 0FHH^('_ "&8?^O=?_0FHH VOA__ ,@:;_KX;_T%:Z:N9^'_ /R!
MIO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHKC-/\ BWX<U3XH:I\/[>XF;Q)IMHMY<1>2PC6,B,CY^A.)4./>
M@#LZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HK$\:>,-,^'_A74O$.LRM#IFGQ>;,\:%VQD
M=220/QI_A#Q5I_CCPQINOZ4\DFG:A"L\#2(48J>F0>E &Q1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'G_ ,0/^0S#_P!>Z_\ H344?$#_ )#,/_7NO_H3
M44 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !1110 4444 %%%%
M !1110 4444 %%%% !1110 5RGCKXI>%_AK]A_X234_[-^V[_L_[B67?LV[O
MN*V,;UZ^M=77R3^WO<>1_P (+SC/V[_VWKT\MPL<;BX8>;:3OMY)LY,76>'H
MRJ1W7^9[!_PU)\,/^AG_ /)"Z_\ C5'_  U)\,/^AG_\D+K_ .-5^=/]H>]'
M]H>]?=?ZK87^:7WK_(^=_MBKV7X_YGZ+?\-2?##_ *&?_P D+K_XU1_PU)\,
M/^AG_P#)"Z_^-5^=/]H>]']H>]'^JV%_FE]Z_P @_MBKV7X_YGZ+?\-2?##_
M *&?_P D+K_XU1_PU)\,/^AG_P#)"Z_^-5^=/]H>]']H>]'^JV%_FE]Z_P @
M_MBKV7X_YGZ+?\-2?##_ *&?_P D+K_XU1_PU)\,/^AG_P#)"Z_^-5^=/]H>
M]']H>]'^JV%_FE]Z_P @_MBKV7X_YGZ+?\-2?##_ *&?_P D+K_XU1_PU)\,
M/^AG_P#)"Z_^-5^=/]H>]']H>]'^JV%_FE]Z_P @_MBKV7X_YGZ@^!?BEX7^
M)7V[_A&]3_M+[%L^T?N)8MF_=M^^JYSL;IZ5U=?)/[!%QY__  G7.<?8?_;B
MOJ[4+Z+3-/N;R<XAMXFE<^BJ"3^@KX7,L+'!8N>'@VTK;^:3/HL)6>(HQJ2W
M?^9X-^T5^UA9_!W48/#6@Z</$?C*Y"XLP6,=ONQLWA?F9FR,(N#@Y)&1G@(_
M%G[6L\":LGAG21 P\S^S66W5@O7!4RAQQQC=NY]:YG]AW1_^%H?%GQQ\2==4
M7.I02 P>8,A)KAG+,OH51-H]GK[FKS#K/%?V=?CUJWQ:EUW1?$_AF7PQXHT/
MROM=NRLJ2"3=AE5_F3[IX)/!!!.>/3?'7BVU\!^#-;\17N/LVF6DETRYQO*J
M2%'NQP![D5LK#&LS3"-1*RA6D"C<0,D GT&3^9KY=_;V\97*^#?#_@+2LRZK
MXHOT4PH>6B1EVK_P*5H\?[AH Y3]F_\ ; \8^./BKIOA[QG%91Z=KD,AL9(;
M4P[9!N*X.3N4E'3G/S <]<_:-?#W[7?PK;X1^$_A;XK\.@1W/A7R-,>X4<ED
M_>Q2'V\Q92?>05]D>#/%-IXW\):/X@L3FTU*TCNHQG)4.H.T^XS@^X- 'AO[
M8'[07B7X&Q^$H?#5O82W&L27/FR7T;2!1%Y0 4!EZF7J?[HKEM4\??M5^'83
M>3^!] U*WB&YX[0+*Q'H$2XWD_[H-<Y_P4>_X_OAA_UTU#^=K7VO0!X=^S?^
MU!IWQW2]TVZT\Z'XHL$\R>P+[TDCR%+QD@'AB 5(R,CDU[C7PG\'6@UO]OGQ
M+?>'2LVD1R7LES-#\R$&/8[9'&#,1@]\U]V4 8'CSQI8_#OP=JWB34HKB:QT
MV$SS1VJJTK*"!A0Q )Y[D52^%OQ*TSXN>![#Q3H\%W;Z?>F18X[Y%24;)&C.
M0K,.JGH3QBO#/VU(?B<_A?57\/W&GIX 72?^)M'*$^T-)YC;MN1G&WR\;2.=
MU>3_ +.]G^T))\+=$?P)>Z-#X5\R;[-'>K#O_P!<_F;LJ6QOW=^G2@#[WHKS
M/X]?'/2O@-X+36-1@:_O[E_(LK")MAGDQDDDYVH!U.#C(')(KPS1[_\ :J^(
MFF0^(M/O-%\+V-POGV^F7%O$KNA/RC$D<C#(_O,IP: /K^BOF3X#_M,>)-1^
M(D_PR^)VE1Z5XNC+B"[B C2X(7=L9<XR5RRLIVL,<=,_3= !7Q!\-OVD_C[\
M:GUB?P=H7ARZ@T]T\V*5?+,8DWE%!>8;N$//M7V_7Q1_P35_X\?B#_UTL?Y7
M% &DW[6WQ.^$/B"QLOB]X$@L]-NVVK>Z:,,!_$5(D>.0C(^4%3[U]=:1JUIK
MVE6>I:?.EU8WD*7$$\9RLD; ,K#V((KYU_;^OM+@^!0MKQXQ?SZC ;&,D;RZ
MY+L!Z!"P)_VAZBN__96L[VP_9[\$1:@C)<?8=X5Q@^6TCM'_ ..%: /G?X:?
MM)?'SXUR:O-X/T3PW<6]A(GFQS+Y9B$FXH,O,-W"'GVKN8_$'[5OF+N\,^%2
MN><RI_\ 'Z\Q_P""??CSPUX+L_'*^(/$6DZ$;B2R,(U*]BM_-VB?=MWL,XR,
MXZ9%?9&C_%KP/XAU*#3M*\9^']3U"<D16MGJD$LLA )(5%<D\ G@=J .BU+4
MK71M.NK^^GCM;*UB:::>4X6-%&68GT !KY$O?VM/B)\8/%=YHGP8\)Q75C:G
M]YJFHIDE<X#G<RI$#@X5MS$ \ Y ZK_@H!XQN/#OP6M]*M9#&VMZA';38XS"
MBM(P_%EC'T)KT?\ 9D\ V?P\^"?A>RMHE6XO+./4+N3;AI)IE#MN/?:&"CV4
M4 >#:]\2?VH/A1I\FN>(=#TK7M&MQYER8HHG\I,#)(A97 '/S8(&"3Q7O/P
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M063U,;*%*]<#W&?L[P3\2O"WQ'L1=^&=>L=9BV[F6WE!DC_WXS\R'D<,!UH
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MGB+2)_.TS4(!/$[<$#NK#LRD$$=B#7S!K7[4'Q!^+OC[4?#'P5T:SN+'3_\
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M)J* -KX?_P#(&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KXW_X*'S&'_A /?\ M#_VVK[(KY&_;\\&
M>)/%W_""?\(_X?U37?L_V_S_ .S;*2X\K=]GV[MBG;G:V,]<'TKZ'A^489E2
ME)V6O_I+/+S1.6$FDNWYH^*?MI]:/MI]:W?^%,_$?_H0/%'_ ();G_XBC_A3
M/Q'_ .A \4?^"6Y_^(K]C^LT/YU]Z/@O9U?Y7]QA?;3ZT?;3ZUN_\*9^(_\
MT('BC_P2W/\ \11_PIGXC_\ 0@>*/_!+<_\ Q%'UFA_.OO0>SJ_RO[C"^VGU
MH^VGUK=_X4S\1_\ H0/%'_@EN?\ XBC_ (4S\1_^A \4?^"6Y_\ B*/K-#^=
M?>@]G5_E?W&%]M/K1]M/K6[_ ,*9^(__ $('BC_P2W/_ ,11_P *9^(__0@>
M*/\ P2W/_P 11]9H?SK[T'LZO\K^XPOMI]:/MI]:W?\ A3/Q'_Z$#Q1_X);G
M_P"(H_X4S\1_^A \4?\ @EN?_B*/K-#^=?>@]G5_E?W'U5_P3PF,W_"?^W]G
M_P#MS7UEXMT^75_"NLV$ S/=64T$?./F:-E'/;DU\N?L!^#/$GA'_A._^$@\
M/ZIH7VC[!Y']I64EOYNW[1NV[U&[&Y<XZ9'K7US7XYQ!*,\RJRB[K3_TE'WN
M5IQPD$UW_-GQ3_P3=UJ);7QSHDC+'=I+;72Q-P[+B1'..N%(3/IN'K7VM7P[
M\7/A'X[_ &>?C%=?$[X;:?)JNCWSR2W=E!$9C#YA#2Q21K\QB9OF#+]W'.-H
M)W;3_@HO87$(@/@#4VUG.P6<-VK*6[C=LW=?]FOGCU#[%K\[_B1\=O#K?MD'
MQ1XABO=1\.^%I#96<&GHDCM+"& ;#.HP)F=\Y_A6O<?#OQH^*?\ PK_X@^/O
M%_A__A'=(@T]5T#2?(Q,;AB55V!'F$%FCR6 !'*CK2?L"_#VX\-_#/5/$NHP
MR1ZEX@O"P,RD.8(LJI.>>7:4^XP: .$^,W[:7PS^*WPP\0>%SHWB6.:^MB+:
M6:TMPD<ZD/$Q(G) #JN<#.,UV/\ P3Y^(O\ PD7PQU#PM<2[KO0+G="K'G[/
M,2RX]<.)/H"M?55?#_AW3;SX"_MR75K!:3+X=\4N54QQDH%N3O7'& %G7;[*
M#0!-_P %)%9KCX:*AVN6U *WH<VO-=)<?LR_'#Q19S:?X@^,K1Z?,I21+/SG
MWJ>H8#R\@^A.#6-_P44T^[OKSX9FVM9K@)+?AC%&6QDVN,X'?!_*OL^@#S+X
M%_ #PY\!M"GL]',MY?W>UKW4KD#S)RH.  .%09.%]^23S7IM%% 'EG[4G_)O
MGCG_ +!S?^A+7.?L1?\ )M?A?_KI>?\ I5+7H?QF\(W/CSX4^*M LPIO;_3Y
M8K=6. 9=N4!/8%@!7QY^S]^U5#\#/ A\ >(O"6N7'B"QNY1:VMO$JLV]]QC=
M6(96#%^BMF@#H?VV NM?'GX2:)?INTF26+>'&482W2)("/\ =1<_6OM15"J
M!@#@ 5\W_MF? [6/BIX8T;Q!X6@DE\2Z"[2);(^V26%@&8+S_K%95('?+ 9.
M!7(Z#_P4#LM%T6*S\:^#M:L_$\,86:.UB18I7'!;$C*R9ZXPV.E &/\ M;VZ
MZ=^U5\)-0L(U.IRS68*J,%RMY\F?7.XCZ"OM>OCCX3^"/%W[0_QVM?BWXQT:
M30/#FEA?['L)R0[F,DQ  @$JK,TA<@ M@ 8SC['H *_,S]DWP#\2/&T'B8^
M?&47A..V>V%Z)&8>?N$FPC:K?=P_I]ZOTSKXP_X)PZ?=Z?9_$ 75K-;%I;$
M31E,X$^>H[4 =/X?_8FNM=\5VVO_ !1\<7OCB2W \NR8.(S@YVL[L3L_V5"Y
M]>HKZFCC6*-410B*,*JC  '84ZB@#\[_ -A_X(^"OC!:^,7\7:+_ &LVGO:"
MV/VJ>'RPXFW?ZMUSG8O7/2OKCPE^RO\ "[P+XBL=>T/PO]BU6R<R6]Q]ONI-
MC$$9VO*5/!/45\7_ +,/QOE_9Q/BJSU?PEJ^HSZA+ -D";#$T7FA@VX=<O\
MI7NJ_P#!03368#_A7WB#KV9?\* #_@HUI;3?"WPWJ R1;ZP(3]'AD.?_ "'^
MM?0?P=UJ'Q#\)_!^HV\BR1SZ3:L2G0,(E#+]0P(^HJM\8/AK9_&?X9ZIX;NV
M:U-[$LEO.Z_-;S+AHV(]B ".X+#O7R+\-_C-X\_8_M9?!OCWPA>:AX;@G8V=
M]:G"QAF);RI"-DB,26"DJP+'..@ /O.OAE9%\;?\%&3)8E9[;3)=LLB]%,%E
MM<'Z2Y7ZUN:_^WM?>,+5])^&W@?5+W7[A=D<MR@E,)/&X11[MY';) SUR.#W
M7[(O[.^I_"^WU3Q;XN._QEK8(DC9P[6T3-O8,PX+NV&;&0-JCUH ^D*\B_:V
M#M^SIXW\O[WV1,_3SH\_IFO7:Y'XO>&&\:?"WQ9H<:>9/?:9<0PJ.\IC/E_^
M/;: /-/V'V0_LV^&]OWA->!_K]ID_IBO=IH4N(GBE19(W4JR.,A@>"".XKY>
M_P"">?B8:I\'M3T=W_TC2=4D C_NQ2HKJ?Q<2_E79_M ?$[XE?"_7M'U'PKX
M0_X2WPNT##4(88G>=)=W!!3+*-O<JPZY[4 8_P 3?V&_AWX[\^ZTF"7PCJ<F
M2)--P;<MZM ?EQ[(4KS+]EWX@>,OAC\<;WX+^+=0;5+51(EHTDA?R'2+SE,;
M'GRWC&=IZ<8QR#M0?M_2ZMYUCI7PQUJ]UV/(:QCF+[&&1\VV,MUQ_"*M_LX_
M!KQIK_Q>U/XQ?$2T_LC4[I6^PZ:RA9%WIY>67K&J1C8%;YCG)QCY@#FHV31O
M^"DDGFG:E[%A&8@<G31_-E('U%?:U?)/[8'PG\3V?C?PY\6O!%G+?ZGHYC%Y
M:VZ%WQ$Q>.78.77!9' [;>,9(K/_ ,%$=)NM'-O8^"M7D\5N/+CL&9&@\[IC
M<#O/.> @)QCC/ !D>$8X]9_X*,>(+F$[TLXI6)]"MG'"W_CS$4?LOLFD_ME?
M%K3Y#AYFU!X]Q'(%ZC >YVMG\#7<?L=_!?Q#X;O/$/Q$\;026_BGQ&S%+>==
MLL43OYDC.O\ "SOM.WJH09ZX'&?M ^"/%7P1^/EI\9/">DS:UI-Q\VIVMN"?
M+;9Y<JN%!(1UPP?! ?.>V0#[1KXF_8_MHM:_:2^,&IQ$M;N]W&KC^[+>%A^B
M5I>(OV^XO%GA^72? ?A'6I_%U]&T-NLD:2+"Q!&]!&6:0CJ!M SUZ8/IG['O
MP+O?@SX!NI]<C$7B76Y5N+R/<&,,:@B.(D<%AN=CCN^.U 'D_P#P3AF6U'Q$
MTN0@7,,UFQ7/4?OU./H1^HK[&UJ[CL-&O[F9ML,-O)([>BA22?R%?$?BK3?$
MO['OQ^UGQKI^AW&M^ M<\QI_L^=L2R/O9&(!".CC*EN"IQG).+_Q(_;"O/CA
MX6NO!'PS\(ZU/J^LQ?9;F::-"887^5PH1F&""5+L5"@D_0 T?^";>GF/POXV
MOL<37EM#G_<1S_[4JI_P4F(^Q?#U5SYYFOMFT^T&?U(KZ#_9O^$/_"E/A7I^
M@SLDFJ2NUYJ$D9RIN' ! /<*JHN>^W/>OG[]KJ/_ (6)^TM\+/!$(^T+$8Y;
MB->=BRS R9^D<&[Z4 ?:$>[RUWX+XYV],TZBB@ HHHH *\B_::E\KP'8'_J)
M1C_R%+7KM>2?M,:1J6M>!+"#2]/NM2N%U*-VBLX6E<+Y4H+$*"<9(&?<4 ?,
M?VRC[94O_" ^,/\ H5=;_P#!=-_\31_P@/C#_H5=;_\ !=-_\30!%]LH^V5+
M_P (#XP_Z%76_P#P73?_ !-'_" ^,/\ H5=;_P#!=-_\30!%]LH^V5+_ ,(#
MXP_Z%76__!=-_P#$T?\ " ^,/^A5UO\ \%TW_P 30!%]LH^V5+_P@/C#_H5=
M;_\ !=-_\31_P@/C#_H5=;_\%TW_ ,30!%]LH^V5+_P@/C#_ *%76_\ P73?
M_$T?\(#XP_Z%76__  73?_$T >L?LRW'F^/+\?\ 4-D/_D6*OIJOFC]F?PSK
MVB^.[^?5-%U'3;=M-D19;RTDB0MYL1"@L ,X!./8U]+T ?"?[-EU_P (G^VU
MX_TJ]98IK]]3@A\P\NWVE9EP>^40FONROD7]JW]G_P 4#QS8_%;X<Q23:_:-
M')>6=LH:8O& $FC3'[SY0%9.20!P<FLS1_\ @H=_9=HMCXK\"7UOKT*JDJVL
MNQ9).Y\N10T>?3+4 ?9M?!G[='Q)TS4OC%X3\*ZD9YO#^A&.[U6&T :5S*RL
MR $@%A"JXR1_K#7KWPI^-OQ-^*7C9==OO"K^#_AG86L\UP;F,M-=$1G9M9E#
M-@\_NU X()/ KB?V,]#U'X@?%WQ_\5-:LYK=YY6@M%G0C:TK;V"Y_N1K&GT>
M@#9U+_@H!\+-6T>ZTNZ\/>*)+&Z@>VEA^QVP4QLI4K_Q\=,$BN _X)Z_$2#3
M?&/B;P4)Y#8:@IO]/\\!6WQG:PP"1N:,J3@G_55]XU\1?M5:1?\ PC_:2\&_
M$_2;.::WNRC7@MXRQ9XL1RJ<=-\#*HSUPWI0!Z9^W[_R0%O^PK;?R>O,OA;\
M$/C?XF^&WARXTOXJKHOA^[L(I+6UADE62"(J"J?*HQ@8'#5ZA^W?#+JG[/\
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MH]',:EOUS7QOJB^*?VY?B!H,@T&Z\/\ PRT>3S'N+H[6N VTO@]&=@H4!<A
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MOD_]B?X=>(+/7O&WC_6M(D\.VWB&8FQTV12A"-(TI8(0,(-RJI(Y&>V,_6%
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M8_-&BOT-NOAWX4O;AY[CPQH\\SG<\DMA$S,?4DKS47_"L?!W_0IZ'_X+8?\
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MC/7Q3XG>*)OVU_'_ (/T[P5X9U.UTC29G-YKE]$(PB.R%LLA8* (R5&[<Q/
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MW5]X6\%_9K::XVWMQN\J,MC*+C./H: /K;2;>*UTJR@@C2&&.%$2.-0JJH4
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M10 4444 %%%% !1110 4444 %%%% !1110 4R2))@ Z*X4AAN&<$<@_6GT4
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M>*+HW#K<1E)%A1FVD@\@LS2-[@K7TK110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %,EB2:-HY$61&&"K#(/U%/HH **** "BB
MB@ HHHH **** &K&L>=JA<G)P,9/K3J** &R1I*I5U5U/56&13J** $90ZE6
M 92,$$9!H50JA5   P .U+10 4444 ?)7[1'AG4_AC^T7X'^+&BZ?=W]G<R+
M9:O'9P-*R@+Y98A03\T+$#WB'J*^M:** /$]6^#>NZM^U5HOQ&DFL_[ TO2&
MLXHS(WG^85F7 7;C'[YCG->V444 %%%% !1110 4444 %%%% !1110 4444
M-DC61=KJ'7T89%.HHH **** "BBB@!JQHK,P50S?>8#DX]:))!#&[MG:H+':
M"3Q[#K3J* /DW]EGPKJGC[XR>//B[K^G7-A]IG>RTN"\B:-PAVC=AAGY8EC3
M(X.Y_2OK*BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \_^('_ "&8
M?^O=?_0FHH^('_(9A_Z]U_\ 0FHH VOA_P#\@:;_ *^&_P#05KIJYGX?_P#(
M&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH \_^('_ "&8?^O=?_0FHH^(
M'_(9A_Z]U_\ 0FHH VOA_P#\@:;_ *^&_P#05KIJYGX?_P#(&F_Z^&_]!6NF
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH \_^('_ "&8?^O=?_0FHH^('_(9A_Z]U_\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>updatedproxycard.jpg
<TEXT>
begin 644 updatedproxycard.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M36ET8V@@0G5C:VQE>0  !9 #  (    4   "II $  (    4   "NI*1  (
M   #-#(  )*2  (    #-#(  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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MA^[NW,1M/3MC(.<5] T %%<[X[\8V7@7PC=:U?\ SF,;+>'.#-*?NH/RR3V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%,C#<&RQ5<<YJK8_&O4I([3[=I]K&ZV$MQ>!$?F9D+VT<?S'[R[,YS_K!C%
M'>?$3P+8_$#PI-I5WLBN5^>TNBN3!)Z_0]"/3W KYC;X ?$97(&AQL <!A>P
M8/OR]>[:9\3K[4I8K>XGTK2;JWLVDNK>]BD#W%PLKQM%$K.A7[BMSN($J#%5
M=/\ BQJ4VD6T]TVEFYO+2&:"-5"[I7FC1HP%F?<0KYQD-R,J.E &.GPV\3^-
M_A>=#\=Z<EGKNDC_ (E6J-/'*94_YYN4)..,$_[IY(.?*O\ A0/Q'_Z *?\
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M:/%O #>781+NP0PSA><$ _4 U/-X7T"Y>1[C0]-E:1W=VDM(V+LX =CD<E@
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MI ZXR!TK(N_ /A&_O);N]\,:3<7$SEY99;*-F=CU))&2:P+8_$3^TM6%VO\
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M%4;#6]*U2:6+3-3L[R2$ R);W"R,@/3(!.,U>H **** "BBB@ HHHH ****
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MV0 0>0%ZGF@"O!H'@_4;ZRE3Q2M[--<B6)5O;=OM,T<DDC$!5Y.9VR%P -O
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M2C(YO]2OIY)H9GN+V<2R,T4F]?FV^O!]JZRBB@ HHHH **** "BBB@ HHHH
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MC^20!B4//#81N.ORGT- &I166GB?09?(\K6].?[0RI#MNXSYK,650O/))1@
M.I4^AI+KQ3X?L5@:]UW3;9;B(30F:\C02QGHZY/*GU'% &K163/XIT"UG\FX
MUFQ23S)(F4W"_(T:%W#<_+M4$G.,?C2-XM\/)(4;7-/!6 7#'[2FU(CMP[-G
M !W+@GKGC- &O16=I>O:=K$D\5E<QM-;R.DD.]2X"NR;MH).TE3@]ZT: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^)8)KF:*.SECFO8W=/(B(^8 #:0J,6W8Y';I0!F6FD^&+FQM=7N/%%] ^JK
ML0FFM5E9_P!T800D>&9?W1"G<HW9(^8D[$^G>%+7PO::-?>(XDM8!+)%++>0
MQL5>-@<8 4*$N!@*  "G;&:*:'X0BN(#'XO"(!;+#!]MMMN[]R8R"4W$R"U3
MC)! ;:!V;#X2\*Z@)?#\/BJ\NKUHVYM[N$3PK$UNN 8T 4J8(UY&>6ZGD &A
MJ/AO0;:XE@E\23:;)K$_VA(?M$ :683"021AT))!(7 RN".,\UGCPYX(NM!B
MT>T\4A(TA_=RVVI1"4+)/'(KA@.I=44''\6.I%3ZS!HE[XBM[6[U:;3+/0K5
M!<B6(P1M^^A>$&66/85+0_PL"2,#O1J7A;PI$RZ1J6O3(L\,2C3VN(@SJ5C@
MWX"[\.J!"<X&6(VGD $EKI'A""TO]1B\1Q-IDUB]NQ^VP^1!#,^TLK@9&YXV
M +,1D,!TQ5'2[;PQI/B5=;'B.VN([.WNHI9;BZ0S3SQXWDQJJC]U$'&5!)$I
M.!U9VAZ7X;GL=3TM/%%C/-K-T'MWMKV":8J@!!4%=N\N))3M3Y6D;'(#5/J/
MAKPM%+$VJ^++B.WBFN +:?4HDB,DZR(X88!9L^<022P.\=!@ %.XTGP/*K2-
MXX6%7B^RJ1J-J-L#$OY'*]#NSDY?I\U;<TWA2TTG2[)?%-I9+I:QS03"]@#%
M&C*J6W J5='/..<Y!KGU\->#_#OBR:VU7Q!>&[DA%Y))J-[ D<>;@2852%QO
MD5VPHV\MTW+G0M/!?A'3=1_X2 :_*T%FPMV6:^C-M%*L:P'(QA9"%13R#E5X
MXQ0!)H_A_P *RWILK+Q!)>WEK($,9N8MX\O[.P7:JC(58HER!W.3DYK)3P5X
M:TZWN-+U?QE+9O:NTS6\>HPPF*V+Y"R?*&VME"V[(W 8('!NZ9:^&=.G:_T_
MQ2--FL'$<\5Y-;C9%&T4#!Q@,%<08!+8!DW 9P DL'A35->OM9U'Q79BVEN8
MI[> 7D2(IBVQ[VW+N)+PR+]XJ0#CGD #;O2_"4?B.TU"/Q#IJKI]VT]^9M1C
M#)M>1UC*CC'G3(QW'CRXQC)S6[<:'X<@U"ZUJZU-8C>WD&Z22XC5!- _RHI(
MZ[D(*YSP1Q7/WNB>##,TDOB9+IK&3R$MI;Z%8;=E\TB&1E0E1M:="7R<.W5@
MI&BT6C>%_"WAJQU/7A!=P21O%<13Q;[B5P5EDQ(#N0^:[,<9 .<T )=:7X.<
MO?CQ/':-<M-)'=0ZA"A4[I@[(V.JM<L,]B$STYHZ7X1\(:]X;%Y;ZQ>36WV!
M8IY9;N-I(T+BXW2G!PW.23V/XTRTT[PA#*-/'BR^DG,?V^+4[B]BE\T"1)2Z
MR,I5BOV0$@C 4-UY(V-'LO#6CZ7=Z+8>*OGO#]C#"^A6:*542(A-H $H+)G@
MG<R^PH S1;Z'9>+;&]T[Q-IL=C!F]NUDU*(EU;SBA";.%W7/#;P,'&#P:32O
M#NAW>CPZOK.M2(NMLXM5EGBC4),;@QQI\HW-MN7."6.1QD"II?!OA33/#=I/
M/XCFM;47L5_!JD]Y"2\H4;#YCJ58'&>AS4LL/AB\T33=-N/$L^GPZ%*LFQ[Z
M*%IUMY?+#RCHT9D0<X SCH: ,O4_#WAG7;9I-*\7P7FJWBR0VUPVHP8>0D,[
M@1KRRGR7PH',48RH9BVMXAL?![68GN=13;'8F*"VM;B(N\44,G$:GJ1'.6^F
MP].JV^D>#3=VT46OPRS131V\<7VZ(LTL8@ 3 YW?Z/'D#GYFZ9&,6V\.^$Y+
MJ33Y?%&I'[!<RV2Q37UNJW4S6RQE515&YDC8*. 0<]>X!H:SX1\+)/>0ZSXM
MO+:YN9UN3]HU.))(05D2-8]PRB#>VW'=1SP06V_ACP>VD^3I_BZ9/-?[$;VW
MU.+SGE(BRF\#F1O)&1U.YN.>$OT\'_$"&VN+G7+G2[B]:,PP"]C@G<(980 G
M.5?SI$/7.<>M167ACPU8>%K>\U?Q+YJPI"D]W#<Q&+RWP%B!"<1L6&&/SX.=
MV* +OAFU\,:5K<,'AOQ9%*X(CFM#<12BX4^<0@*@$OOR<Y8@1D8 )-=]7 Z!
M9>$[^31=1TK765T2*WM[;[3!O=H4<F-L MOVS?.JD=%R,9SWU @HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.$H4C&6P!^[49(. TF #(S5I77A;1KVXEGN;/?+,^]V\QQDYC.>#_P!,8_\
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M1) ZN-C8\LD6K D!3^[7/5<S_P#"3^$1J<=S<BXM[G1A/:1R2VLX2%=VU_F
MV$,8,*2<G:0.<BJ<=UH,$L'C#0[6XU"WA#626]O!Y<PDN9D=G;SW3@DI@8&!
M(QY!^6J;KX?:CJT\%W%?)>7ER\,\#&Z,?FERASL)B7YI,@Y^4R;N"<T &I6G
M@32[3[-::9=3M"]M;,MD+LR0JDKP*0\8+!@7F& =SC<.13[S1OAU;+I[RZ4R
MP7]I<3V\L,<^T1-!'!("%Y7=&44+CKT 8\W+'_A!X])36+22\DMHID =Y+R1
MY7W^>C%&):7E]X8AOE8D';3+>#P#/I-^-*LQ]GT:*2>86D<L&\%2&8/\HF)\
MK[V6PR*<@@$ $UGK_@>R%LD4DD\FE1%[>:XMKBYF@$A161)'5GW'S$4H#N (
M!  X?KMOX*COS-K.F)<R:S!-<&[^S/-\@BCB;# $H60HH"XW=.21G/U2V^'(
MTN:TU&VDEMW)2:-([J5B0?F+;,GK9DEO^F9)/.3>UNY\)Z]H+O+97&JP6CK8
M+;6Y>%I/.98@J[F170DJ0V=N5R#E0:!&!#:_#3-R;FS=$!>6.0S74IE'DK.9
MSC)64AVPQ_>':<'C =]F^&L]Z]I+I(MTCM]XN5BN(I;HEY%DAE( >1@8CF.0
ML6Y^4XJ[JOACPM=>"UU[3-&G)DTYA#-#*!)!#) $+'S)54[449RV1@D<\U#+
M<>$8;"Z>/P[JES#;H]PTIN,.ZJ9/-D#23!MR/,X.<-N<;<X! ,=-/\-+K:E[
M#/<-'<'<MU;7CM-,[(#$^]<RN2D?[IMQ^1?E^48NZE8^!;#[)J#V<T$>L6_D
MPS6'VB-1$L2L !&1Y>Y(D7"@,P 7!&13X/#G@SQ(-6\.MI<]Q!:W*SW#3S2D
M32L&4NLA?<Q!1E)_O*>X-0IK?@77]&M++]Y+9:;% Z+;R2-]C+J\:K(86+(5
M"MDMPO!)S@T -G\/^ UT=+]-.O%L[^X6R,=NUU#@O)Y;1M$"OEH6'SJ0 2 6
M!.*W3XZ\.V]M QFNHTEC1H$_LZX#2(P)!1?+RPP.< X[XJG8:EX.U6TM= LK
MB6:.:59XD)N YDPMR&:0_,&.X-\S9/S#DA@,FWG^&MAJ"ZW;JXN%BB4W"Q73
MB)! @CW\$(/+D0?-C)./O X -X?$;PRZAHKRYF5I'C5X=.N)%=E95."L9!&Y
ME (X).!FKNE>+=,UK7+K2]/\^26UACG:7RCY3HX!4J_3.".#@^G0U@VUCX%L
M=2O+>%)C<:? +BX+O<RB"-/+=?F8D  1QD*#T7 '!I-+UKP+I%V;O3&NH)VM
ME1T%M=EC&-J(&C*_> 08!&[:&8<%C0(UA\0/#+1AQJ7R;!(S?9Y<(#&L@W?+
M\N5=< X).5'S @:-GXBTR_U(V%G.\MPJ.[ 0OM4*YC.6V[0=RL "<G!QD5Q.
MDP^ _-&GW$Z7MZUQ,\A2WGBBE>:<#;M&48!IDV@EMJLKC@[CM6-_X2\+QRR6
MOVNWB1I+>2YEANI4)1W=@97!!^=GYSR?E&< 4 32?$?PREK-/'>33I# L[&*
MSE(VM%YJC=MVAF7H"02<CJ"*<OQ"\/X3SIKN!G#%5DL9NS.H4D*0&)B?"$AS
MC&,\5S\9\#RWEQ#9Z9</;0:?<7UQ_P ?$,; ,7*F-]JNV9Y.O,9^7Y> #5/^
M$27PWJ2Z9:S2S6$D2,;F.[9E=II(A*I)#S%7DF.48DMT8'! ,ZV7Q;I,.C6^
MJF64V4[2*)/(<,OEI(SY0@/P(G&,9SVJL/'FA.@,,EW(?/B@=?L,RM$TDAC7
M>&4;?F5LYP1CW&<.VN?".G^$;#2M4N+J]@2&2X23['=$R%W:&3& 6W;IRI0D
MNN[)]::UYX*NM8O-D4TD(M6O[F^62X$:!)TERA'!&]RS%#QMPW'% '11>-]
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M'MZ5P<NC?"F66>UN=/\ +EN)'>9YH;J-XBQ8%6D(!A5B6^3*AL\ YJ]I6O\
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MEOG=MH V#=@D @59NM+\*%-!N[+1]3U#SS)8V5Q;WDD<ELK*VY"9)4=  CC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\D*;8 G';(SZBK&IW&O17*KH^FZ==0; 6>ZU"2!@V3P%6%P1C'.>YXXYU**
M.?\ MGC'_H!:'_X.IO\ Y%JYJ=QKT5RJZ/ING74&P%GNM0D@8-D\!5A<$8QS
MGN>..=2B@#G_ +9XQ_Z 6A_^#J;_ .1:N:G<:]%<JNCZ;IUU!L!9[K4)(&#9
M/ 587!&,<Y[GCCG4HH Y_P"V>,?^@%H?_@ZF_P#D6KFIW&O17*KH^FZ==0;
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MCIMLD%O;W%Q+9I%(D\*Q6J3',C$HYW/L*@;AP2,4".^^V>,?^@%H?_@ZF_\
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MA\K^Q;"QN\Y\W[7>O;[>F,;8I-V><YQC ZYXT** .?\ MGC'_H!:'_X.IO\
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M>;2?B3X@OHD<QO);:HLBJPZJ2N<'D<>] 'K=%>7_ /"E?^IZ\5?^!W_UJ/\
MA2O_ %/7BK_P._\ K4 >H45Y?_PI7_J>O%7_ ('?_6H_X4K_ -3UXJ_\#O\
MZU 'J%%>7_\ "E?^IZ\5?^!W_P!:C_A2O_4]>*O_  ._^M0!ZA17E_\ PI7_
M *GKQ5_X'?\ UJ/^%*_]3UXJ_P# [_ZU 'J%%>7_ /"E?^IZ\5?^!W_UJ/\
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M=6LUN]*^(_B*]MF)"S6VIK(A(X(W+D4 >C2^'-(F\/#0GT^'^S!&(Q;*NU5
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MHQP:S1\-/"PL;>S^Q77D6K[H%.I7.8ODV84^9D#;QM'&.U<T?@KCKXZ\5?\
M@=_]:HK7X06]]:QW-E\0O$MS;RC='+#J(=''J".#0!Z)I^@Z9I4L;Z=:BV\J
MV6U1(W8(L:DL $SM!RQYQD]S6C7E_P#PI7_J>O%7_@=_]:C_ (4K_P!3UXJ_
M\#O_ *U CU"BO+#\&XA.L!\?>)Q*REUC.H#<5! ) QT!8<^X]:9<_"*ULC$+
MSXB>)+<S2"*+S=2"^8YZ*N>I/H* /5J*\L_X4Y#YSP_\)_XF\U$#NG]H#<JG
M(!(QP#M//L?2B'X-Q7,$<]OX^\3RQ2*'21-0#*ZD9!! Y!'>@#U.BO+(_@Y#
M,TJP^/\ Q-(T+[) NH E&P#@\<'!!QZ$4_\ X4K_ -3UXJ_\#O\ ZU 'J%%>
M7_\ "E?^IZ\5?^!W_P!:C_A2O_4]>*O_  ._^M0!ZA17E_\ PI7_ *GKQ5_X
M'?\ UJ/^%*_]3UXJ_P# [_ZU 'J%%>7_ /"E?^IZ\5?^!W_UJ/\ A2O_ %/7
MBK_P._\ K4 >H45Y?_PI7_J>O%7_ ('?_6H_X4K_ -3UXJ_\#O\ ZU 'J%%>
M7_\ "E?^IZ\5?^!W_P!:C_A2O_4]>*O_  ._^M0!ZA17E_\ PI7_ *GKQ5_X
M'?\ UJ/^%*_]3UXJ_P# [_ZU 'J%%>7_ /"E?^IZ\5?^!W_UJ/\ A2O_ %/7
MBK_P._\ K4 >H45Y?_PI7_J>O%7_ ('?_6H_X4K_ -3UXJ_\#O\ ZU 'J%%>
M*:_9:]\'+K3M<M?$^H:SH<UVEM?66IR^85# G>IZ#@'ICG&<C./:Z "O+]=_
MY.6\,?\ 8)G_ /:M>H5Y?KO_ "<MX8_[!,__ +5H WOB'X/OO&5K8VMI+:6\
M=J[W'F3*69I A5(\8_U;;COYR0,8.>(_"G@_6=&\;ZMKVJZA97*ZI;H)$AB=
M720.Q"Y+$%$0A < D!>%P=W;4V4R+"YA17D"DHK-M#'L"<' ]\&@#R32?@S?
M:9_95Q%KDL%]%ILUI>SPNAR2J"-(PT1'EC#Y)&[D<^CM!^%_BC2[ZSU&XU32
MWN([1=.F@1),?9EMQ$ LO?YE5]I0<Y^;UV[;XDZD/+-_X9&)-2N-.5+&_$TA
M>!)3(P#I&N,Q<98<$GC&#HZ1\3?#VM^(+71["61KB[A66(ML&=T(F"[=V_.P
MYSMVYR,Y&*!G$K\'-<2VLXSJ-G++;16\B7$CL&CFAM9(T4!8P"BRLK!CAMN<
MY(&81\&?$WVYKE-;TZ(PN;Z%3$\@EO6@1'=ON[0)%9E8;B,YQVKK=1^*=II'
MC74M$U&S1+;3T+R7,=SOE"BW68L8=O"_-L!W'+8'>KS_ !)TJ":*&^L[ZRN&
MO4LI8+@1!X'<(4+ 2'<")4/R;B!DD#!P 96M>"=?OK/Q):6XTEU\0)YDEQ--
M(LEM+Y"IL&(SNCRG!RI 8\&JNI> ?$^IV<\<]W8O+J6EC3+V6>X+-$HGDD$B
M%(45SMD(VE4Q@<GDG0U/XLV-GIMY<6>BZG=2VR74@1E2-72W<1O)NW'";R%R
M 3G/& :Z'Q-XNL/"RP_;H;F=I8Y9BML@8I%$H:20Y(^501G&3SP#0!R^L?#>
M_P!4AOX([NVMEN]=DU 2H6WQPM9&#@8^^&.<9QCOGBL_5OAWXKUQ-)5[K0]+
M70K=OL4=LLDJ3S[-JNX(3R]N 01OP<GGI7;^'?$TGB'4M9A33GMK33;E;>*Y
M>96^TL4#DA5^Z-K(1D\A^Q! Y>T^*UPVEZ;>:CX?6V&K11360BOO-5U:>*%@
MQV JR^<K8P0<8R* )K_PAKU]<>)4GMM+GM=;:VG4B_FA>*6**)>,1' #1E@V
M3T&1U%7+_0?$6L_#S4O#.H-;&[;3X[:*_9\)<RE/G8JHRJ@X'3)Y.*CC^+?A
MYM8ATZ:*\MI9KDVZ-.(T#?OC"'4;]S*9%9?E!(VDD #-/C^)EI+<V4@TF]CT
MJZM+J]&HRM$%\F *3($#%BIW=P&Z?*020 <UJ'PAU2\U*XE@U2"VM[^[U&>[
M168G,RSK"ZC'W@LP5QD A1@G%>@Z%'K<"1P:I8Z3:P)&5_T"=VY&P+A6C4 $
M;\C)QA1SDXPF^*FDK(L+:7J_VC9+)+;K;H\D"(D<FY@KG@I,A&W/?.",5K1^
M,]/D\"2>+!%-]@C@><HK1R2%5)!QL<KGCIN^N#Q0(Z&BN(;XKZ#%>WEE<07T
M%Y9PK));2(@DW,8U$>W?G=F:,<X4Y."=K8DOOB;I>F"Z:_T_4H4M-Z32%(F5
M9T@,YM\B0YDV#M\N>-U '9T5Q ^*FD(M\;K3M4MC9033NLL4>6\I8V=5VN?F
MVS1MS@8;KD$5%)\7M MX[G[9;7UI-;S+ 8;GR8R[EY4(#&38,-!("68=.,YH
M [RBN(7XKZ"Q:7R+\6*J";\Q)Y63:_:@N-V_/EY_AZ@CTRFG?$^SO=:CTVYT
MJ]LI;B[6VM_.:,$YACEW/E@%.)0 JEF.,@=0 #N**PM:\7:?H&LZ;IU^D@?4
M94ABD5H\!W;:H*E@YR<<JI [XI-9\86&B:Q!IEW#<O<W*QM (E4B4O,L6%RP
MY4NI;L%.>>E &]17"R_%.QDM8I-+TF^O'FN+5(HV,<1EAGE,23H2V"I92 #@
MYQG:#N&MX3\>:+XRENX]&D9FM0K-N9#N1BP5AM8XSM/RMAAQD#(R =)17GVF
M_$Z75CY%CIEC+>S7[V5M:KJ>6!3S2S3_ +O]T-L)90-Y;-10_%I)_$6CZ7'H
M_.I)'O!NQYL;F>6%PJ!<.J-"Q+;A\O.* /1J*Y7Q9XT?PO>" :1->*=,O-0,
MPF1%'V= Q0YR>=P&<<;EP#\VW-N/B]X?L((VU2&ZLIC*\4L$QB5HMJQL6.7P
MPQ,A 7+')^7@X .\HHHH \TUGP5<ZCXRU::+5;&X>ZNK:^.@W$RB.Z@CA2(^
M</+9P"Z\'YDX&03TM?"SPQ;:!#J4KZAIVH7UY(DZRV-R90EJR*(U_P!T,D@4
M]P.O4!;;P3X@M_B;<>+CJ5C(MS.(7M&C?=':*C*H63^\258KMQD?>XYO> O"
M%_X6S_:$UM)G2[&S_<,Q^>'S=YY4<'S%QWX/ H&<L/A%J@UT70OK,6O]H;?+
M!;=_9WG>?Y/W?O;^/3'>HG^&1TJ2]O-8?08[.\O()KJYN)"A"KJ#S&,DIAM\
M<B+R1\T:KR,$>P5R'Q"\(7_C6PL]+M[VVM+$2M+=&>%I2Y"D(H0%<C+%L[A@
MJO6@1Y\OPQOY6BL1KNCC7(WB$X2Z8RR0QV,4;PL-H;:S;"1_<=3UP*T/^%3Z
MU_:ES>%-&-K-(CQZ29I/L\"@7 \M2(_NJ9ED7"CY@>%X-;OA7P1X@TWQA#KF
MNW5C.X@>.8P2.6=C!:Q!N5'4V[D_[P_#T.@9R5UHDEC\&9- O;RSMYHM!-A)
M<S2[($<0>7N+$9"9YSCIVKF8O ]UJ\^EZCI'B"SU:TAB@1=0:=6>+RGD,B1&
M) A63>$;H<)SN-=QXST6X\1^"M5T>R>*.XO+9HHVF)" GU(!./P-<6_P^\17
MFJ6]]=W%C'.MA/:RW N6>4R.LJI.-D,:%XU=57Y =K.,\#(!)J'POO+WP!H/
MA6VNK&RM[:,/J3&-YUFF$6W*KE<@N6;)*X(4XI^B>$=9T[Q%I5]XAU'36NCJ
M F8),VZX*Z:;<[0RC+$J7([*">V*HR?#75QJ&F7J+8V<-A;1QFTL)@ C(S,S
M)F LWF[OF ,9/0L_&*?@OX9ZC;?\(YK=W8:; UK]DE-A+O#(!;LDDAW1_+,6
M9&*XQNA7YA@$ 'L59WB'3Y=7\,:IIMNR)+>6<L",Y(4,Z%03CMDUHUD>*=%_
MX2'P_)II6)DEG@:1)ONO&DR.ZG@YRJD8]Z!&/X=\*7ND^)I=0G6S1"MT'G@=
MC->>=,LD?F@J,>4JE%^9N#QM'RGE=:^&&IW/B?4K@:Q9II^IPW5M#:3,P8LY
M^TQXX^\+@RN<9^1  #D@37'PPU62&[MT?3=D@N5@G9W#PPO'-'':@!/]4/,1
MSSP5(VG (CU?X72+)$FG2Z38)<OJ,;1Y,8G\Y)1;H %YV(Y&.P#8S0,M6GPL
M>#5+^\:VTI)&NH9K2>/(D4"\:>0GY!M8HPCX)R$&2 <"C)\,;BS:"TM#HJJ=
M"6U,#R&/R;H!5>_0!#EUP@#?*QS]Y>\FK?"?4KG7-4ETF\@T^QN%Q8):R+";
M#,9#;5\EB [N2P1TSW)XVPV7@B\AN8EMCI\YN!#>69>[CE@@\IY?,V(ENJNI
M%PI"A%Y).]2%- &MHW@2]M_$MGK .EW</]HRWZWJRL9DAD6?;#'\F"A,ROG<
M!DMP>#5G6_!NM:AXWEUNV&F+%&(C -YB>;9+;2;92L1/_+&0!BS8#* HY)L6
MUG?+\.;[0]62WTJ6YBDLK$W%RNUC/'E(QCIL:3R@.2?+R.HK%/@-+?4[Z'P_
M_P (^'D\Q#9/M/[H_8R59=C ;2DC#*L TJ'!W&@".W^&LDFM0G7(=#E>[E:[
MN80Y9I"K71( * NH^U0?,<8V 8Z5%'X"GMY].LO$5[HLLT^P3-<3%I=4V36\
MKJR,HW"-(75?O</SMYR_3?A7J5C=Z7>.VFS2VH07<;._^F*D%LBQN^P$JKPN
MXR",[>,,V/3+S3K2\DBGGM8);FW#_9YI(PS0EA@E6(RN1P<=10!Y%9^"EFT6
MV32+G3K_ .V75M;SWVEN9@\7V7[/<QR,JX"A-SJ2W+,. <;NQ\<^&/[1U"#6
M?^)6D-K:M'=/?R>6K1K/#-L9]I_=LL<B-G@"0\,"0>?U'X;ZJ^CV>GOJEG-<
MMID-A#=74@22VDC27?'"%C&Y) VULX;:A)W8&.OUWPM+?>&;'0=(%A9V,<L?
MVB.6$O&8D^8((U*[@SJ@(W#Y=W7." 9QT.X?P6VAZ7J&FP:Y;7+WMI$DNZ*U
M83B98P  WEJDB)]T?*PP "!7.6O@"WO%NK'2+G1-2BT_$)#7/F23E9X72*Y
M1MFQ8'B!^8X8\#Y@VWX0\+WWAC6)+G7=6L)_LMK*K.LA5_)V6T<<CAON_+:L
M6))&>YY-5KOP)KU_H\EA+/8R1IJDU_;M)<,5,;O*_DX6)2JOY@1\M)\I? /
MH V/"'@VYT/3-6M-6F6^_M!FW[W5TFR&!9D$28+!OFR7)P/F.*Y;4? $UII2
M6<]YHML8=)*/<S3F-D1+-H)(\;?]1YDBREB?O'E<X(JZ_P##O4[7P]Y\ALX/
ML6G26Y%E.%>[G*;?..Z LTDQVJRAP3A1O;.!T'A7P-'#>VU_<V6BRVKVUU:3
MVMN?-C@5C$/+3*?,NZ.7<IQ@R-UYH T?&/AJY\2>&].L_"ITN&VC"O!*54"%
M0H\MH2$<* /[H4XQAEKFM5^'5Y#=J;<0AM2O3'<&UB8[XI9;KSC(P48_<3J
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M?8/+\W[7&BYW[L8VLW]PYSCM784 >3_M&_\ )+XO^PC%_P"@O7K%>3_M&_\
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M%@8F-Q*X3"R(  S$ !9I !C W=.!C0D\/Z;+J4U^T#BZG:!I9$F==_DL6CR
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MR>7=I,V5VE2"JD?4^E5?"_P[U'0_%-Q?W-S$UL9)_LRPS*/*A8;8X"IAW%%
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M_P!!>O6*!!7E^N_\G+>&/^P3/_[5KU"O+]=_Y.6\,?\ 8)G_ /:M 'J%%%%
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M_(U '045S_\ PCFJ?]#GKG_?FQ_^1J/^$<U3_H<]<_[\V/\ \C4 =!17/_\
M".:I_P!#GKG_ 'YL?_D:C_A'-4_Z'/7/^_-C_P#(U '045S_ /PCFJ?]#GKG
M_?FQ_P#D:C_A'-4_Z'/7/^_-C_\ (U '045S_P#PCFJ?]#GKG_?FQ_\ D:C_
M (1S5/\ H<]<_P"_-C_\C4 =!17/_P#".:I_T.>N?]^;'_Y&H_X1S5/^ASUS
M_OS8_P#R-0!T%%<__P (YJG_ $.>N?\ ?FQ_^1J/^$<U3_H<]<_[\V/_ ,C4
M =!17/\ _".:I_T.>N?]^;'_ .1J/^$<U3_H<]<_[\V/_P C4 =!16?I>FW6
MG^;]KUJ^U3S,;?M:0+Y>,YQY4:=<\YST&,<YT* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#P#]EW_F:?\ MT_]K5[_ %Y!\!O WB+P7_;W_"2Z=]B^
MU_9_(_?QR;]GF[ON,<8W+U]:]?H&>3_M&_\ )+XO^PC%_P"@O7K%>3_M&_\
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M ;=[-O*,9LEW2O)Y;%I!*TGR$MDJ/DSC.U:ZCXT6R:]U"[OW9+Z"%+2UL/\
M7P^2"Q#-;!E)9OF9U1<H5RF<BE<2^-M+DCFLY-6NA<W=Z;EYE9OL\?VB)(RB
MB)P/D3('EMP[L!C)&GX8U+Q,_B2Q?Q--J3G[+,MS#%I\BVBN6MUB=#Y2DE@7
M8AB2GS@A0#0!Z-1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110!&8(3<+<&)#,J%%D*C<%)!(!ZX)4''L/2I*** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y/\ M&_\DOB_
M[",7_H+UZQ7D_P"T;_R2^+_L(Q?^@O7K% !7E^N_\G+>&/\ L$S_ /M6O4*\
MOUW_ ).6\,?]@F?_ -JT >H4444 %%%% &=J^@Z;KT*1:K;F9$)P!(R9###*
M2I&58<%3D$=0:JOX4TYIO-#7)9[B&>8RW,DQD\IS)&N78[5#G=A<#CWK;HH
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M8G#7$2N)I#D#[VY<'J0O(&!79T4 >3_M&_\ )+XO^PC%_P"@O7K%>3_M&_\
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MQ(FC.0V!N'.0P7,M/BG:&""XU72;RPMYM/2],N])1'NCGDVL%.>4MV((!SD
M[3Q61IWBW0_#5I::SJ^DFQFU"U^T6LHU1KJ2=)#&&$DDY3#@1Q?>)X7 /&"7
MNK^ K#0EO9M(NYM'9OLT%RTP,<NV*<E$#RAL*DDZX( YVKDA10!K:K\5+"T\
M,1:UI]M%<1M=2VTD<U[&FQXX7E*AX_,1V8( H!P2P&16C=?$'3[1;AY+&\\J
M$3LDS/!&DXAE$4I4O*N-KL!\VW/5=U<KKWB/PPVAW=IJ.A:Y=VFF&:02W-^Q
M5SF6WPTGG-)L=EDCP0>#RN*?=ZAX)EO[:/5]'U*RU"\NS&MO)=E&MY':%V*!
M)L)O:XB9A%RV26'RM@ V+[XIV4-M>2Z=HVHZ@+>V-RLB&)(W01Q2%LE]P $\
M6?ES\QP&VG%WQ'X_@T"/4/+TJ]O6LRT6^,QK&\RP>>8]Q;<,1_,6VD<$ EOE
M/.ZW!X9A^&L'B :"(+*2#S!:7FJ/:221-&BJ@,3.'+K!#B,G!PN<$&NA@T?2
M/$FMZ\-4TDI);W/V>0"\D*3[[9!YNP$*KF.39N +;1C=CB@"75?%MYI=_)')
MI436]G8PWM\YN\21+([J0BA"'*^6QY9<]JR&^,.B6UE%/J%G=VX:%)2V^'8<
MPK,RJ6=2Y577("Y)8  GBG^*9[:#QDGVO15O+B2"%;=TU.5$?_2(TC6XB"[
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MC<R10VVDZI+<SVJWT%NJ1;YK5@2)QF3 7C&TD/D@;>16ROAK34GMYU^V">W
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MG+;5&&RW%);_ !7T6ZC,MO9:A) SK#%,BQ%)KAD#"!").7P<9^YG^+I6A%X
MT@WE]<7WVB[:YG66/?=3 P;8XD!4[_\ 69A!\P8?WJY+X-T.XA:.XM))@TOG
M%Y;F5W,GE>4'WEMV0G .>.O7F@# /Q8TJW:2'4K"\MKM%N7-L&B=PL+3C'WQ
MDD6TA^7*@X!;E2=33_&@O_$G]D_V/>6SQP323O.\687C,?R$*[9RLJ-D''S+
M_M;9H_ OA^**6-+6?;/%)%.#>SGSU=G9A)E_G^:60@MD@L<8J^OA[3$U9]32
MW*WCF0O(LKC=O6-6R,X((BCXQQMR,'- '*6_Q>T*XF@@%I?)=7/E""U9H/-D
M>0(8T"B4X)65&W'"@$@L""!*GQ/LI+M+=-(O_,E 6.)WAC?S/,F0QMN<(&S
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M7//2NAH ***Q-;UV[L-6T[2M*L8;R^ODFE47-R8(T2+9N)8(YSF10!M]>>*
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MK!Y$+R& PN3M1I9&5-I4;0J&,#!/<8  )V*** "BBB@ HHHH **** "BBB@
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M==H,1,0%?K]TDC!Z'(J6/7-)EMKFXBU2R>"T)%Q*MPA6''7><X7\:X>/X4-
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M1F199Y&9EDE9VW?:&X+Y##<#V%%/A/"MND;ZHTI^W2WDJE)8T?S4C5UQ%*A
MS'E>2 #C!QF@#J+_ ,9^'-+U*2PU+6;2UN8FC61)9-HC+JS+N)X7(1CR?3^\
M,Z,6JZ?<7DMI!?6TMS"@>6%)E+HI&02H.0"".3ZUB:GX1_M'Q5%J[7BK$@B+
M6[0;BS1I<(#NW<#%P3C!Y4<\UG^$OATOA:Y,G]HM>XMF@C:42[T+B/>0#*8P
MI,8. @/"_,<<@&];^+?#EYO^R>(-+G\N-I7\J]C;:@ZL<'@#N>E%[XL\/Z?9
MO=7>LV,<4=N+HD3JQ,). X ))4D@ CJ2 *Y6Y^%4=SHL5@=7=#%)#()4A*D^
M5:+;A<JX."5#G!'4C/\ %35^$\"B\VZCC[59R0<_:'$4CQLAD4/.01\Q)#!F
MR3AAV .N@\4Z#<3"&+6++SF$C+$TZJY5&978*3DJ"C\XQ\I/2I(O$6B3:7)J
M4.L6$EA$VR2Z2Z0Q(W'!?. >1QGN*X^[^&;2Z?>++J;RO<+*76"V"EBXO,A0
MSX'_ !^'&3CY!GKQ9T;PSK-SIES<ZI+#9:G)K)U*'-LI1<1K$ \:RL#E03Q(
M>2#G(Q0!U,6O:1.TRP:K8R-!")Y0EPA,<1&X.V#PI'.3QBJY\7>&UV;O$&E#
MS(VE3-['\R#=EA\W(&QLGI\I]#6;HG@V30=&UFULM49;O4V:47:P &"1HPNY
M5SC 8%@N> <=LUDQ_#58=$OK:\O3?_:GCEE2.$@R[+F:X9 9)"<OYQ3+-[DG
M- '976M:796[3WNI6=O"DODM)+.J*LG7823][VZU2D\8>'H]<31VUBU;4&WY
MMTDW,FT9;?CA. ?O8Z&N=3P+J5W\+[3P]-JQLKR=))-3E,9D$\DRN95.UT)&
M^3.0<': 002*S=:^&-Y?:U8C[<)K MJ$;[+94>WCNEF9V9RYWD/( H"=#SW)
M .^M_$&C7<*36NK6,\4GW'CN496^94X(//S.J_5@.XJLGC#PS(ZHGB+269E9
MU47T9)5<[C][H-K9]-I]*P+GP!>WFJ+J4^M6_P!IENA/=^78$)(%:U8*@\TE
M#_H:#)+?>;CH!%>?#!+KPK/HRZKY?G6-G:><+;[OV=G;=C=_%O(QGCWS0!T\
M/BSP[<QR26^OZ7*D4?F2-'>1L$3.-Q(/ R0,^IJ*[\9^&;#S/M6OZ=&T80R+
M]J0L@<J%8@'(!WISTPP/2L+5/ANNH3S2Q:H;8R3^>BI"0$8&T(Y5U;K:#E2I
M^?@@C)CG^&8;2[6UM-2CMFM+^&^AQ;,R*8K>.)4P9-Q7,:MRV<<9S\U '2:C
MXMT'2+V6TU/5;:VGBCCDD21L%$D?RU8^@W$ GH,@G (J6;Q-H5ON^T:UIT6V
M%;AM]VBXB8@*YR?NG(P>AR*H:MX6?4]>74%OEB0K:>9$8-Q8V]QYRD-N& =S
M*1@]0>Q!YNV^$L5N]N'U031P-:R*&BE&'A6%#A1-Y>&6 #E"1G[QP!0!V+>*
M- 2%YGUS35BCD$3N;N,*KG)"DYX/!XZ\&IM*UO3M;6Z;2KI+I;.Y:UG9 <+*
MH!9<GKC<.1D5QMA\,)-*N3=6&KQ_:5B>VCENH);C]PQ8E65YRI8%L@J$'+94
MAL#I?"_AP^%])ATRVN_/M(FF?]Y&?,)>3>OS;L< D'CYC@\8P0#<HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#R?\ :-_Y)?%_V$8O_07KUBO)_P!HW_DE
M\7_81B_]!>O6* "O+]=_Y.6\,?\ 8)G_ /:M>H5Y?KO_ "<MX8_[!,__ +5H
M ]0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \G_:-_Y)?%_V$8O_ $%Z]8KR
M?]HW_DE\7_81B_\ 07KUB@ KR_7?^3EO#'_8)G_]JUZA7E^N_P#)RWAC_L$S
M_P#M6@#U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R?]HW_ ))?%_V$8O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \G_
M &C?^27Q?]A&+_T%Z]8KR?\ :-_Y)?%_V$8O_07KUB@ KR_7?^3EO#'_ &"9
M_P#VK7J%>7Z[_P G+>&/^P3/_P"U: /4**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /)_VC?^27Q?]A&+_P!!>O6*\G_:-_Y)?%_V$8O_ $%Z]8H *\OUW_DY
M;PQ_V"9__:M>H5Y?KO\ R<MX8_[!,_\ [5H ]0HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \G_:-_P"27Q?]A&+_ -!>O6*\G_:-_P"27Q?]A&+_ -!>O6*
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M]'M?%$EY:RVZ06ZBY@'D1,LL21@! P_X^RH#Y;=L!YX.MX7^'R>&]2>[-_\
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M44 %%%% !1110 4444 %%%% !1110!Y/^T;_ ,DOB_[",7_H+UZQ7D_[1O\
MR2^+_L(Q?^@O7K% !7E^N_\ )RWAC_L$S_\ M6O4*\OUW_DY;PQ_V"9__:M
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M "BBN?\ %,U]]JT&RT_49].^WZBT,TUND;/L%M/)@>8C*/FC7G% '045S_\
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M0"97!4 #&  , T 6;WPYIEAJZZ;<^._B L[:A'8#&K C<\:NLGW?]7EU3/\
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MAD@_[\R__$T?\+E^'_\ T,D'_?F7_P")H [BBN'_ .%R_#__ *&2#_OS+_\
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M^%GA.&XBTGQ!;HEP^XC['L( S@;DB4MC)Y<L?>MS_A<OP_\ ^AD@_P"_,O\
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M0P))8#^]GTX]>*]QH *:Z)+&R2*KHPPRL,@CZ4ZB@#'_ .$1\-GKX>TK_P
MH_\ XFC_ (1#PW_T+VE?^ 4?_P 36Q10!C_\(AX;_P"A>TK_ , H_P#XFC_A
M$/#?_0O:5_X!1_\ Q-;%% &/_P (AX;_ .A>TK_P"C_^)H_X1#PW_P!"]I7_
M (!1_P#Q-;%% &/_ ,(AX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q1
M0!C_ /"(>&_^A>TK_P  H_\ XFC_ (1#PW_T+VE?^ 4?_P 36Q10!C_\(AX;
M_P"A>TK_ , H_P#XFC_A$/#?_0O:5_X!1_\ Q-;%% &/_P (AX;_ .A>TK_P
M"C_^)H_X1#PW_P!"]I7_ (!1_P#Q-;%% &/_ ,(AX;_Z%[2O_ */_P")H_X1
M#PW_ -"]I7_@%'_\36Q10!C_ /"(>&_^A>TK_P  H_\ XFC_ (1#PW_T+VE?
M^ 4?_P 36Q10!C_\(AX;_P"A>TK_ , H_P#XFC_A$/#?_0O:5_X!1_\ Q-;%
M% &/_P (AX;_ .A>TK_P"C_^)H_X1#PW_P!"]I7_ (!1_P#Q-;%% &/_ ,(A
MX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q10!C_ /"(>&_^A>TK_P
MH_\ XFC_ (1#PW_T+VE?^ 4?_P 36Q10!C_\(AX;_P"A>TK_ , H_P#XFC_A
M$/#?_0O:5_X!1_\ Q-;%% &/_P (AX;_ .A>TK_P"C_^)H_X1#PW_P!"]I7_
M (!1_P#Q-;%% &/_ ,(AX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q1
M0!C_ /"(>&_^A>TK_P  H_\ XFC_ (1#PW_T+VE?^ 4?_P 36Q10!C_\(AX;
M_P"A>TK_ , H_P#XFC_A$/#?_0O:5_X!1_\ Q-;%% &/_P (AX;_ .A>TK_P
M"C_^)H_X1#PW_P!"]I7_ (!1_P#Q-;%% &/_ ,(AX;_Z%[2O_ */_P")H_X1
M#PW_ -"]I7_@%'_\36Q10!C_ /"(>&_^A>TK_P  H_\ XFC_ (1#PW_T+VE?
M^ 4?_P 36Q10!C_\(AX;_P"A>TK_ , H_P#XFC_A$/#?_0O:5_X!1_\ Q-;%
M% &/_P (AX;_ .A>TK_P"C_^)H_X1#PW_P!"]I7_ (!1_P#Q-;%% &/_ ,(A
MX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q10!C_ /"(>&_^A>TK_P
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MX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q10!C_ /"(>&_^A>TK_P
MH_\ XFC_ (1#PW_T+VE?^ 4?_P 36Q10!C_\(AX;_P"A>TK_ , H_P#XFC_A
M$/#?_0O:5_X!1_\ Q-;%% &/_P (AX;_ .A>TK_P"C_^)H_X1#PW_P!"]I7_
M (!1_P#Q-;%% &/_ ,(AX;_Z%[2O_ */_P")H_X1#PW_ -"]I7_@%'_\36Q1
M0!4L=*T_2U9=,L+:S5SEA;PK&&^N *MT44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
